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ABSTRACT 
Availability of glucose precursors and a proper interorgan coordination during the metabolic 
cascade of adaptations occurring during periods of lower DMI, are the vital importance to 
achieve a successful transition from late gestation to lactation. The aim of the study was to 
determine metabolic responses to a short-term period of negative energy balance induced by feed 
restriction (FR) and the effect of abomasal supplementation of different amino acids (AA) or 
glucose. Seven multiparous Holstein cows (93 ± 15 DIM) were randomly assigned to 7 
treatments in a 7 × 4 incomplete Latin square design. In 6 treatments, daily DMI was restricted to 
provide 60% of energy requirements during 5 d; the 7th treatment consisted of ad libitum (AL) 
intake. Feed was provided once daily at 0900 h. Effects of FR (AL vs RC), day, time within day, 
and interactions were evaluated with ANOVA using the MIXED procedure of SAS. Evaluating 
the effect of FR, milk yield (P < 0.01), milk protein concentration (P = 0.03) and yield (P < 
0.01), and lactose yield (P < 0.01) were lower for RC, whereas milk fat (P < 0.01) and urea N 
concentrations were higher (P < 0.01). Treatment RC induced lower plasma insulin (P = 0.01) 
and glucose (P = 0.04) concentrations, with quadratic (P < 0.01 for both) decreasing trends 
reaching nadir on d 3. Concentration of NEFA was higher (P < 0.01) and increased quadratically 
(P < 0.01) with its maximum on d 3 during FR. Serum BHBA increased linearly (P = 0.04) for 
RC (RC x d; P = 0.16) with its peak at d 4. Catabolism of amino acids (AA) increased early 
during FR as indicated by plasma urea N increasing (P < 0.01) quadratically (P < 0.01), with its 
peak on d 2 and decreasing afterward. Accounting for all the amino-N circulating in form of urea 
or eliminated in milk as MUN, the decrease in concentration of all the AA in circulation 
analyzed here was not sufficient for the amount of urea synthetized. Therefore, it seems probable 
that body tissue protein was rapidly mobilized, to produce the energy required to support the 
higher ECM especially through milk fat and lactose. Plasma 3-methylhistidine increased linearly 
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(P < 0.01) denoting protein tissue mobilization of contractile fibers. A group of AA (Glu, Val, 
Leu, Tyr, Phe, Ser, His, Thr, Asn, Ala, Pro, Met) decreased in a quadratic manner with the nadir 
at d 2 and 3, while Asp, Trp and Ile decreased linearly. Concentrations of other AA increased 
(Gln, Gly, Cys) or did not vary (Lys, Arg) during FR. Plasma AA concentrations decreased after 
feed delivery in both diets, coinciding with the increase of insulin, except for Glu that increased 
in all treatments and Gln that increased after feeding only during FR. Metabolic adaptations to 
low insulin during FR seemed to select catabolism of AA as the first energy source before later 
relying more on fatty acids. Based on responses of plasma AA and insulin to feeding, protein 
synthesis in tissues likely remained sensitive to insulin within day.  
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INTRODUCTION 
Negative energy and protein balance characteristic of the transition period triggers a 
metabolic cascade of reactions that have the purpose of counteracting this imbalance. The 
hormonal reaction stimulated by the drop in dry matter intake across the transition period will 
induce mobilization of tissue. Adipose tissue will be mobilized and fatty acids oxidized by the 
liver in order to provide ketone bodies for peripheral uptake. However, excess of ketone bodies 
concentrations can lead to undesirables metabolic complications. In addition, tissue protein is 
degraded for amino acid (AA) supply for protein and glucose synthesis, or for ATP synthesis 
after complete oxidation. In fact, skeletal muscle and other peripheral tissue play an important 
role in the supply of AA and their recycling from the liver. Since most AA are received by the 
liver from arterial supply, AA that are not only used by the overloaded liver are important 
sources of energy in other organs. Even though AA are not large suppliers of glucose in most 
normal situations, they still are part of a considerable quantitative contribution to 
gluconeogenesis in critical situations such as the transition period. Cows show less severe 
reactions to a NEB during a more advanced phase of lactation than do early postpartum cows, 
however feed restriction models applied in mid-lactation cows have been validated as a model to 
mimic the metabolic adaptations to a lower DMI phase such as the one that characterizes the 
transition period. The objective of the work presented in this thesis is to understand the most 
demanded fates that AA have in a situation of nutrient deficiency. For that matter, the relation 
and synchrony of protein catabolism with other metabolic adaptations such as lipid mobilization, 
are the vital importance to evaluate the role that AA have on this adaptations. In addition, the 
identification of the AA with the largest decreases in concentration will point out also possible 
candidates for supplementation in situations of NEB such as the transition period.     
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CHAPTER 1 LITERATURE REVIEW 
Introduction 
 The effects on milk production and metabolism during negative energy balance (NEB), 
such as occurs during the transition period, have been studied successfully over the last decades 
using mid-lactation cows in a feed-restriction condition (Akbar et al., 2013; Gross et al., 2011; 
Velez & Donkin, 2005). Feed-restriction models may not be able to simulate the natural decrease 
of dry matter intake (DMI) around calving, but they have been suitable to increase knowledge 
about the metabolic adaptations to nutrient deficiency at a molecular level (Bradford & Allen, 
2005), without the collateral effects of the substantial hormonal regulation that occurs during the 
transition period (Akbar et al., 2013). One of the purposes of this experiment was to supply data 
for a better understanding of energy and protein metabolism by using this model. 
 Restricted DMI leads to an ordered cascade of metabolic changes in metabolism of long-
chain fatty acids and glucose. Under this condition, the evidence indicates that there is an excess 
of lipogenic compounds and long-chain fatty acids, in detriment to amino acids (AA) and 
glucogenic compounds (Drackley, 1999). This excessive lipid mobilization from adipose tissue 
that occurs during feed restriction or around calving is strongly related to the increased 
probabilities of metabolic disorders and infectious diseases such as ketosis, displacement of 
abomasum, mastitis, and retained placenta among others (Cameron et al., 1998; Drackley et al., 
2005; Goff & Horst, 1997). The enormous potential to jeopardize milk production, welfare, and, 
consequently, economic performance of cows, makes management of this imbalance among 
energy sources a major key to a successful transition. 
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Changes during Feed Restriction 
 Even though cows show less severe reactions to a NEB during a more advanced phase of 
lactation than do early postpartum cows (Carlson et al., 2006; Gross & Bruckmaier, 2015), feed 
restriction models applied in mid-lactation cows have been validated as a model to mimic the 
metabolic adaptations to a lower DMI phase such as the one that characterizes the transition 
period (Drackley et al., 2001; Grummer, 1993). Restricted feed models typically offer between 
50 and 60% of calculated energy requirements (NRC, 2001).  In the majority of studies, such 
restrictions  caused an increase in fat mobilization measured as nonesterified fatty acids (NEFA; 
Ferraretto et al., 2014; Gross et al., 2013; Veenhuizen et al., 1991), a concomitant decrease in 
milk production from 30% to a 90 % among studies (with this big variation probably due to 
differences in DMI), decreased body weight (BW), and decreased body condition score (BCS) in 
comparison with full-fed control treatments (Ferraretto et al., 2014; Gross et al., 2011). However, 
other important indicators of NEB have shown a variety of responses. While Moyes et al. (2009) 
and Ferraretto et al. (2014) observed a significant decrease in glucose and insulin during feed 
restriction, other authors reported no effect on glucose (Gross et al., 2011; Gross & Bruckmaier, 
2015; Laeger et al., 2012). When measured, other indicators of a high degree of fat mobilization 
such as β-hydroxybutyrate (BHB) and liver triglyceride (TG) content did not show a common 
response during short periods of restriction among studies (Gross et al., 2013). Researchers have 
observed a lag between the mobilization of adipose tissue TG and a substantial increase in 
plasma BHB (Doepel et al., 2002; Gross et al., 2011; Nielsen et al., 2003). Evidently, the 
infiltration of TG in the liver begins after increased concentration of NEFA in plasma (Vazquez-
Añon et al., 1994). However, Kuhla et al. (2009) found an increase of 274% (DM basis) in total 
liver fat concentration after 60 h of almost total restriction (wheat straw was fed to provide 16% 
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of the energy in the control group) in comparison with the group fed for ad libitum DMI. Moyes 
et al. (2009) also found higher circulating concentrations of serum TG, cholesterol, and BHB 
during 5 d of feed restriction. Presumably, the length and severity of the restriction period, the 
demands of milk production, feeding frequency (restricted but daily), and blood sampling timing 
are causes for this wide variation of effects among studies with feed restriction. 
Hepatic Metabolism of Lipids 
The main organ responsible for coordinating such vital tasks is the liver, which is the 
central regulator of the metabolic adaptations to counteract the abrupt changes of the mixed fuels 
that power metabolism, and is also the first organ to receive and suffer its consequences 
(Drackley, 1999; Drackley et al., 2001; Grummer, 1993). It is well stablished that the liver 
increases its metabolic functions rapidly around calving (Drackley et al., 2001), due to an 
increased blood flow and an increased oxygen utilization rate (Reynolds, 2000). 
Increased blood concentrations of NEFA derived from mobilization of adipose TG 
reserves causes an increased uptake of NEFA by the liver (Drackley, 1999) and a consequent 
lipid accumulation in the form of TG after the acute rise of plasma NEFA (Vazquez-Añon et al., 
1994). When the pace of the esterification of fatty acids in the liver exceeds the oxidation of TG 
fatty acids and TG export in the form of very low density lipoproteins (VLDL), the syndrome of 
hepatic lipidosis, commonly called “fatty liver”, may occur (Drackley, 1999; Grummer, 1993). 
The bovine liver does not carry out a significant export of TG as VLDL per se; thus, the 
possibility to develop a fatty liver represents a risk for the lipid recycling metabolism during 
NEB and therefore for the wellbeing of the cow (Katoh, 2002). 
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Hepatic lipidosis can impair liver function due to different factors and in different ways. 
The increased accumulation of TG in the liver can indirectly restrain glucose synthesis due to 
increased concentrations of ammonia derived from a low rate of urea synthesis, thereby 
inhibiting the glucogenic capacity of hepatocytes (Overton et al., 1999). Decreased hormonal 
metabolism and endotoxin detoxification can result from TG infiltration in hepatocytes (Bobe et 
al., 2004). Fatty liver also has negative consequences on the production and physiological 
functions of the lipoproteins responsible to export lipids from the liver and return the residual 
lipid from peripheral tissues to the liver (Bobe et al., 2004; Katoh, 2002), and also may decrease 
energy precursors such as citrate and glycogen (Bobe et al., 2004; Doepel et al., 2002) 
 A different pathway for the metabolism of NEFA in the liver other than esterification or 
export is β-oxidation in the mitochondria and peroxisomes (Katoh, 2002). This route is not the 
primary one but is activated under feed restriction conditions or NEB (Dann & Drackley, 2005; 
Drackley, 1999). The acetyl-coenzyme A (Acetyl-CoA) derived from mitochondrial β-oxidation 
can be oxidized further if it is bonded with oxaloacetic acid to enter into the TCA cycle (Katoh, 
2002). However, the intense activity of gluconeogenesis in the liver and the shortage of glucose 
precursors (Grummer, 1993) characteristic in a feed restriction or NEB condition results in a 
direct production of ketone bodies, mainly acetoacetate and BHB (Goff & Horst, 1997; Katoh, 
2002; White, 2015). These ketone bodies in the blood are used as an energy source for organs 
such as heart, liver, and mammary gland (MG) (Gropper et al., 2009). However, among other 
effects BHB acts as a central anorexigenic signal inhibiting feed intake (Laeger et al., 2012). An 
excess concentration of ketone bodies therefore will have negative effects on cow health and 
production (Goff & Horst, 1997; Li et al., 2016; Piantoni et al., 2015; White, 2015). 
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Glucose Metabolism  
The delicate and risky balance between NEFA mobilization and utilization makes it even 
more crucial to meet the basic requirements for glucose when supply of nutrients is insufficient 
when DMI does not support all requirements for pregnancy and subsequent lactation. Glucose is 
an essential nutrient that needs to be always maintained within a narrow concentration range in 
the blood, to be available for tissues like brain, kidney medulla, erythrocytes, and MG 
(Aschenbach et al., 2010). Overton (1998) estimated an increase in the metabolic glucose 
demand from 1000-1100 g/d to 2500 g/d from the fortnight before parturition until the fortnight 
after. Along the same line, Bell (1995) estimated that the requirements for glucose, AA, and fatty 
acids increase around 2.7, 2.0, and 4.5 times, respectively, in comparison with the requirements 
during the last phase of gestation. 
Since ruminants ferment the majority of carbohydrates ingested from the feed into 
volatile fatty acids (VFA; also called short-chain fatty acids) in the rumen, the liver has the vital 
function to regulate the processes to achieve the required glucose concentration in the blood. The 
two main processes are glycogenolysis and gluconeogenesis. Glycogenolysis consists of the 
release of glucose that is stored in the liver as glycogen, however this is a limited resource and is 
depleted quickly in cows with high adipose TG mobilization (Veenhuizen et al., 1991). 
Therefore, the synthesis de novo of glucose (gluconeogenesis) is the more important mechanism 
to provide the necessary amounts of glucose to maintain optimal concentration in circulation (De 
Koster & Opsomer, 2013). 
 Of the total glucose available to the cow, <25% usually is provided from direct intestinal 
absorption from feed.  The portal-drained viscera (PDV; consisting of gastrointestinal tract, 
pancreas, spleen, mesenteric and omental fat) plays an important role in accounting for this low 
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percentage. Through metabolism of glucose by its tissues, the PDV decreases the glucose 
available after intestinal absorption through the enterocytes by ~30% before reaching the blood 
(Larsen & Kristensen, 2009b). Therefore, the majority of glucose must be synthesized in the liver 
(Galindo et al., 2011). The principal precursors of glucose are, in order of quantitative 
contribution, propionate (60 to 74%), lactate (16 to 26%), alanine (3 to 5%), valerate and 
isobutyrate (5 to 6%), glycerol (0.5 to 3%), and other AA (8 to 11%) (De Koster & Opsomer, 
2013; Galindo et al., 2015).  
Depending on feed intake, propionate is the first and main precursor for gluconeogenesis. 
Propionate is one of the VFA produced by carbohydrate fermentation in the rumen and is 
absorbed through the reticulorumen wall into the portal blood. Propionate absorption and uptake 
by the liver will drive gluconeogenesis (Aschenbach et al., 2010; Larsen & Kristensen, 2009b). 
Even more, it has been demonstrated that the ability of the liver to convert propionate to glucose 
is modulated according to propionate supply (Armentano et al., 1991). Other studies have 
demonstrated that liver cells are able to increase the rate of conversion to glucose during 
situations of low supply of propionate, such as the transition period (Drackley et al., 2001). 
However, in conditions of low production of propionate and high fatty acid oxidation (e.g., feed 
restriction, pre- and post- partum), there will be a change in the glucose precursors available, 
resulting in a greater use of lactate, glycerol, and AA (especially alanine) (Erfle et al., 1971; 
Hammon et al., 2009; Larsen & Kristensen, 2013; Reynolds et al., 2003). 
The adaptations toward alternative glucose precursors have been delineated recently at 
the gene expression level (Akbar et al., 2013; Loor et al., 2007; Velez & Donkin, 2005). 
Physiologically, ketogenesis can boost gluconeogenesis during the export of acetoacetate through 
the mitochondrial membrane. This transport is made by exchange for pyruvate, which is one of 
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the intermediates in the pathway of lactate and alanine (Ala) to enter the gluconeogenesis cycle 
(Zammit, 1990). The expected high infiltration and accumulation of fatty acids in the liver cells 
that occurs during adipose TG mobilization can increase blood ammonia concentrations due to 
the lower ureagenesis capacity in the liver (Zhu et al., 2000). In contrast, Overton (1998) found 
that the capacity to produce glucose from alanine did not decrease when blood ammonia is 
increased. The latter observation opens the possibility for a better energetic efficiency with 
substrates different than propionate during situations of lower feed intake. 
Regulation of Glucose Metabolism 
One of the primary hormones responsible for the regulation of gluconeogenesis and 
glucose use is insulin. Propionate is an insulin secretagogue, thus high concentrations will be 
expected in a normal feeding situation with high production of propionate (Doepel et al., 2002; 
Grummer, 1993). Insulin directs the gluconeogenesis pathways toward the use of propionate in 
detriment to other substrates. Insulin inhibits several key enzymes of gluconeogenesis from non-
propionate precursors and decreases the availability of other glucose precursors, but does not 
inhibit propionate conversion to glucose (De Koster & Opsomer, 2013; Smith et al., 2008). The 
lack of inhibitory effect of insulin on gluconeogenesis from propionate led some to think about a 
possible evolutionary adaptation to avoid the harmful effects of accumulation of propionate 
(Aschenbach et al., 2010).  
To coordinate usage of different fuels, liver in ruminants has the capacity to signal the 
specific substrate to be used for gluconeogenesis. In other species, lipogenesis and fatty acid 
oxidation in liver are regulated reciprocally by the lipogenic intermediate malonyl-CoA, which 
inhibits carnitine palmitoyltransferase (CPT-1), the enzyme responsible for controlling the uptake 
of long chain fatty acids into the mitochondria where β-oxidation occurs. Insulin increases 
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lipogenesis and so also malonyl-CoA, and thus inhibits concurrent fatty acid oxidation. Although 
ruminant liver has little lipogenic activity, concentrations of malonyl-CoA are regulated similarly 
by insulin (Brindle et al., 1985). According to Zammit (1990), methylmalonyl-CoA, an 
intermediate of propionate metabolism, also inhibits CPT-1 as does malonyl-CoA. Thus, with 
decreased propionate supply the β-oxidation of fatty acids would be increased. Because lactate 
and Ala do not produce methylmalonyl-CoA, ketogenesis is compatible and complimentary with 
gluconeogenesis from sources other than propionate (Drackley et al., 2001). 
With the same premises, this “symbiotic” relationship between insulin and propionate 
maintain a stable fatty acid balance among organs. For instance, insulin has a direct antilipolytic 
effect on adipose tissue (Weber et al., 2016), avoiding the release of NEFA in normal feeding 
conditions; on the other hand, propionate plays a strong anti-ketogenic role by inhibiting β-
oxidation (Armentano et al., 1991). The lower concentrations of insulin around calving 
(Reynolds et al., 2003) allow for an increased hepatic uptake of substrates other than propionate 
to produce glucose (Drackley et al., 2001). Therefore, these homeorhetic adaptations that occur 
during a period of NEB facilitate the supply of alternative glucose precursors when DMI is 
diminished for any reason.   
However, not all organs have the same insulin-response mechanism. The MG and 
placenta do not require insulin stimulation for glucose uptake, unlike adipose tissues and muscle. 
The cow undergoes a temporary insulin-resistant phase during the transition period, when the 
demand for glucose increases dramatically (Bell, 1995). In this period, utilization of glucose by 
peripheral insulin-dependent tissues is decreased, which drives glucose towards the organs with 
high demand such as MG and placenta. The non-sensitive condition of the MG, therefore, is 
coupled with a high priority for glucose utilization (Aschenbach et al., 2010). The result allows 
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the cow to support the growing fetus and the onset of lactation based on the endogenous 
production of glucose (Bell, 1995; De Koster & Opsomer, 2013). 
Inter-Organ Metabolism of Amino Acids  
Amino acids uptake by the liver can end up in two completely different sets of 
transformations: anabolic processes as part of export (albumin, hormones, and immune proteins) 
or constitutive proteins; or catabolic processes like gluconeogenesis and complete oxidation 
(Larsen et al., 2015). The storage of AA in animals is limited; once the requirements for synthesis 
of protein and other nitrogenous compounds are completed, excess AA will be deaminated. The 
N will end up incorporated in urea that is either excreted or recycled into the rumen (Doepel et 
al., 2009), and the AA carbons skeletons will be available to provide energy as reviewed earlier 
(Bender, 2012). Therefore, there is potential supply of energy from AA due to their capacity to 
support gluconeogenesis as alternatives to propionate, or to their ability to be completed oxidized 
during catabolic processes.  
Even though AA are not large suppliers of glucose in most normal situations, they still are 
part of a considerable quantitative contribution to gluconeogenesis in critical situations such as 
the transition period. Reilly and Ford (1971) showed in sheep that total glucose production was 
positively correlated with AA supply. Bergman (1978) defined that Ala and glutamine (Gln) 
together explain between 40 to 60% of the potential glucogenic supply of all AA in sheep. 
Overton (1998) found that the relative increase of capacity for bovine liver tissue to produce 
glucose at d 1 and 21 postpartum in comparison to d 21 prepartum was larger for Ala than for 
propionate (Drackley et al., 2001). In accordance, Reynolds et al. (2003) measured that, at d 11 
postpartum, the contribution of propionate to glucose production reached its nadir whereas Ala 
was at its maximal contribution. The same conclusion was reached by Larsen and Kristensen 
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(2009a), who found that Ala and Gln, together with glycine (Gly), were the non-essential AA 
(NEAA) with the greatest liver extraction in the early postpartum period. 
 The two main organs receiving increased nutrient supply around parturition are the 
developing fetus before calving and the MG after calving, which results from the decreased 
glucose oxidation in skeletal muscle and decreased uptake by adipose tissue thanks to the 
aforementioned temporal insulin-resistant phase during the transition period (De Koster & 
Opsomer, 2013). Consequently, AA are an important part of these requirements, but not only as 
the basic units to synthesize protein. Bell (1995) pointed out that between 30 to 40% of the 
substrate oxidized by the fetus is attributed to AA, but only ~30% of the AA-N uptake is 
deposited as tissue protein. This implies that the requirements of the fetus in terms of 
metabolizable protein are significantly greater than the actual requirement for growth. The 
remarkably high requirement for protein in the late gestation by the fetus (220 g/d) contrasts with 
the almost irrelevant requirement for fat deposition (12 g/d) (Bell et al., 1992). In the same way, 
bovine placenta also has a considerable catabolism of AA during late lactation (Reynolds et al., 
1986). Bell et al. (2000) estimated that the dry cow requires around 742 g/d of AA supply during 
late pregnancy. The significant catabolic fate of AA during the last phase of pregnancy is the 
result of the oncoming metabolic adaptations toward the new lactation. Steel and Leng (1973) 
observed an increasing endogenous production of glucose according to the stage of gestation and 
fetal number in feed-restricted sheep. More recently, Doepel (2002) found that the plasma 
concentration of 3-methylhistidine (3-MH), which is used as an indicator of muscle protein 
catabolism (Blum et al., 1985), was higher and increased earlier prepartum for cows fed a low 
crude protein (CP) diet in comparison with those fed a high CP diet. 
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 The onset of lactation imposes an even greater gap between the MG requirements and the 
supply of nutrients through the feed. The high demand for glucose is required to produce lactose, 
which is the main osmotic solute in the milk and so determines directly the amount of milk 
produced (Bell, 1995; Rigout et al., 2002). Between 50 to 85% of the whole-body consumption 
of glucose occurs in the MG (De Koster & Opsomer, 2013). Nonetheless, accounting for all the 
dietary precursors of hepatic gluconeogenesis, there is still a shortage of the estimated glucose 
required to supply the lactose for milk production. Muscle protein serves as the main AA pool 
from which cows pull AA to boost gluconeogenesis or protein synthesis during the transition 
period to close that gap (Bell, 1995; Ji, 2013; Larsen & Kristensen, 2013; Van der Drift et al., 
2012). The imbalance of required AA and supplied AA is even more substantial during the first 
and second week postpartum (Bauman & Elliot, 1983). Regardless of the amount of dietary CP 
during prepartum, Doepel (2002) determined that, according to the evaluation of the muscle 
mobilized, the greater demand for AA was in the first week postpartum. Reflecting the key role 
of AA mobilization from muscle, Brockman and Bergman (1975) determined that muscle protein 
supported the increasing rate of glucose production from Ala. Appuhamy et al. (2011) concluded 
that the increased milk protein production in early postpartum cows also was supported by 
muscle protein mobilization. Bell et al. (2000) estimated that in order to meet the requirements 
for glucose and AA for milk production during the 10 d postpartum, a high producing cow would 
need to mobilize around 1000 g of tissue protein per day. These results are in agreement with 
those of McNeill et al. (1997), who reported a greater loss of carcass protein in ewes fed a diet 
below their protein requirements during the last month of pregnancy. 
 Synthesis of lactose by MG cells is not only function of whole-body glucose availability, 
but also depends on the uptake and use by the MG itself. There is no strong positive relationship 
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between lactose yield and whole-body glucose rate of appearance (WB-Ra; represents sum of 
synthesis de novo, absorption of glucose, and glycogenolysis) in accordance with the extensive 
research about glucogenic precursors (Lemosquet et al., 2009). Galindo et al. (2015) found an 
increase of energy corrected milk (ECM) and lactose yield with a higher WB-Ra of glucose 
during casein infusion. Similar results were reported by Lemosquet et al. (2009), who found an 
increase of milk and lactose yields during abomasal casein infusions in comparison with ruminal 
infusion of propionate; however, the whole-body WB-Ra of glucose was increased with both 
treatments compared with controls. Since the mammary uptake of glucose was the same for both 
treatments, the calculated half-udder balance of carbons suggests that more anabolic pathways 
were activated with casein infusion to support increased milk components and yield. Given that 
the appearance of glucose is a function of direct absorption, synthesis, and release from reserves, 
these results (Lemosquet et al., 2009) must be interpreted carefully. Under different conditions, 
Doepel et al. (2009) reported that from dry period to lactation (and therefore higher portal 
absorption), the amount of lactose produced by the mammary gland could not be supported by 
the net release of glucose from the splanchnic tissues, and they suggested that other metabolic 
processes must have been activated. 
 Absorption of AA by MG cells depends on the amount of AA that cross the gland (blood 
AA concentration × blood flow) per unit of time, and the process by which AA are transported 
through the cell membrane of the mammary cells (Arriola Apelo et al., 2014; Mepham, 1982). 
Amino acids can end up being part of milk protein, retained as structural protein, metabolized to 
other components (e.g., CO2, NEAA, urea) or simply pass unaltered to the milk (Mepham, 
1982). In general terms, the classification of AA made by Mepham (1982) based on the 
difference between the individual AA uptake by the MG and the output in milk remains valid. 
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Group 1 (His, Met, Phe + Tyr, Thr, and Trp) consists of the AA whose ratio uptake/output is close 
to 1. Group 2 (BCAA plus Lys) includes AA with higher uptake than secretion. Finally, Group 3 
(NEAA except Tyr) are the AA with higher output in the milk than the mammary uptake (Raggio 
et al., 2006). 
 Dietary supply of AA is one of the main tools to correct and improve the imbalance of 
glucose precursors during the transition period. Amino acid supply includes the microbial protein 
and the undegraded feed protein that passed from the rumen. A small part of the protein ingested 
reaches the small intestine intact, and free AA do not survive long in the rumen. In order to 
minimize the degradation of AA in the rumen and also to avoid the uncertain profile of AA 
released after rumen fermentation, feeding rumen protected amino acids (RPAA) is the well-
established commercial approach (Atasoglu & Wallace, 2003). Abomasal infusion of the desired 
free AA has been a common technique used in research conditions for many years (Papas et al., 
1974; Schwab et al., 1975). 
 Previously in this review, the important withdrawal by the PDV of the glucose absorbed 
intestinally was mentioned. Such a noticeable reduction also occurs among the glucogenic 
precursors (Aschenbach et al., 2010) such as AA, which is what we are concerned about in this 
study. Arriola Apelo et al. (2014) summarized that the use of AA by the PDV includes three 
primary fates: cell turnover, production of export proteins, and catabolism to provide energy. 
Berthiaume et al. (2001) measured net fluxes of AA across the gastrointestinal tract (GIT). Their 
observations suggested that the GIT uses around 30% of the total AA absorbed. For instance, 
Glu, Asp, and Gln had net portal fluxes close to zero, and even negative in the case of Gln, which 
indicates the huge importance of those AA to the GIT. Lobley et al. (2007) also showed that Leu 
and Met had a significant disappearance in the PDV (23 and 11%, respectively) due to their 
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oxidation to provide energy. This remarkable use of AA by the PDV suggests that an indirect 
positive effect of the supply of AA is to spare glucose rather than contribute to the direct effect of 
increasing the liver supply of glucose. In fact, some studies have found an increase in the WB-Ra 
of glucose or an increased hepatic release of glucose with an increased supply of AA, even when 
the net hepatic removal of AA by the liver remained invariable (Doepel et al., 2009). 
Furthermore, Galindo et al. (2015) found that abomasal supply of casein increased the WB-Ra of 
glucose without altering either the hepatic release or the arterial utilization of glucose. From the 
same study, Larsen et al. (2015) calculated that the BCAA were the most catabolized AA in the 
PDV among the essential AA (EAA), and that Asp, Glu, and Tyr were the most catabolized 
among the NEAA during the casein infusion. 
 Accounting for the effect of the liver in AA removal, net removal of EAA by splanchnic 
tissues (i.e., PDV plus liver) can be the same or even greater than the removal by the MG for 
production of milk protein (Hanigan et al., 2001). Most of this removal is explained by the 
considerably larger AA influx received by the splanchnic tissues, which in turn comes from the 
AA released from the MG. Therefore, Arriola Apelo et al. (2014) asserted that the effect of 
splanchnic tissues is mainly dependent on the EAA released by the MG. Thus, the different AA 
affinities and blood flows of these two tissues will determine the concentration of AA in 
circulation (Arriola Apelo et al., 2014). Given that most of the EAA that the liver receives come 
from arterial supply and that liver removal is not a direct function of portal absorption (Doepel et 
al., 2009), providing AA that are scarcely removed by the liver (e.g., BCAA and Lys) could 
improve AA utilization in MG and splanchnic tissues and thereby reduce AA catabolism (Arriola 
Apelo et al., 2014).  
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Other recent studies have demonstrated that the transition period does not impose a 
radical change in the net liver uptake of AA, but instead the increasing hepatic affinity 
postpartum for lactate would quantitatively support the larger amount of glucose release (Larsen 
& Kristensen, 2013), while AA would be derived mostly for milk protein synthesis (Doepel et 
al., 2009). Even with increased net fluxes of AA through splanchnic tissues, the net uptake of AA 
by the liver remains almost constant from pre- to postpartum (Doepel et al., 2009). The 
tremendously important roles of muscle mobilization and the alternative pathways activated in 
the liver and MG account for the required AA supply for the increasing production of milk and 
milk components (Dalbach et al., 2011). Larsen and Kristensen (2009a) also suggested that the 
remainder of EAA required to account for the production of milk protein during the first days of 
lactation may be provided by an inter-organ transfer of AA where the liver is not involved. 
 Another mechanism originating from an increased AA supply that results in a greater 
availability of glucose is the higher starch digestion in the small intestine as a result of an 
increased secretion of α-amylase from the pancreas (Richards et al., 2003). Swanson et al. (2004) 
found an increase of trypsin and chymotrypsin secretion as well as α-amylase during abomasal 
casein infusion, although none of the hormones and blood metabolites analyzed helped to 
understand how this effect is produced. Findings by the same authors (Swanson et al., 2003) 
during in vitro experiments indicated that cholecystokinin (CKK), which is one of the hormones 
responsible for stimulating secretion of digestive enzymes in pancreatic juice in response to 
luminal nutrient flow, only increased the concentration of trypsin and α-amylase when the 
pancreatic tissue had been extracted from calves that received casein infusion or when tissue was 
cultured with AA (i.e., recommended media concentration of AA for in vitro tissue incubation 
plus Gln). Behavior of CCK has been addressed by many researchers (Furuse et al., 1992; 
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Konturek et al., 2003; Zabielski, 2003), but a clear definition of the link between CCK and small 
intestinal starch digestion is still missing. More recently, Brake et al. (2014) compared different 
duodenal protein supplies and found that casein and EAA increased pancreatic α-amylase 
production, while Glu and NEAA increased small intestine starch digestion. 
 Besides the direct nutritional effect of AA as an energy source, the supply of AA might 
increase the synthesis of apolipoprotein B, which is the main component of the compounds 
necessary for export of excess fatty acids in the liver as TG and cholesterol esters in the form of 
VLDL (Bell et al., 2000).  Bauchart (1998) demonstrated that increased intestinal supply of Lys 
and Met can increase hepatic concentration of apolipoprotein B100 in postpartum cows; as a 
consequence they also found less liver TG and less ketone bodies in plasma. 
 Regardless of how AA are used (milk protein synthesis, catabolic processes to provide 
energy, synthesis of tissue for turnover or growing fetus) or where the uptake of AA occurs 
(PDV, liver, MG, muscle tissue), it has been clarified after this review that AA metabolism plays 
an important function in the homeostatic evolution from the last phase of pregnancy to post-
calving and consequent lactation.  A simpler way to evaluate the net utilization of AA during that 
period is with the analysis of the concentration of free AA in arterial or venous blood. The pool 
of AA in the body is much bigger than the pool in plasma, but any substantial alteration in the 
supply or utilization of AA should be reflected in the plasma AA concentration (Meijer et al., 
1995). These concentrations are a reflection of the AA (and other metabolites as well) available 
for use, no matter where they come from (mobilization, infusion, or feed digestion). Maeda et al. 
(2012) monitored the jugular plasma concentrations of AA during the transition period (-30 d to 
+60 d) in healthy cows and reported that except for Gly and Ser, which increased continuously 
from the prepartum period until +60 d after calving, the rest of the AA decreased their 
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concentration as cows were getting close to calving, with the day of calving having the lowest 
value. Thereafter, all AA except Glu and Gln recovered quickly and even exceeded their 
prepartum concentrations between 15 and 30 d after calving.  However, Glu and Gln remained 
lower than prepartum values at 60 d after calving. Verbere et al. (1972) monitored daily the 
concentration of AA for 1 wk around calving and found that all AA decreased their concentration 
before parturition with the lowest value on the day of calving. At day +3 all AA had recovered 
their initial value with the exception of Gln. Meijer et al. (1995) measured the AA concentration 
in plasma and muscle from 2 wk before to 15 wk after calving. Except for Gly and Ser that 
increased from prepartum to early lactation, the remainder of the AA showed similar patterns to 
those described in the other studies, decreasing until the day of calving and thereafter recovering. 
However, no recovery was found for Gln, Met, and Phe. Muscle concentrations of AA increased 
as parturition neared, but concentration of Gln decreased. All EAA (except Leu and Val) and all 
NEAA (except Ala, Gln, Glu, and Gly) recovered their pre-calving values by 15 wk after calving. 
Similarly, Doepel (2002) reported a decrease at calving of most of the AA, suggesting their use 
for gluconeogenesis and milk protein. That suggestion paired with the observed increase of 
glucose at calving (Sun et al., 2016), probably due to the stimulation of gluconeogenesis and 
glycogenolysis by the increased glucocorticoid concentration at calving (Vazquez-Añon et al., 
1994). Once again, Gln was the only NEAA that decreased from day +1 to +21. Results from 
Dalbach et al. (2011) determined that Glu and Gln were the only AA with no increase in plasma 
arterial concentration from calving until 29 DIM. 
 A few studies have analyzed the effect of feed restriction in mid-lactation cows on protein 
metabolism at the AA level. In order to study the effect of different metabolites as hunger or 
satiety signals, Laeger et al. (2012) analyzed their concentration in the blood and cerebrospinal 
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fluid. Regarding AA, after 4 d of feed restriction Leu and Lys increased in plasma probably due 
to their mobilization from protein tissue breakdown, and concentration of 3-MH also increased 
as a reflection of tissue protein mobilization (Blum et al., 1985). Arginine increased in plasma, 
likely because of its role in the urea cycle (Bender, 2012) to recycle the N from the catabolism of 
AA. In contrast, Trp decreased likely because of its role as a precursor for milk protein or as 
serotonin and melatonin precursor. On the other hand, the author (Bender, 2012) proposed that 
Ser, Tyr, and Thr may have acted as anorexigenic signals since their concentrations in the 
cerebrospinal fluid decreased. 
Summary and Objectives 
According to this brief but broad review, the role that the 20 AA play during the 
adaptation processes that take place during the transition to lactation is not exactly known but it 
is clear that role is important. Protein and energy metabolism are closely related in many aspects. 
Free AA are required as substrates (for catabolism) or are produced (anabolism) on a continuous 
basis during the homeostatic processes of the transition. Whether synthesizing protein, being 
deaminated to produce energy via ATP, producing export proteins, or being glucose precursors, 
the demand for AA by the organs responsible for the success of the transition is constant. This 
demand is not equal for all AA, and even differs for AA that belong to the same classification 
group (e.g., EAA vs. NEAA). The metabolic changes triggered by feed restriction will be 
assessed by comparing positive (ad libitum diet) and negative (feed-restricted diet) controls. 
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CHAPTER 2. EFFECTS OF FEED RESTRICTION ON MILK PRODUCTION AND 
METABOLISM IN MID-LACTATION DAIRY COWS 
INTRODUCTION 
Multiple factors around parturition from natural changes in homeorhetic hormone 
concentrations (Laeger et al., 2013) to farm feeding management (Janovick et al., 2011) will 
cause an inherent decrease of DMI (Bell, 1995; Drackley, 1999). The lower DMI will trigger a 
synchronized cascade of metabolic adaptations destined to maintain optimal concentrations of 
glucose in circulation and energy supply at the cellular level (Aschenbach et al., 2010; De Koster 
& Opsomer, 2013). Mobilization of stored lipids is a major mechanism to provide energy (Bell, 
1979; Drackley et al., 2001). However, excessive use of storage lipid can lead to metabolic 
malfunctions due to hepatic accumulation and excessive ketone bodies formation (Bobe et al., 
2004; Drackley et al., 2005; Zammit, 1990). Therefore, availability of other precursors of 
glucose and energy, such as amino acids (AA), plays a vital role during periods of negative 
energy balance (Arriola Apelo et al., 2014; Bequette & Nelson, 2006; Larsen et al., 2015; 
Overton et al., 1999). In fact, body tissue protein mobilization also is an important mechanism 
switched on around parturition, as a source of AA (Lobley, 1998; Nishizawa, 1989; Van der 
Drift et al., 2012).  
Distribution and efficient use of required AA during a period of lower DMI requires 
inter-organ coordination between liver and peripheral tissues (Arriola Apelo et al., 2014; Larsen 
& Kristensen, 2009). Uptake by the mammary gland has a relevant importance because of the 
relative amount consumed in comparison with the splanchnic tissues (Hanigan et al., 2001), and 
also because the mammary gland is able to alter extraction efficiency according to its 
requirements (Mackle et al., 2000; Mepham, 1982). Accordingly, the negative protein balance 
during the transition period is reflected in lower concentrations of the majority of essential and 
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non-essential AA in circulation (Doepel et al., 2002; Larsen et al., 2015; Maeda et al., 2012; 
Zhou Z. et al., 2016), which recover “pre-transition” values sooner or later during lactation. 
Nevertheless, analysis of the AA individually during the transition period can sometimes lead to 
misleading conclusions due to the effect of different feeding or grouping techniques applied 
(Dann et al., 2006; Doepel et al., 2002). In addition, an excessive time between sampling might 
prevent detection of quick changes in metabolite concentrations (Laeger et al., 2012; Zhu et al., 
2000).   
Feed-restriction models do not simulate exactly the natural negative energy balance 
occurring across the transition period, but have been a valid system to appreciate the metabolic 
adaptations to nutrient deficiency at a molecular level (Block et al., 2003; Bradford & Allen, 
2005; Chelikani et al., 2004; Gross & Bruckmaier, 2015; Nielsen et al., 2003) without the 
collateral effect of hormonal influences characteristic of parturition and onset of lactation (Akbar 
et al., 2013). However, research investigating the effects of feed restriction on protein 
metabolism is not recent (Baird et al., 1972; Lomax & Baird, 1983), or it was focused on roles 
other than energy purposes (Ferraretto et al., 2014; Laeger et al., 2012; Rius et al., 2010).  
The objective of the research reported in this chapter was to compare and analyze the 
effects of feed restriction on the relationships between protein and energy metabolism across 
time. The hypothesis was that the timing, synchrony, and magnitude of variation in blood 
metabolite concentrations will indicate the preference and requirements of specific AA for 
maintenance of milk production and basal metabolism when DMI is deficient.   
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MATERIALS AND METHODS 
All procedures involving animals were approved by the Institutional Animal care and Use 
Committee at the University at Urbana-Champaign (IACUC protocol #15167) 
Experimental Design 
The experiment was conducted as a 7 x 4 Youdin Square (incomplete Latin Square) 
design with experimental periods of 10 d length, where 7 cows received 1 different treatment 
during each of the consecutive 4 periods. During d 1 to d 5 of each period, cows in 6 out of the 7 
treatments had the amount of feed offered restricted to provide only 60% of their NEL (Mcal/d) 
requirements at the start of each period. Additionally, feed-restricted cows during the first 5 d 
received the infusion treatments and frequent sampling of blood and milk was performed. During 
the following 5 d (d 6 to d 10) cows were fed for ad libitum DMI as a recovery and wash-out 
period. A detailed trial timeline can be observed in Figure 1.  
Animals and Diets 
Seven multiparous Holstein cows past peak lactation (93 ± 15.5 d in milk) were used to 
evaluate the effects of different AA and glucose abomasal infusions on energy and protein 
metabolism derived from a 5-d feed restriction period. All cows were housed in tie stalls and 
were milked in a parallel parlor at the Dairy Research Unit of the University of Illinois during 
the duration of the trial. 
All cows had their ruminal cannula fitted previous to this experiment, and thus no 
cannulation surgeries were performed for this experiment. Cows were adapted to the tie stalls 
and to feed for 7 d before beginning the respective treatments. 
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The diet, fed as a total mixed ration (TMR), was formulated according with the NRC 
(2001) requirements for a lactation diet. The diet composition and nutrient content is detailed in 
Table 1. The TMR was mixed daily and offered at 0900 h. The restricted amount to offer during 
the restriction phase was calculated as the 60% of the specific NEL requirements of each cow at 
the beginning of each treatment period; body weight (BW), milk production (kg /day), number of 
lactations, and days in milk were the parameters involved in this calculation. The restricted feed 
amount also provided 60 % of the EAA required approximately (Table 2). Dry matter content of 
the TMR was calculated every day before feed delivery in attempt to offer accurately the same 
amount of TMR DM during the experiment. Dry matter content was measured using a Koster 
tester (Koster Moisture Tester; Koster Crop Tester, Inc., Strongsville, OH). The Koster tester 
provided a fast and reliable method with small requirement of time and effort (Oetzel et al., 
1993) . Additionally, the TMR was sampled every second day and analyzed by Dairy One 
Cooperative Inc., Ithaca, NY; forages and concentrate components were sampled every week.  
Near Infrared Reflectance (NIR) spectroscopy was the method elected to analyze the feed 
samples because of the speed of getting the results, which allowed us to adjust the feed amount 
offered according to the restriction requirements. 
During the last 5 d of each period cows were fed ad libitum and refusals were weighed to 
calculate the DMI. 
Blood Sampling 
Indwelling catheters were inserted into a jugular vein of each cow on the afternoon of the 
day before d 1 of each period. The procedure area was prepared using a #40 clipper blade to 
remove hair in a 7 cm × 14 cm area centered over the jugular groove. The area was cleaned with 
povidone iodine scrub and alcohol. Wearing sterile gloves (Triflex, Cardinal Health, McGaw 
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Park, IL), the jugular vein was partially occluded with digital pressure to identify a location for 
catheter placement. After that, pressure on the vein was released and 3 to 5 mL of lidocaine 
solution were injected subcutaneously over the region of the jugular vein. The area was cleaned 
again with povidone iodine scrub and alcohol. While tenting the skin, a small (0.5 cm) stab 
incision through the skin was made with a #15 stainless steel disposable scalpel (Integra Miltex, 
Integra LifeSciences Corporation©, Lyon, France). The jugular vein was partially occluded with 
digital pressure. A 16-gauge 8.25 cm. I.V. catheter (BD Angiocath, Becton, Dickinson and Co., 
Franklin Lakes, NJ) were inserted through the stab incision and towards the jugular vein at 
approximately 60 degrees to the vein. When blood entered the catheter, the hub of the catheter 
was moved almost parallel to the vein and the catheter was advanced into the vein without 
moving the stylet. A T-Port extension set (B. Braun Medical Inc. Bethlehem, PA) was attached 
to the hub of the catheter and extension set and the catheter was flushed with 3 to 5 mL of 
heparizined saline (10 mL Heparin + 1000 mL NaCl 0.9% solution, B. Braun Medical Inc.). The 
hub of the catheter was secured to the skin with a simple interrupted suture of a non-absorbable 
suture material (Braunamid, B. Braun Medical Inc.). Using the same suture in a horizontal 
mattress pattern, the skin was folded dorsal and ventral to the catheter over the catheter to protect 
the catheter site. The extension set was secured to the neck with one or two simple interrupted 
sutures. Catheters were filled with sterile saline, capped, and secured with surgical wrap around 
the neck. 
Abomasal Infusions 
At the beginning of the adaptation period, the infusion line was placed in each cow. 
Abomasal infusion was accomplished by passing an infusion tubing through the rumino-omasal 
orifice into the abomasum by way of the rumen cannula. An infusion tube (Tygon tubing), fitted 
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at the end with a 60-mL plastic bottle with the bottom removed and with an approximately 8 cm 
rubber flange, was inserted through the rumen cannula and passed into the abomasum via the 
rumino-omasal orifice. To do so, the flange was compressed within the hand and the tubing 
guided through the orifice by hand. Once inside the abomasum, the flange was allowed to open, 
which prevented the tubing from being dislodged from the abomasum. The tubing remained in 
place for the duration of the experiment (40 d). The infusion apparatus was connected to an 
external infusion line via a hole in the rumen cannula plug. The line was connected to the 
external line by way of a quick-disconnect fitting. The location of the abomasum and the 
infusion line placement was performed following the directions by Litherland et al. (2005). 
The correct placement of the infusion line was confirmed each day of the treatment 
period shortly before the infusion time. Furthermore, the infusion lines were flushed with 
distilled water before the infusion to eliminate possible clogs caused by digesta that got into the 
line from the end inserted in the abomasum. 
Treatment solutions were infused using a rotary peristaltic pump (SentinelTM Enteral 
Feeding Pump, Alcor Scientific Inc., Smithfield, RI). The infusions were initiated at the same 
time that the restricted amount of feed was offered; the doses (225 mL/h) were programmed to 
last 4 h to simulate the effect of each treatment if they would be included in the feed. In this 
chapter, only the effect of feed restriction was evaluated. Therefore, only the treatments where 
water was infused are described. 
The treatments were as follows: 
1. AD LIBITUM (AL): This treatment was used as a positive control. 
During this treatment cows were fed the same ration as the cows in the restricted 
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treatments but for ad libitum DMI. The TMR offered and refusals were individually 
weighted to calculate and ensure a daily orts of around 10 to 15% of the amount of feed 
delivered on an as-fed basis. Cows assigned to this treatment did not receive any infused 
treatment. However, to simulate the same conditions among all treatments, cows were 
infused with 0.9 mL of distilled water added to the infusate volume during the same 4 h 
as the other treatments. 
 
2. RESTRICTED CONTROL (RC):  This treatment was used as a negative 
control. During this treatment cows were fed the calculated restricted amount of feed 
according with the calculation previously explained. Cows were infused with only 
distilled water in the same way as cows in the AL treatment. 
Measurements 
Milk Samples 
Cows were milked twice daily at 0600 and 1700 in a parallel parlor. Milk was sampled at 
each milking and milk production was recorded during length of the experiment. One aliquot of 
each daily milking sample was preserved (800 Broad Spectrum Microtabs II; D&F Control 
Systems, Inc., San Ramon, CA), refrigerated, and then analyzed (Dairy Lab Services, Dubuque, 
IA) for contents of fat, protein, milk urea nitrogen (MUN), lactose, and total solids. Another 
aliquot was immediately frozen at -20°C. 
Body Weight 
Body weight was measured on d 1 of the restriction before feeding and also after the 5-d 
restriction on d 6 before the first ad libitum offer of TMR. 
43 
 
 
Blood Sampling 
Blood samples (40 mL) were withdrawn via the catheter on d 1 to 5 at 0800, 0900, 1200, 
1300, 1400, and 2300.  After sampling was completed on d 5 in each period, the catheters were 
removed. From d 6 to d 10, to have an indication of metabolic state between the intensive 
sampling periods, one blood collection was made at 0900. Samples were transferred into 
evacuated tubes (BD Vacutainer, BD and Co., Franklin Lakes, NJ) containing clot activator for 
serum and K2EDTA for plasma. After blood collection, tubes for plasma were placed on ice and 
tubes for serum were kept at 21°C until centrifugation (~15 min). Serum and plasma were 
obtained by centrifugation at 2,000 × g for 15 min at 4°C. Aliquots of serum and plasma were 
frozen (−20°C) until further analysis. Concentrations of NEFA, BHB, total protein, albumin, 
total alkaline phosphatase, aspartate aminotransferase, gamma-glutamyl transferase, total 
bilirubin, total cholesterol, glutamate dehydrogenase, and triglycerides were determined at the 
University of Illinois College of Veterinary Medicine diagnostic laboratory by automated 
analysis methods. Globulin concentration was calculated by the difference between total protein 
and albumin. Plasma glucose concentration was analyzed by the University of Missouri 
Experiment Station Laboratory. Concentrations of plasma AA and N components were analyzed 
by Ajinomoto Co., Inc. (Tokyo, Japan).  Insulin, leptin, serum amyloid A and haptoglobin were 
analyzed using commercial ELISA kits from Mercodia (catalog no. 10-1201-01), MyBioSource 
(catalog no. MBS703026) and Tridelta Development Ltd. (catalog no. TP 802 and TP801) 
respectively. Variables included in acute-phase response and liver function sections plus leptin, 
were only analyzed in one sample (0900) per day. 
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Statistical Analysis 
Comparisons were made using the MIXED procedure of SAS version 9.4 (SAS Institute, 
2012) according to the following model: 
𝑌ijklm =µ + Cowi + Treatmentj + Periodk+ Dayl +Hourm + (Treatment × Day) + (Treatment × Time) + ɛijkl 
Effects of treatment, period, day, and hour were included as fixed effects in the class 
statemen while cow was included as a random effect. t. The repeated fixed effects of day nested 
within period was used in the REPEATED statement with cow nested in treatment the subject. 
For each variable with equal time spacing between samples, the subject was tested for 3 different 
covariance structures: autoregressive order 1, compound symmetry, and spatial power. For 
variables with unequal spacing, spatial power law, Gaussian and SPH were tested. The 
covariance structure that resulted in the smallest Bayesian information criterion was chosen 
(Littell, 2006). The degrees of freedom were estimated with the Kenward-Roger specification in 
the model statement. Other measurements including initial (d1) BW, initial milk production 
(kg/d), number of lactations, and days in milk (DIM) were tested as covariates including them in 
the model statement, and then removed according with their significance explaining the variance 
in the model and with their influence on the Bayesian criteria. Furthermore, a set of covariates 
was created and included to account for the carry-over effect between consecutive treatments on 
each variable (Doelman et al., 2015). 
In order to gain power during the feed restriction effects analysis, an additional model 
was performed to estimate the effect of all feed-restricted treatments grouped together (RES) and 
compared with AL, where the data points affected directly by the infusion itself were removed. 
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This comparison will be also referred as the effect of “diet”. The MIXED procedure was applied 
according with the following model: 
𝑌ijkl =µ + Cowi + Dietj + Periodk+ Dayl + (Diet × Day) + ɛijkl 
The PROC UNIVARIATE procedure was applied to each variable to check for normality 
and for the presence of outliers. Graph plots and P-values from the Shapiro-Wilk and 
Kolmogorov-Smirnov tests were used to evaluate both homogeneity and normality of residuals. 
When appropriate, variables were transformed to accomplish the above-mentioned criteria. Non-
transformed LSMEANS and standard errors (SE) were reported. The CONTRAST statement was 
used to compare AL and RC, or AL and RES. When interactions between treatment and day 
were significant, the SLICE statement was applied in order to identify the difference among 
treatments and days. The linear and quadratic trends were evaluated using the ESTIMATE 
statement from PROC MIXED, to classify the evolution along time according with feed 
condition (RES or AL), or with the infusion treatments on each variable. The smaller P-value 
from either linear or quadratic trend was reported. Correlations between concentrations of AA in 
plasma, and between milk components were identified using the CORR procedure.  
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RESULTS AND DISCUSSION 
 
Production Variables 
 Milk and blood variables reacted markedly to the 5-d feed restriction model in mid-
lactation cows. Success of this model had been validated in similar conditions by others (Baird et 
al., 1972; Lomax & Baird, 1983; Moyes et al., 2009; Toerien & Cant, 2007; Velez & Donkin, 
2005). To establish the basis of the metabolic adaptations that occur during the feed restriction 
period, the comparison of variation in concentrations of plasma metabolites, milk production, 
and milk components between AL and RC are described in this section. 
 According with the previously mentioned calculations to determine the amount of feed to 
be delivered during treatments under feed restriction, the average DMI for the RC treatment 
(12.4 kg /d) was 54.7% lower (P < 0.0001) than in the AL (27.5 kg/d) treatment (Table 3, Fig. 2). 
The DMI during feed restriction was constrained to be constant, while during ad libitum feeding, 
the intake increased following a quadratic trend along the 5 experimental days with its peak on d 
3 (Fig. 2). This reduced DMI is within the range (65% to 40%) observed in other studies where 
the purpose was to compare the metabolic responses during restriction with the previous fed 
state, or with other treatments during ad libitum conditions. This reduction has been proven to be 
effective in causing the desired metabolic cascade of adaptations (Akbar et al., 2013; Carlson et 
al., 2006; Moyes et al., 2009). The short period of feed restriction likely indicates that the 
significantly lower BW after feed restriction (-69 kg) at the end of the period (Fig. 3 ) was 
probably mostly due to the reduced DMI (Laeger et al., 2012) but also to a lesser degree the lipid 
storage mobilization (Drackley et al., 2001). 
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 Dry matter intake is the main factor that drives milk production (Dado & Allen, 1994; 
Drackley et al., 2006) and vice versa (Cardoso et al., 2013; Drackley et al., 2005; Janovick et al., 
2011). Therefore, a decrease in milk production in our study would be expected just by the 
reduced DMI in treatments under feed restriction. The average milk production for RC (30.5 
kg/d) was -19% lower (P = 0.002) than daily milk production for AL (37.7 kg /d). Similar 
decreases have been reported previously in similar conditions (Contreras et al., 2016; Ferraretto 
et al., 2014; Velez & Donkin, 2005). Across time, milk yield for RC decreased continuously (P = 
0.008, Fig. 4) in a linear trend (P = 0.001), while for AL milk had a weak increasing tendency (P 
= 0.063) matching the same pattern as DMI (Fig. 2). 
Due to the energetic and protein imbalance, the high availability of fatty acids from fat 
mobilization, the lower duodenal AA flux, and the countervailing hormonal adjustments also will 
alter milk composition (Arriola Apelo et al., 2014; Contreras et al., 2016; Doepel et al., 2004). 
As a result, daily averages of milk protein percentage and yield were lower (P = 0.034 and P = 
0.001, respectively) during RC (2.95%, 0.9 kg/d) in comparison with AL (3.09%, 1.15 kg/d). 
Both variables manifested a linear (P < 0.0001, Fig. 4 and 5) decreasing effect across time (P < 
0.0001 and P = 0.001 respectively). During AL treatment, milk protein percentage and yield 
were not different across time (P = 0.16 and P = 0.43, respectively). Similar effects also were 
reported by Gross et al. (2011) and Carlson et al. (2006). In contrast, milk fat percentage was 
higher (P = 0.005) during RC (4.30%) than during AL (2.53%), following a weak linear 
tendency (P = 0.1, Fig. 8) but without a significant change across the 5-d period (treatment by 
day, P = 0.34). However, considering the group formed by all restricted treatments (RES), milk 
fat did increase (RES by day, P < 0.0001). No differences (P = 0.99) were detected in milk fat 
yields between AL and RC, with no variation across periods (P = 0.28, Fig. 8). This finding is in 
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agreement with the results of other experiments using short-term feed restriction periods 
(Chelikani et al., 2004; Nielsen et al., 2003). Other authors also did report differences in fat 
yields (Contreras et al., 2016). Despite being numerically lower during RC, the high standard 
deviations found in our study did not allow for more significant differences (Fig. 8).  
Milk production is sustained largely by the mammary production of lactose, which is the 
biggest osmotic solute present in milk (Bell, 1995) and therefore determines the milk volume. 
Lactose is secreted into the alveolar lumen, and the concomitant transport of water drives the 
consequent milk production (Rigout et al., 2002). Glucose is the principal precursor of lactose, 
and is able to promote its synthesis in mammary cells and also induce cell viability and 
proliferation (Ye et al., 2016). Milk lactose percentage decreased linearly (P < 0.0001, Fig. 9) 
during RES, but remained steady (P = 0.87) in AL during the 5 d. Nevertheless, there were no 
significant effects of day or treatment with day (Table 3). Neither were there differences (P = 
0.2) between daily average lactose percentage between AL and RC (4.66% and 4.56%, 
respectively) since only at d 5 of the period did RC have lower lactose concentration than AL 
(Fig. 9). However, milk lactose yields per day were greater (P = 0.001) for AL treatment (1.75 
kg/d) than during RC (1.38 kg/d), in agreement with the result observed by Velez and Donkin 
(2005). Lactose yield per day decreased following a linear trend (Fig. 10). Milk lactose content 
has been reported to decrease during feed restriction or fasting in many studies (Carlson et al., 
2006; Chelikani et al., 2004; Contreras et al., 2016; Moyes et al., 2009), while others did not find 
that effect (Gross et al., 2011; Nielsen et al., 2003) even though plasma glucose was decreased. 
Since synthesis of lactose also depends on glucose uptake by the mammary gland, other anabolic 
mechanisms are probably activated to promote lactose synthesis during glucose shortage 
(Lemosquet et al., 2009). As a consequence of feed restriction, the percentage of milk solids 
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decreased during RC (Fig. 11), but total solids concentrations were not different between AL and 
RC (P = 0.68). However, the yield of total solids decreased progressively across time (P = 0.013) 
in a linear trend (Fig. 12), resulting in a lower (P = 0.007) average yield for RC.  
Milk production (kg/d) was negatively correlated with fat percentage (-0.31), protein (-
0.35) percentage, and DIM (-0.46), while the correlation was positive with lactose (0.27) content 
(Table 9). Therefore, even though the homeostatic and homeorhetic responses to NEB have a 
smaller magnitude in mid-lactation (Gross & Bruckmaier, 2015), the adaptive mechanisms of 
synthesis of milk components and milk production still applied in the same way as in the onset of 
lactation. 
These adaptations in milk components to counteract the decreasing milk production led to 
only a tendency (P = 0.078) for lower energy-corrected milk (ECM) production during RC (Fig. 
13). A similar tendency was found (P = 0.065) considering all treatments under feed restriction 
(Table 3). This compensatory effect for a reduced energy intake also was reported in other 
experiments under similar conditions as well as during early post-partum (Gross & Bruckmaier, 
2015; Nielsen et al., 2003). This effect also explains why even though feed efficiency (milk 
yield/DMI) decreased (RC by day, P = 0.007) linearly (P = 0.001) during RC, no differences 
were detected between treatments (Fig. 15) or between AL and RES (Table 3). In contrast, when 
FE is corrected by using ECM (Fig. 14), there was an opposite reaction in which there was no 
interaction (Trt by day, P = 0.1), but there was a strong effect of treatment (AL vs RC, P = 
0.022). The latter result was also observed but in a reverse direction when energy balance (EB) 
was calculated (Fig. 16). Therefore, even though energy intake was reduced, cows successfully 
adapted to try to provide the same energy output through milk components, as reflected by the 
lack of difference in TS percentage between AL and RC. Deserving special mention is the milk 
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components with higher energy content like milk lactose, whose concentration in milk did not 
vary significantly, and milk fat, whose concentration increased during feed restriction (Table 3). 
An imbalance between the requirements and the intake of nutrients will cause an 
adjustment of N metabolism (Nousiainen et al., 2004). Excessive amounts of ammonia will be 
produced from ruminal degradation in case of an excess protein intake, or also from AA 
catabolism in tissues to provide energy during NEB (Morris, 2002; Reynolds, 2006). This 
surplus of ammonia will be detoxified by conversion into urea in the liver (Bender, 2012c). Since 
urea reaches rapidly a balance in all body fluids, milk urea N (MUN) constitute a good indicator 
of AA catabolism (Nousiainen et al., 2004). The average daily concentration of MUN was higher 
(P = 0.007) during RC (15.26 mg/dL) than during AL (10.48 mg/dL). While MUN did not vary 
(P = 0.92, Fig. 17) during the 5 experimental days in the AL treatment, it did increase (P = 
0.037) during RC, following a quadratic pattern (P = 0.004) with a peak at d 2. Similar findings 
were reported during short-term feed restriction periods in other studies (Carlson et al., 2006; 
Velez & Donkin, 2005). According with this data, MUN reflects that catabolism of AA occurred 
during RC. The response was fairly fast since at d 2 cows were still in the beginning of the 
experimental period. This could mean either that catabolism of AA is the first option as source of 
glucose and energy in NEB or that capacity to detoxify the NH3 derived from catabolism in the 
ureagenic pathway decreased in favor to other export routes such as the glutamine pathway 
(Bender, 2012c; Noro & Wittwer, 2012; Zhu et al., 2000). 
Energy-Related Metabolites and Hormones 
 As a consequence of the reduced feed intake, the daily average concentration of NEFA 
during RC treatment was 19% higher (P = 0.001, Table 3) than the daily average in AL due to fat 
mobilization (Drackley, 1999; Katoh, 2002). The pattern across time showed that NEFA 
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increased (P < 0.0001) during RC treatment following a quadratic trend (P < 0.0001, Fig. 18). 
After a linear increase of 170% to reach its peak at d 3 (0.412 mEq/L), NEFA concentration 
decreased slowly thereafter until d 5. In contrast, NEFA did not show variation across time (P = 
0.14) for AL, resulting in a significant difference in d 2 and subsequent days (Fig. 18). This rapid 
increase in NEFA was also found in other experiments during short periods of feed restriction. 
For instance, Nielsen et al. (2003) reported a linear increase of 121% for NEFA during 3 d of 
feed restriction of 65% in DMI, and more recently Contreras et al. (2016) reported a 75% higher 
NEFA concentration in a group of cows with intake 47% lower in comparison with the ad 
libitum fed group.  
 The contrasting effects of lipolysis of triglycerides plus reesterification of NEFA within 
adipocytes are the reasons for the increase of NEFA in blood during periods of fat mobilization, 
and both processes are regulated by the antilipolytic effect of insulin (De Koster & Opsomer, 
2013; Weber et al., 2016). Since propionate is an insulin secretagogue (Grummer, 1993), the 
reduced DMI will lead to a reduced flux of volatile fatty acids to the liver ending with the 
consequent decrease of insulin (Harmon, 1992). Even though there were no a remarkable effect 
of treatments on insulin concentration overall (P = 0.09), the RC treatment did result in lower (P 
= 0.013) daily mean concentration of insulin than AL (0.44 vs 0.64 µg/L). Similarly, Contreras et 
al. (2016) reported just a tendency for lower insulin concentration in feed restricted cows after 4 
d of restriction. Even more, Velez and Donkin (2005) did not find any effect of feed restriction 
on insulin concentration after 5 d of limited feeding. In contrast, Ferraretto et al. (2014) and 
Carlson et al. (2006) found a considerable decrease of insulin concentration (<50%) after 4 d 
with a feed restriction of 50% of DM. The differences among studies can be due to differences 
between lactation stage of animals (Gross et al., 2011), blood samples timing (Piantoni et al., 
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2015), composition of the offered diet (Harmon, 1992), and differences between the animals 
themselves (Ferraretto et al., 2014; Gross & Bruckmaier, 2015). Nevertheless, in our study 
insulin decreased (P < 0.0001) in a quadratic manner (P < 0.0001, Fig. 20) across days with the 
lowest value at d 3 and thereafter remaining invariable until d 5. 
The observed insulin depression matches with the increase of NEFA concentration. Both 
converged with d 3 being their inflexion point.  This synchrony mimics the usual behavior of 
both metabolites around calving (Drackley et al., 2001; Grummer, 1993; Vazquez-Añon et al., 
1994). Moreover, these two metabolites act accordingly in the same opposite direction  within 
day (Allen, 2014) as observed in this study. While NEFA concentration was lower in the samples 
from 3, 4, and 5 h after feeding (Fig. 19), insulin concentration was higher than the values pre-
feeding (Fig. 21). This insulin-NEFA reaction to feeding had the same effect across all 
treatments. However, the magnitude of the differences in concentrations of NEFA relative to 
changes of insulin within day were 2 times higher during feed restriction than during AL 
treatment, reflecting the difference the interactions of diet by time (Table 8). While variations 
within day of insulin only tended to differ between diets (P = 0.07, Table 3), variations of NEFA 
were totally different depending on the diet (P = 0.003). Similar results were reported by 
Piantoni et al. (2015) who found no variations of NEFA 4 h after feeding in cows in late 
lactation, but a marked effect in cows during their post-partum period (12.6 ± 3.8 DIM). This 
different reaction between insulin and NEFA reveals that lipolytic and antilipolytic mechanisms 
are heavily influenced by the hourly feeding behavior (Allen et al., 2005), and that even the 
insulin sensitivity of tissues has more importance than the insulin concentration during NEB 
conditions other than the post-partum period (Janovick et al., 2011; Piantoni et al., 2015). 
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 Leptin is another protein hormone involved during processes unleashed by low DMI. 
Leptin is considered a satiety hormone, thus its main purpose is to send signals to decrease feed 
intake (Ahima & Flier, 2000) and also interacts with other hormones implicated in regulation of 
feed intake such as growth hormone (GH) and insulin (Allen et al., 2005; Block et al., 2003). 
Leptin is synthetized by adipocytes, and therefore the status of adipose tissue regulates the 
expression of leptin and its concentration in blood is correlated with the amount of total body fat 
stores (Ahima & Flier, 2000; Block et al., 2001). In contrast leptin is not related to differences in 
hepatic fat infiltration (Hammon et al., 2009). Consequently, other than just a restricted feeding 
situation, a phase of NEB also would alter leptin concentration due to adipocyte fat mobilization. 
Furthermore, it has been demonstrated that leptin has anti-inflammatory effects and also boosts 
the immune system (Johnson & Finck, 2001). Many studies proved a marked decreasing plasma 
concentration of leptin during the onset of lactation, a period that is characterized by lower DMI 
and NEB caused by the increasing milk production (Block et al., 2001; Hammon et al., 2009; 
Reist et al., 2003). Besides the clear relation with NEB, Liefers et al. (2003) also found a 
significant increase in detection of first estrus postpartum in cows with higher plasma leptin 
concentration. Alterations of leptin were also provoked by short periods of feed restriction 
(Block et al., 2003; Chelikani et al., 2004) or by altering the energy balance in periods of milking 
or no milking (Block et al., 2001). In our study, RC had a slightly lower numeric concentration 
of leptin than AL (4.99 vs 4.87 ng/ml) but with no statistical difference (P = 0.32). Neither 
treatment showed a significant trend over time either (Table 5, Fig. 22). Similarly, Reist et al. 
(2002) did not find a correlation between leptin and other energy-related blood metabolites in the 
first 100 wk postpartum. However, it is valuable to mention that during our study, there was a 
tendency for leptin in AL to be higher than the group formed by all treatments with feed 
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restriction (RES) in the experiment (P = 0.061) and also that the RES group showed a linear 
decrease (P < 0.0001) over the 5 d.  
Increasing plasma concentrations of glucagon is another endocrine response to maintain 
the desired mix of fuels in order to resist changes in glucose concentration in circulation 
(Aschenbach et al., 2010). Glucagon activates the release of glucose from liver glycogen, 
promotes gluconeogenesis from propionate (Donkin & Armentano, 1995), and also regulates 
malonyl-CoA, which plays a key role in regulating fatty acid oxidation in liver cells (Brindle et 
al., 1985). The beginning of the lactation is characterized by lower DMI, where the pancreas 
balances the concentrations of insulin and glucagon in circulation to achieve that goal. Hammon 
et al. (2009) reported that glucagon and the glucagon/insulin ratio increased after parturition until 
2 wk postpartum in cows with high and low liver content of fat. The lack of information 
regarding glucagon concentration in mid-lactation cows under feed restriction, complicates the 
discussion of our results. Early lactation cows in a restriction condition were studied by Toerien 
and Cant (2007), who found that even though there were no significance differences, glucagon 
concentration tended to increase during the 18 h after beginning of the restriction, and then 6 h 
later decreased to similar values as the initial point. The authors pointed out that this later 
decrease 24 h after restriction was synchronized with the biggest drop in milk production, 
meaning that the mechanism required to save glucose may no longer be necessary after that. Our 
results showed no important differences between AL and RC treatments (P = 0.67). However, 
due to the extremely high standard errors obtained, only comparing AL to the RES group leads 
to clearer but still cautious conclusions. There was an interaction of diet with day (P = 0.001). 
During feed restriction, glucagon concentration remained constant on d 1, 2 and 3; thereafter, it 
decreased and remained lower during d 4 and 5 (Fig. 23, Table 4). In accordance with Toerien 
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and Cant (2007), it seems that glucagon concentration remained high to compensate for the 
decrease of glucose and later reach a constant concentration in tune with glucose during the last 3 
d of the period. The same pattern was pointed out by Heitmann et al. (1987) in sheep and steers, 
where the decrease of insulin was coupled with constant values of glucagon during fasting. This 
would lead to a higher ratio of glucagon/insulin and therefore trigger the concomitant energetic 
homeostatic processes. As hypothesized by de Boer et al. (1985), glucagon synthesis could be 
inhibited by ketone body and NEFA concentrations, or it could be also limited by availability of 
substrate what would explain the decline toward the end of the period when rumen content is 
very limited and BHBA and NEFA concentration are high. 
 The principal aim of all these adaptations is to maintain an optimal balance of the energy 
fuels for the cells in a situation of lower glucose concentration due to a reduced feed intake 
(Drackley, 1999). In this study, glucose concentration per day in RC was lower (P = 0.031) than 
AL (59.3 vs 64.4 mg/dL). Glucose concentration decreased (RC by day, P < 0.0001) linearly 
from d 1 to d 3 (-12%) and later remained invariable until the end of the feed restriction period 
(Fig. 25). This slight decrease led to a non-significant difference between AL and all treatments 
under feed restriction (P = 0.16). This could be a reflection of the homeostatic processes 
triggered by metabolism to keep an optimal and constant flux of glucose in the blood (Bell, 
1995). These adaptive mechanisms seemed to produce different results in plasma glucose 
concentration in some of the studies reviewed. For instance, Carlson et al. (2006) found no 
difference after 4 d of restriction and they attributed this to the measured depletion of liver 
glycogen that would be used to release glucose into the blood stream. On the other hand, 
Ferraretto et al. (2014) did find a significant decrease after 4 d of restriction in similar conditions. 
Probably, the lower energy density (NEL=1.65 Mcal/kg) in Ferraretto’s diet, the fact that cows on 
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their study were in late lactation with 204 ± 29 DIM (versus 132 ± 36 DIM), and with a bigger 
drop in milk production (-10 kg/d) than during Carlson’s trial (-4.9 kg/d) were some of the 
reasons why glucose behaved differently in the 2 studies. Glucose concentration decreased after 
feeding for all treatments with no important differences between treatments (P = 0.89), similar to 
Piantoni et al. (2015) and Ferraretto et al. (2014). During the postprandial phase glucose is driven 
toward insulin sensitive cells due to the increase of insulin stimulated by the VFA from the feed 
digestion (Allen et al., 2005; Ferraretto et al., 2014), decreasing the glucose concentration in 
plasma. However, similarly to the variation of NEFA in reaction to changes in insulin 
concentrations, there were a different reaction of glucose in RC and RES in comparison with AL. 
While insulin response to feeding within day tended to differ depending on the diet (diet by hour, 
P = 0.071), glucose variation within day was practically the same regardless of the diet 
restriction (diet by hour, P = 0.75). This different reaction is even more remarkable during the 
night sampling (14 h after feeding) where large differences in concentrations of insulin (Fig. 21) 
between AL and RC match with similar concentrations of glucose between treatments (Fig. 26). 
Therefore, it seems that there was a difference in the insulin sensitivity of tissue more than a 
reaction to the concentration change, since the decrease of both metabolites across the period 
have similar significance (Table 3). This finding is in agreement with Piantoni et al. (2015), who 
reported no proportional relation between changes in insulin with changes in NEFA and glucose 
across groups of cows with different energy balance (late lactation and early postpartum), or as 
observed in humans and mice where feed or caloric restriction increases insulin sensitivity 
(Barnosky et al., 2014; Cheng et al., 2017). 
 Once the increasing flux of NEFA through the blood reaches the liver, they might be 
oxidized to provide the energy required (Drackley, 1999) during feed restriction. To avoid the 
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dangerous consequences of an excessive accumulation of fatty acids within the liver (Vazquez-
Añon et al., 1994), the hydrolysis of stored triglycerides (TG) and their export in form of very 
low density lipoproteins (VLDL) and cholesterol must be very efficient (Grummer, 1993). 
During a period of feed restriction, the concentration of TG in plasma released from the liver will 
rise (Gross et al., 2015) in a rate proportional to the concentration of NEFA in plasma 
(Grummer, 1993). In our study, restricted diets increased (P = 0.02) TG concentration in all 
treatments. Cows under RC treatment had a daily average concentration of TG of 10.5 mg/dL, 
being 30 % higher (P = 0.015) than cows in the AL treatment (8.0 mg/dL). Plasma TG increased 
(RES by day, P = 0.033) in a quadratic pattern (P = 0.001, Fig. 27) with a maximum at d 3 and 
decreasing progressively thereafter, following a pattern similar to NEFA (Fig. 18). Increases in 
TG also were reported in some studies in which cows were subjected to feed restriction (Carlson 
et al., 2006; Gross & Bruckmaier, 2015; Moyes et al., 2009) but not in another (Capuco et al., 
2001). As reported by Ohgi et al. (2005), liver TG infiltration takes place after NEFA 
concentration reaches its maximum concentration (Grummer, 1993; Vazquez-Añon et al., 1994). 
In our study, the plasma concentration of TG decreased after concentration of NEFA reached its 
peak in blood, suggesting that hepatic infiltration of TG might have started around d 3 since TG 
concentration in blood also decreased that day in the RES group (Table 4).  
 The NEFA recently re-esterified into TG must be exported from the liver. Ruminants 
have a low capacity for TG export from liver in comparison with non-ruminant species (Pullen et 
al., 1990). The VLDL are the lipoproteins in charge of the export of TG and cholesterol. In this 
study, there were no differences (P = 0.47) in serum concentrations of cholesterol between AL 
(190.9 mg/dL) and RC (195.3 mg/dL). This finding is in agreement with Capuco et al. (2001), 
who found no difference after 6 d of feed restriction at 80% of the AL group intake. However, it 
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is noteworthy that RC showed a weak quadratic increasing (P = 0.19, Fig. 28) trend of 
cholesterol. Moreover, considering all the restricted treatments (RES), feed restriction induced a 
tendency to higher cholesterol (P = 0.11), manifesting a linear increasing trend (Table 5). The 
short period of time under restriction, the severity of the restriction, or differences in other 
factors that affect the capacity of cholesterol export may be reasons for lack of a greater 
difference between AL and restricted intake. For instance, Gross et al. (2015) reported an 
increase of cholesterol after 3 wk of restriction to 50% of ad libitum DMI, and DiMarco et al. 
(1981) reported a 10% higher serum cholesterol after 9 d of fasting. In accordance with this 
export from the liver, Kuhla et al. (2009) measured that liver of mid- lactation cows after 60 h of 
feeding a straw diet (18 ±1.1 MJ NEL vs 110.2 ±11.2 MJ NEL in AL group ) had 73% less liver 
cholesterol concentration (DM basis) than the AL group. In summary, this variation matches 
with the natural increase of blood cholesterol that occurs after calving (Gross & Bruckmaier, 
2015; Ohgi et al., 2005) during a healthy transition period (Bobe et al., 2004).  
During periods of NEB and intense mobilization of adipose TG, high concentrations of 
NEFA lead to increased β-oxidation of fatty acids within hepatic mitochondria. The lack of 
glucogenic precursors to bind the acetyl-CoA product of β-oxidation for entry into the TCA 
cycle for complete oxidation to CO2 (Zammit, 1990), leads to an increase in formation of ketone 
bodies instead (Katoh, 2002). Hence, higher concentrations of ketone bodies, primarily as β-
hydroxybutyrate (BHB), have been widely reported during the postpartum period (Bell, 1995; 
Drackley, 1999; Grummer, 1993) or even before parturition (Grum et al., 1996), as well as 
during short periods of feed restriction during mid-lactation (Gross et al., 2011; Moyes et al., 
2009; Nielsen et al., 2003). However, cows in late stages of lactation have a less intense reaction 
to increase ketone bodies formation (Carlson et al., 2006; Gross & Bruckmaier, 2015; Gross et 
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al., 2013). This modest response was observed in our study, where there were no differences (P = 
0.46) between RC (0.59 mmol/L) and AL (0.61 mmol/L) for overall BHB concentrations. 
However, the 2 treatments differed in their evolution across time (Table 5, Fig. 29). While AL 
did not have any important deviation from d 1 on subsequent days (P = 0.8), as expected, RC 
displayed a weak tendency across days (P = 0.16) to follow a linear increasing trend (P = 0.042) 
that reached its maximum at d 4, after the peak of NEFA concentration occurred (Fig. 18). This 
“delayed” reaction is in agreement with other studies (Gross et al., 2011; Gross & Bruckmaier, 
2015; Van Den Top et al., 1996), and follows the biologic process previously mentioned wherein 
TG infiltration (Vazquez-Añon et al., 1994) and ketone bodies formation (Goff & Horst, 1997) 
likely would start when NEFA uptake exceeded the capacity for TG export and complete 
oxidation. Similarly, considering all the treatments under RES, the interaction of diet with day 
became stronger (P < 0.0001) with the BHB peak at d 4 (Table 4). The short period under 
restriction that resulted in a significant increase at d 4, the different initial values, and the 
relatively large standard errors likely did not allow for bigger differences in BHB concentrations 
between the two treatments.  
Ketones bodies are also produced from the butyrate produced during rumen fermentation 
(Brockman, 2005). During the postprandial phase, butyrate is highly metabolized into BHB 
(Emmanuel, 1980) by the epithelium lining the rumen walls. This process is in accordance with 
our data, where independent of treatment or fed vs fasting condition, BHB increased 88% by 3 h 
post-feeding (Fig. 30). The net portal flux of BHB does not vary substantially, regardless of the 
amount of butyrate produced in the rumen (Menahan et al., 1966; Nozière et al., 2000). In 
agreement, we observed in our study that there were no differences in BHB concentration 
between RC and AL on d 1, 2, or 3 during the post-absorptive phase even though the amount of 
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feed ingested was different. Our data also agrees with Piantoni et al. (2015), who reported a 
positive correlation between DMI and the increase in BHB after feeding only in late lactation 
cows and not in post-partum cows. However, the amount of butyrate produced in the rumen 
strongly affects the concentration of BHB in arterial plasma (Herrick et al., 2016; Nozière et al., 
2000). Therefore, the higher concentration of BHB during the RC treatment could be a mix 
between BHB that was produced by the liver due to the greater availability of NEFA in 
circulation (Katz & Bergman, 1969) because of  lower insulin concentration in the pre-feeding 
time points, and also as a result of greater uptake of BHB by mesenteric-drained viscera (Nozière 
et al., 2000). Nevertheless, the samples taken before feeding displayed the greatest increase 
across the period (Table 6). In addition, during the fed state BHB is the main ketone body 
synthesized by the liver and rumen epithelium, whereas in the fasted state the BHBA to 
acetoacetate ratio decreases and acetoacetate can account for between 20 to 30% of total ketone 
body production in the liver (Heitmann et al., 1987; Katz & Bergman, 1969; Toerien & Cant, 
2007) during a time when BHB production by rumen epithelium would be decreased due to lack 
of feed intake. Therefore, since we only measured BHB, the magnitude of hepatic ketone body 
production in RC or RES likely was underestimated. 
Acute-Phase Response 
 Free fatty acids or NEFA are transported in blood by binding with albumin (Bell, 1979). 
Thus, in a situation of intense fat mobilization, albumin concentration potentially could be 
reduced by deficiency of albumin production of the liver, resulting in greater NEFA uptake into 
tissues (Moyes et al., 2009; Seifi et al., 2007). On the other hand, serum albumin belongs to the 
negative acute-phase proteins, whose production can be diminished by the effect of cytokines 
(Bertoni et al., 2008). Cytokines are released around calving due to diseases, stressors, or even 
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nutritional imbalances (Drackley et al., 2005). Cytokines, among many other effects and 
implications (Bradford et al., 2015), stimulate the acute phase response, which is defined by 
increasing positive acute-phase response proteins and decreasing the synthesis of negative acute-
phase protein such as albumin (Bertoni et al., 2008). Because of both reasons combined, lower 
albumin concentrations have been related to higher fat infiltration in the liver (Reid et al., 1983; 
West, 1990). This makes albumin a good indicator of transition period performance (Trevisi et 
al., 2010; Zhou et al., 2016). Cows under feed restriction in the RC treatment had lower albumin 
concentration (P = 0.053) than AL. Albumin was slightly altered across time by the effect of the 
restriction (RC by day, P = 0.16), with the biggest difference on d 3 and 4 since albumin 
concentration declined following a quadratic trend (P = 0.032, Fig. 31). This temporal pattern 
suggests the use of albumin as NEFA transporter during periods of fat mobilization. Moyes et al. 
(2009) also found a decrease in albumin concentration 2 days after the beginning of the 
restriction with a recovery to initial concentrations 2 d later. 
 As mentioned in the previous section, albumin is a classic negative acute phase protein, 
whose synthesis is decreased in response to pro-inflammatory signals. Globulin, in contrast, is a 
positive acute-phase respondent and its synthesis will be stimulated by cytokines (Drackley et 
al., 2005). Therefore, it constitutes a good indicator of inflammatory status (Bertoni et al., 2008) 
and impaired hepatic lipid metabolism (Crookenden et al., 2017). No effects of diet or treatment 
were detected in globulin concentration (Table 3, Fig. 32) 
 Albumin and globulin account for the total concentration of so-called total protein (TP) in 
blood. Bertoni et al. (2008) observed that TP concentration in serum increased from d 7 to d 28 
postpartum following an inverse pattern from NEFA, similar that reported for albumin (Seifi et 
al., 2007), and with no relationship between concentrations of TP and fat content in liver cells 
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(Reid et al., 1983). During our study, the concentration of TP did not differ between AL and RC 
(P = 0.92) and there were no detectable patterns over time for those treatments (Table 5, Fig. 33), 
similar to the response for globulin concentration. Therefore, under the conditions of our trial, it 
seems that only albumin was affected by feed restriction.  
 Haptoglobin (Hp) and serum amyloid A (SAA) also belong to the group of positive 
acute-phase proteins whose synthesis is stimulated by pro-inflammatory cytokines and 
glucocorticoids (Drackley et al., 2005; Katoh, 2002). Haptoglobin is an acute-phase glycoprotein 
that has been used as an indicator of liver health status due to its quick response (Bertoni et al., 
2008) to an inflammatory event (Godson et al., 1996). It also plays an important role in lipid 
metabolism (Katoh, 2002; Katoh et al., 2002) because it is synthesized also by adipocytes 
(Friedrichs et al., 1995). As observed with globulin, under our conditions Hp did not seem to be 
activated by feed restriction since no differences were detected between diets (P = 0.25), days (P 
= 0.52), or interactions with day (Trt by day, P = 0.14). We observed a significant quadratic 
increase of Hp during AL that might be explained as due to possible inflammation in the catheter 
implantation site or to other unnoticed infection (Fig. 34). However, because of the large 
standard error of this result and the lack of correlation with other infection-related metabolites, 
the real reason behind this increase in Hp is not clear. On the other hand, SAA in plasma is 
associated with HDL because it helps transport of free cholesterol to damaged tissue for its repair 
(Liang & Sipe, 1995) and has other properties related with the immune system (Katoh, 2002). 
Similar to the response observed in Hp concentrations, there were no differences between diets 
(P = 0.44), among days (P = 0.47), or any interaction (Trt by day, P = 0.79) (Fig. 35). 
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Liver Function Indicators  
Serum concentration of total bilirubin (TB) is an indicator of liver function during the 
homeostatic processes occurring during NEB (Trevisi et al., 2010; Zhou et al., 2016). High 
concentrations of TB in circulation can derive from an increase of its synthesis or, more likely, 
from a decrease of TB clearance (Reid et al., 1983). During periods of high fat mobilization, 
NEFA competes with TB for binding with albumin (Naylor et al., 1980) in the serum to be 
transported to tissues such as liver (Listowsky et al., 1978). Therefore, in a feed restriction 
condition as is our experiment, we would expect higher concentrations of TB in serum due to the 
impaired clearance function of the liver (Reid et al., 1983) and also because of the decrease in 
albumin observed (Fig. 31). The TB concentration in the RC group was 58% higher (P = 0.013) 
than AL. Total bilirubin increased across time (P = 0.04, Fig. 36) during feed restriction, 
showing a weak quadratic tendency (P = 0.12) that reached its peak at d 3 and smoothly 
decreased thereafter until d 5, which is a similar pattern to NEFA (Fig. 18). Even though Ohgi et 
al. (2005) only detected a slight increase of TB in the first week postpartum, the authors found 
higher TB concentration in serum from cows with higher fat liver content. This positive 
correlation between TB in serum and liver fat concentration also was proven by other studies 
(Bertoni et al., 2008; Reid et al., 1983; West, 1990). Hence, TB has a fast response to fat 
mobilization, which makes it also a good indicator of liver function during short periods of 
deprived feeding. 
 Total alkaline phosphatase (APT) has been used as another signal for impaired liver 
function (Aiello, 2016). Alkaline phosphatase is formed by a group of isoenzymes that are 
synthetized in the liver and bones, which have a long half-life (Sato et al., 2005). However, the 
range of values for activities found in serum is wide due to the number of non-nutritional and 
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physiological factors involved: blood group, age, sex, seasonal fluctuations, and many others. 
(McComb et al., 1979). Regarding the factor we are concerned about, even the difference 
between lactation and pregnancy is not clear. Gahne (1967) found lower APT activity after 
calving, while Sato et al. (2005) reported higher activities during the entire lactation in 
comparison with the dry period. In contrast, Dann et al. (2006) did not observe any effect of 
prepartum dietary energy on APT. More recently Bertoni et al. (2008) found no difference during 
28 d post-partum between cows with different levels of liver activity index, which is based on 
the response of acute-phase proteins. Nevertheless, APT activity (36.5 U/L) during RC tended 
weakly to be lower (P = 0.18) than during AL (39.9 U/L). However, the difference gains 
significance if we consider the whole group of RES, and APT activity was lower during diet 
restriction (P = 0.042). While APT for AL stayed invariable (P = 0.64), for RES it decreased 
(RES by day, P < 0.0001) across period (Table 4) linearly (P = 0.002, Table 5) as RC did (Fig. 
37). These results are in agreement with Li et al. (2016) who observed a numerically lower 
serum APT activity in ketotic cows (clinical and subclinical) than in healthy postpartum cows, 
and showing activities in the same range as ours. Again, the short period of time or the high 
variation, as in Li’s study, probably did not allow more significant differences but at least the 
tendency seems to a lower activity of APT during periods of NEB. Since increased activities of 
APT would be expected as a sign of liver damage (Aiello, 2016), it seems that the lower 
activities probably derive from the malnutrition (McComb et al., 1979; Miller Wj Fau - Martin et 
al., 1969)  rather than from hepatic impairment in the conditions of our study. 
 Aspartate aminotransferase (AST) is another enzyme that is valuable to evaluate liver 
function. AST catalyzes the transfer of the amino group from 2-oxo-glutarate to aspartate 
resulting in creation of glutamate and oxaloacetate (Bender, 2012d). Higher serum activities of 
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AST means that there is a leakage into the blood due to damage in the liver cell membrane (Reid 
et al., 1983). However, AST is not liver specific so high activities of AST could also mean 
damage in other tissues (Reid et al., 1983). In consequence, increasing activities of AST have 
been positively associated with high fat accumulation in the liver and metabolic disorders (Bobe 
et al., 2004; Dann et al., 2005; Ohgi et al., 2005), as well as with high blood concentrations of 
NEFA and BHBA (Li et al., 2016). In fact, it has been reported in numerous studies that AST 
increases sharply after calving and decreases progressively until reaching the lowest values 
during the dry period (Bertoni et al., 2008; Ohgi et al., 2005; Van Den Top et al., 1996; Weber et 
al., 2015; Zvonko Stojević & Maja Zdelar-Tuk, 2005). Dann et al. (2006) tested different 
combinations of diets during far off and close-up prepartum, and detected that cows fed with a 
diet with 150% of the energy requirements (NRC, 2001) during the far off period had higher 
AST activities than cows fed with a diet meeting 100 or 80% of the requirements. However, in 
the conditions of our study, we did not find any difference (P = 0.72) between cows fed ad 
libitum or restricted diets, and neither any significant change across time in either condition 
(Table 5, Fig. 38). As a matter of fact, AST activity decreased during all treatments (AL 
included; Table 4), but only the RES grouping showed a quadratic decreasing trend (P = 0.009) 
with its peak on day 3.  
 Gamma glutamyl transferase (GGT) is an enzyme that participates in glutathione 
breakdown, forming cysteine and in this way keeping a correct oxidative stress balance 
(Yokoyama, 2007). Therefore, its activity could be increased due to greater oxidative stress such 
as during the transition period (Drackley et al., 2005). The GGT also acts as mediator catalyzing 
the transfer of a gamma-glutamyl group to different molecules such as water, AA, and peptides 
(Schulman et al., 1975). Nevertheless, in many studies there were no differences in GGT serum 
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activities between healthy cows and cows with different levels of ketosis or liver function 
(Bertoni et al., 2008; Dann et al., 2005; Gröhn et al., 1983). In contrast, Ohgi et al. (2005) 
detected a higher activity postpartum in cows with higher liver fat. However, in this last study 
the values of cows with higher liver fat [18 to 27 U/L] were even lower than the group with the 
best liver function [27.5 to 29.3 U/L] in Bertoni et al. (2008), making it even more complicated 
to draw conclusions. In addition, GGT activities were not different before and after calving 
among different far-off diets or even between ad libitum and restricted rations during the close-
up period (Dann et al., 2006). In our study, there were no differences (P = 0.98) of average 
activities of GGT between AL and RC, with no significant patterns of evolution over time in 
either treatment (Table 5, Fig. 39). However, considering the group of RES, restricted intake 
tended (P = 0.099) to increase quadratically (P = 0.001) the GGT activity. Nevertheless, GGT 
total activities in AL and RC (28.4 and 29.5 U/L) were above the reference range (6 to 17.4 U/L; 
Aiello, 2016).  
 Glutamate dehydrogenase (GLDH) is a liver-specific enzyme that, together with 
glutaminase, represents the biggest mechanism for elimination of NH3 in the form of urea, via 
the glutamate pathway (Bender, 2012b). Activity of GLDH converts ammonium and 2-oxo-
glutarate into glutamate (Bender, 2012b). To prevent any NH3 passing into circulation, GLDH is 
located in the mitochondrial matrix of the hepatic cells bordering the central vein that drains the 
liver (Bender, 2012c; Reynolds, 1992). Even though activity of GLDH is not altered by moderate 
infiltration of fat in the liver (Reid et al., 1983), GLDH is considered an indicator of liver health 
(Bobe et al., 2004; Wemheuer, 1987) since it would mean that the damaged liver cells are 
leaking the enzyme into the blood (Aiello, 2016). For instance, several studies have reported an 
increase in GLDH serum activity during the early postpartum period (Hoedemaker et al., 2004; 
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Reist et al., 2003; Weber et al., 2015).Therefore, in almost all situations GLDH is positively 
correlated with NEB (Hoedemaker et al., 2004; Reist et al., 2002), with impaired liver 
functioning, or with metabolic disorders (Stengärde et al., 2010). During our trial, there were no 
differences (P = 0.21) in GLDH serum activities between AL and RC groups and neither was 
there significant variation across period (Trt by day, P = 0.94). Only an effect of day (P < 
0.0001) was observed, which means that GLDH decreased during all the experiment, similar to 
the effect observed for AST (Fig. 38). However, RC manifested a linear (P = 0.042) decreasing 
evolution, as did the whole group of RES (Table 5), while AL did not change (Fig. 40). The big 
difference between both groups already on d 1 possibly prevented finding significant differences 
due to that trend. Our results are in accordance with Kuhla et al. (2009), who found a 
downregulation of glutamate dehydrogenase 1 (GLUD1; EC 1.4.1.3) after 60 h of feed restriction 
(only chopped straw provided to avoid rumen collapse). The reduction of circulating ammonia 
by this and other mechanisms, together with the reduction of TCA intermediates that would 
reduce the presence of  2-oxo-glutarate available for synthesis of glutamate (Noro & Wittwer, 
2012), may explain why GLDH decreased during feed restriction. It is important to mention that 
in our study, the total activities in AL and RC (51 and 59 U/L, respectively) are in the upper edge 
of the ranges observed in other studies.  
Protein Metabolism Variables 
Moving forward to analyze the effect of feed restriction, we next analyze the 
consequences on protein metabolism and it adaptations to counteract dietary energy and protein 
deficiencies. Urea is one of the N compounds derived from catabolism of AA, together with 
purines, uric acid, and ammonium salts (Bender, 2012c). Enzymes participating in the urea cycle 
are activated when there is an excess of protein intake in order to eliminate the overload of 
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ammonium from the AA catabolism. In addition, those enzymes are also activated by glucagon 
and glucocorticoid hormones in fasting situations (Bender, 2012c; Schoneveld et al., 2007) to 
eliminate ammonium produced by the AA catabolized for gluconeogenesis, as reported by Kuhla 
et al. (2009) after feed restriction during 2.5 d or by Loor et al. (2007) after 10 to 14 d of feed 
restriction. Plasma concentrations of urea have been positively correlated with better liver 
function (Bobe et al., 2004; Reist et al., 2002; West, 1990) because TG infiltration in hepatic 
cells impaired ureagenesis (Strang et al., 1997) and ammonia reduced the capacity to produce 
glucose from propionate (Drackley, 1999; Overton et al., 1999). Moreover, Bertoni et al. (2008) 
also found lower plasma urea concentration in cows with lower acute phase response after 
calving. Therefore, in healthy cows we expect to observe an increase of plasma urea 
concentration after calving in comparison with during the dry period (Fiore et al., 2015; Weber et 
al., 2015) due to the inherent energy shortage of this stage.  
In our study, daily plasma concentration of urea for RC (530 µmol/dL) tended to be 
higher (P = 0.077) than its concentration for AL (426 µmol/dl).  Urea increased (P < 0.0001) in a 
quadratic trend (P < 0.0001), rapidly reaching its peak at d 2 with a 33% increase, and decreasing 
progressively thereafter (Fig. 41). The same effect was observed during all RES treatments (RES 
by day, P < 0.0001). The fast increase and recovery probably did not allow for higher significant 
differences of total concentrations of urea in our study and in other feed restriction studies 
(Carlson et al., 2006; Laeger et al., 2012) or even during the onset of lactation ( Osorio et al., 
2014; Zhu et al., 2000). However, plasma ammonia concentrations probably are a better 
indicator of liver function than urea in cows during periods of NEB as suggested by Zhu et al. 
(2000). Nonetheless, ammonia was not different in RC than in AL in our study (P = 0.29), and 
no relevant evolution across time was detected in any of treatments (Trt by day, P = 0.24, Fig. 
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43). Ammonia concentration in plasma decreased during the post-feeding phase with no 
important differences between treatments (Fig. 44) and was higher at night, exhibiting an inverse 
progression within day compared with urea, which increased during the post-feeding hours (Fig. 
42). This coupled behavior within day demonstrates the ammonia detoxification function of urea, 
which increases quickly after the peak of ruminal ammonia due to feed fermentation in the 
rumen (Bender, 2012c; Gustafsson & Palmquist, 1993). Therefore, it seems that the higher 
concentration of urea during feed restriction periods serves to keep a constant optimal level of 
ammonia in blood. This mechanism seems to not be activated during post-calving in agreement 
with the higher ammonia concentrations in blood observed by Zhu et al. (2000) and with 
Hartwell et al. (2001), who reported no activation of the genes responsible for ureagenesis after 
calving. 
Glutamate 
Glutamate (Glu), together with Gln, are the two main AA responsible for the 
transamination among AA and also for the detoxification of nitrogen in form of ammonia 
(Bender, 2012b).  Glutamate synthetized in the liver can be later be deaminated again by GLDH 
or transaminated into Aspartate (Asp), participating in the urea and TCA cycles (Watford, 2000). 
Asp, oxaloacetate, α-ketoglutarate, and Glu are interconnected due to their participation in 
ureagenesis, the TCA cycle, and gluconeogenesis in the liver (Noro & Wittwer, 2012). One mole 
of NH4 and 1 mol of the amino group from Asp are needed to produce 1 mol of urea (Noro & 
Wittwer, 2012). Glutamate, besides providing α-ketoglutarate, which is another intermediate of 
the TCA cycle (Bender, 2012a), also provides the α-amino N required to synthetize Asp from 
oxaloacetate (Lobley et al., 2000; Reynolds, 1992). The double withdrawal of oxaloacetate from 
the urea and TCA cycle is compensated by its regeneration from the malate produced by 
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fumarate released in the urea cycle (Noro & Wittwer, 2012; Reynolds, 1992). In normal 
conditions, more oxaloacetate is synthetized than is required for both mechanisms. Therefore, 
after decarboxylation, it can be used as phosphoenolpyruvate (PEP) to produce glucose or to re-
enter the TCA cycle as acetyl-CoA once dephosphorylated to pyruvate (Bender, 2012b). 
However, when an imbalance in the availability of any of the intermediates in the urea cycle 
occurs, the NH4 cannot be removed and it accumulates in tissues (Visek, 1984).  
In this study, plasma concentration of Glu tended to be lower (P = 0.095) during RC than 
during AL. While Glu concentration remained invariable (P = 0.21) during AL, in RC treatment 
there was a decreasing effect across time (P = 0.005) that manifested a quadratic trend (P = 
0.015, Fig. 45). Within day, plasma Glu concentration had a significant variation (RC by hour, P 
= 0.002) and it was higher in the time points after feeding (Fig. 46) than in samples taken pre-
feeding, and was lower again at night (2300 h). In contrast, Glu remained invariable during the 
fed condition (AL by hour, P = 0.17, Fig. 46). Because insulin also was higher after feeding (Fig. 
21) and insulin drives the circulating AA towards peripheral tissues for anabolic processes (De 
Koster & Opsomer, 2013; Lobley et al., 2000; Noro & Wittwer, 2012), it seems that Glu, as 
concluded by Egan. (1968), is derived primarily for gluconeogenesis rather than for protein 
synthesis during milk synthesis and other anabolic processes.  
Proline 
Proline (Pro) is a semi-indispensable AA since it can be synthesized from Arginine (Arg) 
via Glu (Basch et al., 1997; Bequette, 2006). Because synthesis in the liver is not sufficient to 
meet the requirements for milk protein, Arg extracted by the udder is used as precursor of Pro 
(Bruckental et al., 1991). Since Pro is the AA with greatest abundance in the body, due to its 
function in collagen synthesis (Bender, 2012b; Stein et al., 1999), its demand may overcome 
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supply. In a nutrient stress situation, Pro can be metabolized to be used as metabolic fuel since 
proline oxidase will be activated, yielding Glu and then α-ketoglutarate, which is a TCA 
intermediate (Bender, 2012b; Gropper et al., 2009). Even collagen can be catabolized in order to 
supply more Pro (Phang et al., 2008). Hydroxyproline (OH-PRO) is an amino-acidic compound 
that participates in collagen synthesis and also is a marker of bone turnover (Peterson et al., 
2005). The OH-PRO is formed from the residue of Pro when it is metabolized only during 
protein synthesis, and also can be oxidized by proline oxidase yielding Glu and pyruvate.  
In our study, plasma concentration of Pro decreased (-26%) during RC (RC by day, P < 
0.0001) in a quadratic trend (P = 0.005, Fig. 47), whereas it did not vary (AL by day, P = 0.13) 
during AL treatment. However, this decrease did not allow us to find a significant difference 
between average daily Pro concentration (P = 0.24). On the other hand, OH-PRO was neither 
affected by feed intake (P = 0.22) nor by day (P = 0.10) in any of the treatments, and there were 
no interaction (P = 0.66) with day. However, Larsen et al. (2014) found a quick but sharp 
increase of OH-PRO at 4 DIM in comparison with prepartum values, which decreased thereafter. 
Therefore, it seems that there were no variation in the synthesis and catabolism of OH-PRO even 
though its precursor Pro did decrease during feed restriction. Accordingly, Pro concentration 
around calving also shows a decrease during prepartum with a nadir on the day of calving, and 
then an increase to recover prepartum values quickly in early lactation (Larsen & Kristensen, 
2009; Maeda et al., 2012; Meijer et al., 1995; Verbeke et al., 1972; Zhou Z. et al., 2016). In 
contrast, Laeger et al. (2012) did not find any variation after feed restriction. Within day, Pro 
decreased after feed delivery and then started to recover 14 hours after (2300) (Fig. 48) during all 
treatments (Table 6). 
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Asparagine 
Asparagine (Asn) is a dispensable AA than is synthesized from Asp and therefore can 
also be degraded back to Asp and NH3 (Wu, 2013). The NH3 can be taken up by α-ketoglutarate 
or pyruvate to form Glu or Ala respectively, and the carbon skeleton goes to oxaloacetate 
(Bender, 2012g; Gropper et al., 2009). Even though its chemical structure is very similar to Gln, 
Asn is not degraded by the enterocytes (Wu, 2013). Although statistically non-significant, 
Laeger et al. (2012) found a decrease in plasma Asn concentration after 4 d of feed restriction. 
Similarly, we detected no significant lower total concentration during RC (P = 0.47) in 
comparison with AL treatment. However, Asn concentration did decrease (-37%) across days (P 
< 0.0001) in a quadratic trend (P = 0.001, Fig. 51), reaching its nadir at d 3. Meanwhile, there 
were no interaction between AL treatment and day (P = 0.32), with Asn remaining stable during 
the 5 experimental days (Table 4). Asparagine also shows a decreasing plasma concentration 
around calving and a posterior recovery during early lactation (Doepel et al., 2002; Maeda et al., 
2012; Meijer et al., 1995; Verbeke et al., 1972). Concentration of Asn also decreased after feed 
delivery without differences between treatments (Table 6, Fig. 52)  
Histidine 
Histidine (His) is an indispensable glucogenic AA since during its catabolism it yields α-
ketoglutarate as intermediate for the TCA cycle (Gropper et al., 2009). On the other hand, His 
also is a precursor of the central neurotransmitter histamine (Bender, 2012f). Histamine plays a 
role in the gastrointestinal tract as secretagogue of gastric secretions, and in the immunologic 
system (Gropper et al., 2009). Histidine also is required for synthesis of carnosine (in reaction 
with β-alanine),  some of whose functions are still unknown but it is supposed to act within cells 
as buffer and antioxidant, and also helping during muscle contraction (Artioli et al., 2010; 
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Derave et al., 2010). Since it is present also in food, it can be a source of His and β-Alanine 
during digestion (Gropper et al., 2009). On the top of that, His seems to have a tremendous 
influence on milk protein synthesis and may be a limiting AA in some lactation rations (Bequette 
et al., 2000; Huhtanen et al., 2002).  
During our trial we detected a weak tendency (P = 0.17) for a lower concentration of 
plasma His during RC treatment. Histidine concentration decreased (P < 0.0001) from d 1 to d 3 
(-26%) and then remained at the same level until d 5, therefore manifesting a quadratic trend (P < 
0.0001, Fig. 53). As observed for the rest of AA, His concentration during AL remained constant 
during the 5 d, however, His seemed to be affected by AL (AL by day, P = 0.035) since there 
was a significant decrease from d 4 to d 5 (Fig. 53). This singular alteration was due to only one 
cow that had a remarkable drop (-47%) of His concentration from d 4 to d 5 without a logical 
explanation. Histidine concentration decreased slowly after feeding and increased again at the 
night sampling (Fig. 54, Table 6).  
Results from the literature are diverse. Histidine concentration did not decrease after feed 
restriction or even after starvation in mid-lactation cows (Baird et al., 1972; Laeger et al., 2012). 
However during the transition period and early lactation His seems to undergo a high uptake by 
the mammary gland (Larsen et al., 2015) or a deficiency of His since arterial levels did not return 
to pre-calving levels in most studies (Doepel et al., 2002; Maeda et al., 2012; Meijer et al., 1995; 
Zhou Z. et al., 2016). 
Another relevant function of His in body protein is that it is methylated when the muscle 
contracting proteins (actin and myosin) are broken down during protein mobilization (Gropper et 
al., 2009; Plaizier et al., 2000), after activation of the ubiquitin-proteasome pathway (Hasselgren 
& Fischer, 1997) by the decrease of insulin (Chen et al., 2011) and higher presence of cytokines 
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and glucocorticoids during fasting (Dardevet et al., 1995; Hasselgren, 1999; Hasselgren & 
Fischer, 1997). This new form is called 3-methylhistidine (3-MH) and it cannot be recycled for 
protein synthesis. Therefore, it has to be excreted, and as such it is used as an index of protein 
mobilization (Blum et al., 1985; Doepel et al., 2002). The 3-MH increased in both treatments 
across days (Table 4); however, during RC the concentration increased continuously and it was 
greater than during AL (Fig. 55). During RC, 3-MH began to increase on d 2 and reached its 
peak on d 5. Nevertheless, 3-MH has to be considered as an indicator of tissue protein turnover 
rather than simply mobilization. The ratio 3-MH:creatinine would give a better insight of this 
mechanism, because creatinine has a positive strong correlation with body muscle tissue mass 
(Costa e Silva et al., 2014). Creatinine concentrations were not measured in this study, but we 
would predict that during AL, creatinine in circulation would remain constant or increase, 
indicating a higher synthesis than degradation. On the other hand, during RC creatinine would 
probably have decreased, resulting in a greater ratio of 3-MH:creatinine as expected during NEB 
(Doepel et al., 2002), indicating higher protein degradation than synthesis. Moreover, 3-MH is 
not a proportional indicator of amount of muscle mobilized because its incomplete recovery in 
urine suggest a pool of non-protein bound 3-MH in muscle (Harris & Milne, 1980; Lobley, 
1998), as occurs in pigs (H.N.A. van den Hemel-Grooten et al., 1996) . On the top of that, 
muscle degradation occurs first in non-contractile myofibers, and then if any in contractile 
protein (MacLean et al., 1994). Therefore, amount and rate of degraded muscle cannot be 
accurately assessed using only 3-MH. 
Another methylated form of His is called 1-methylhistidine (1-MH).  Together with β-
alanine they form anserine, which is a methylated form of carnosine that also is present in 
skeletal muscle (Houweling et al., 2012). Like 3-MH, during carnosine catabolism, 1-MH is also 
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eliminated in urine since it cannot be recycled in the body (Bender, 2012f). No difference in 
concentration of 1-MH was found between RC and AL (P = 0.57), and no significant interactions 
either (P = 0.13). However, AL again showed a linear increasing trend (P = 0.033), while RC 
increased until d 3 and decreased thereafter, manifesting a quadratic trend (P = 0.019, Fig. 57). 
Similarly, Laeger et al. (2012) found increases in 1- and 3-MH after feed restriction. While, as 
mentioned previously, 3-MH and 1-MH must be excreted through the urine, β-alanine can be 
catabolized to yield acetyl-CoA in tissues (Wu, 2013). However, no significant differences were 
found during feed restriction in RC (Table 3, Fig. 59) and no interactions of any treatments with 
day (Table 7) either. Consequently, no big differences were detected in carnosine concentrations 
between AL and RC (P = 0.99) and neither were there interactions with day (Table 3). 
Nevertheless, during RC, carnosine (-9%) and β-alanine (-15%) showed similar weak decreasing 
quadratic trends (Fig. 61 and 59 respectively) that matched the quadratic increase of 1-MH 
(+8%); in contrast there were no changes during the AL treatment. The same opposite pattern 
across time between carnosine and 1-MH was reported by Laeger et al. (2012). These results 
suggest that carnosine likely was effectively degraded during restriction, releasing β-alanine that 
also was degraded and 1-MH that was excreted. 
Alanine  
Alanine (Ala) is a dispensable AA that can be a precursor for pyruvate and yield the N-
group for Glu synthesis (Gropper et al., 2009). Therefore Ala is considered a glucogenic AA. It 
is part of the important inter-organ connection called the Glucose-Alanine cycle, in which 
pyruvate receives the N-group from BCAA transamination in muscle to form Ala, and this Ala 
later yields the N-group for α-ketoglutarate and pyruvate in the liver (Gropper et al., 2009). This 
mechanism gains importance during NEB because it makes available Glu and pyruvate for 
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glucose synthesis and energy (Wu, 2013). For this reason is has been considered as one of the 
principal gluconeogenic precursors during the transition period (Bergman, 1978; Galindo et al., 
2015; Overton, 1998). In this study, Ala decreased (-18%) (P < 0.0001) from d 1 to d 5 in a 
quadratic trend (P < 0.0001, Fig. 63), with d 3 presenting the biggest difference between 
treatments. Even though Ala concentration in AL treatments showed a linear decreasing trend (P 
= 0.05), there was no interaction between AL and day (P = 0.34). In addition, since in RC the 
Ala concentration increased a small amount by the end of the period, possibly due to release 
from muscle, Ala concentration was not different on d 4 and 5 between treatments. A similar 
decrease (-13%) was reported by Laeger et al. (2012) after feed restriction, while Baird et al. 
(1972) found a bigger decrease (-37%) after 6 d of complete starvation. Alanine also showed a 
decreased concentration from pre-calving toward calving day, and a corresponding increase 
during lactation (Larsen & Kristensen, 2009; Maeda et al., 2012; Meijer et al., 1995) 
Branched-Chain Amino Acids 
 Contrary to other essential AA, the branched-chain AA (BCAA) are metabolized to 
common intermediates (Bender, 2012d; Bequette, 2003). Leucine is ketogenic (i.e., forms acetyl-
CoA and acetoacetate), Ile is both ketogenic and glucogenic (forms acetyl-CoA and propionyl-
CoA) and Val is just glucogenic (forms succinyl-CoA) (Bender, 2012d; Wu, 2013).  
 During shortage of dietary energy as in the fasting state, the pyruvate that comes from 
glycolysis of muscle glycogen receives the amino group from BCAA, forming Ala that will be 
later metabolized in the liver for gluconeogenesis or Gln to eliminate the amino group (Bender, 
2012d).  Unlike most AA, transamination of the BCAA occurs mostly in the skeletal muscle 
instead of in the liver (D'Mello, 2003). The keto-acids yielded from this transamination are then 
either transported to the liver to be back transformed to the AA (reacting with alanine), or can 
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also be oxidized in the muscle as a fuel source (Bender, 2012d; D'Mello, 2003). During fasting, 
the multi-unit complex of enzymes that form the branched-chain keto-acid dehydrogenase 
increases its activity, allowing for a greater capacity for BCAA oxidation in muscle (Bender, 
2012d). Furthermore, during fasting the oxidation of branched-chain keto-acids is increased due 
to the lower expression of branched-chain keto-acid kinase (Harris et al., 2001; Joshi et al., 
2006). The BCAA are also more oxidizable in the mammary gland than other essential AA, at 
least in sows  (Kim & Easter, 2003). On the other hand, BCAA also helps to develop a proper 
immune response since those are required for synthesis of acute-phase proteins, 
immunoglobulins, and cytokines, among other proteins (Calder, 2006; Zhou Z. et al., 2016).  
 In our study, no differences were observed between RC and AL for the daily mean 
concentrations of any of the BCAA (Table 3). However, during RC, all BCAA had a decreasing 
(quadratic for Val and Leu, linear for Ile; Fig. 65, 67, and 69) interaction with day during RC 
(Table 7). In general, BCAA plasma concentrations decreased linearly until d 3 and thereafter 
remained steady until the end of the experimental period. Meanwhile in AL, plasma 
concentrations of BCAA had no variation across days (Table 7) except for Valine (P = 0.049), 
even though it did not manifest any significant dynamic trend during the 5 days (Fig. 65, Table 
5).  
 These results are in accordance with other studies that found a significant decrease of 
BCAA during the onset of lactation when energy requirements are not met (Dalbach et al., 2011; 
Larsen et al., 2015; Maeda et al., 2012; Zhou Z. et al., 2016). Moreover, Larsen et al. (2015) 
found a higher catabolism of BCAA in the portal drained viscera (PDV) and mammary gland 
when greater supply of AA is provided during the beginning of lactation. Nevertheless, our 
results contrast with other studies with feed restriction performed in mid-lactation cows where 
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BCAA concentration increased after the feed restriction period (Baird et al., 1972; Laeger et al., 
2012), especially Leu. This effect could be due to greater muscle and peripheral tissue 
mobilization. Furthermore, in both studies there were only two time points compared (pre-
starvation and post-starvation), therefore we cannot conclude whether there was an earlier 
decline in the BCAA plasma concentration. 
 The BCAA, especially Leu, also act as signals of the availability of AA, together or 
separated with insulin after feeding (Bender, 2012d; Bequette, 2003). Therefore, the BCAA also 
stimulate the synthesis of protein (Bender, 2012d; Escobar et al., 2006).  
 In our study, the 3 BCAA decreased after feeding but only Leu and Ile had a significant 
decrease of plasma concentration (Table 6, Fig. 68 and 70), with no difference between 
treatments (Table 3). Valine had no significant variation within day (Table 6, Fig. 66). These 
results are in accordance with the anabolic effect that insulin exerts over the AA after feeding, 
which drives them toward tissue uptake (Lobley, 1992) to synthesize protein. 
Aromatic Amino Acids 
 Phenylalanine (Phe), Tyrosine (Tyr) and Tryptophan (Trp) belong to this special 
classification because their structure is characterized by side chains containing aromatic rings 
(Wu, 2013). Only Phe and Trp are dietary indispensable because Tyr can be  synthesized easily 
from Phe (Bender, 2012c). Both Phe and Tyr are both glucogenic and ketogenic since each can 
be metabolized to produce fumarate, which is a glucose precursor, and acetoacetate (Gropper et 
al., 2009). Phenylalanine hydroxylase, which is the enzyme that catalyzes the conversion from 
Phe to Tyr, is increased by glucagon and inhibited by insulin (Gropper et al., 2009). Degradation 
of Tyr is regulated by tyrosine transaminase, whose activity is induced by cortisol and other 
79 
 
glucocorticoid hormones, and also by its own concentration; Tyr then is converted to fumarate 
and acetoacetate (Bender, 2012c; Gropper et al., 2009). Therefore, in a feed restriction condition 
as the one established in our study, it is expected that a higher degradation of Phe will occur due 
to the observed decrease in insulin concentration (Table 5, Fig. 20). In addition, the concomitant 
increase of Tyr concentration and the possible higher plasma cortisol concentration (not 
measured in this study) will drive greater Tyr degradation to increase gluconeogenesis from 
these AA (Bender, 2012c) and reduce protein synthesis (Doepel et al., 2016). In our study, the 
role of Phe as precursor of Tyr was detected through their high correlation (r = 0.61, Table 10), 
which was the highest correlation for Phe with any compound.  
 During this study, total concentrations of Phe (P = 0.032) and Tyr (P = 0.001) were lower 
during RC treatment than AL (Table 3). Plasma concentration varied across periods (Table 7) for 
both AA during restriction (Fig. 71 and 73). Both Phe and Tyr decreased quadratically (Table 5) 
reaching a nadir on d 3. In contrast, during AL treatment Phe and Tyr plasma concentrations did 
not vary across days (Table 7). Within day, both AA decreased after delivering feed (Fig. 72 and 
73, Table 6) without differences between treatments. This decrease during the postprandial phase 
corresponds to the increase of insulin concentration after feeding that drives the circulating AA 
into insulin sensitive tissue for protein synthesis (De Koster & Opsomer, 2013; Lobley et al., 
2000). Therefore, the lower daily concentration of insulin and higher values of glucagon and 
perhaps glucocorticoid hormones occurring during feed restriction lead to greater degradation of 
Phe and Tyr (Bender, 2012c; Gropper et al., 2009). Laeger et al. (2012) did not find any effect on 
Phe concentration after 4 d on feed restriction (50% of the previous ad libitum intake), but did 
find a tendency for a lower Tyr plasma concentration and also a lower Tyr concentration in 
cerebrospinal fluid (CSF). This finding suggests a potential central anorexic effect of Tyr 
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(Laeger et al., 2012). Tyrosine is a precursor of melanin in the skin, thyroid hormones in the 
thyroid gland, neurotransmitters (catecholamines) and hormone precursor in neurons and adrenal 
medulla, respectively (Bender, 2012c; Gropper et al., 2009). Among the catecholamines 
synthesized from Tyr, adrenaline, noradrenaline, and dopamine have a recognized anorexic 
effect (Laeger et al., 2012). Thyroid hormones and catecholamines also activate mechanisms to 
counteract the negative energy balance. However, during feed restriction synthesis of thyroid 
hormones seems to decrease (Capuco et al., 2001), while catecholamines in circulation increase 
in order to decrease milk production and increase lipogenesis (Salin et al., 2017). Therefore, this 
pathway seems to be highly dependent on Phe and Trp. Similar results have been found during 
the onset of lactation when energy balance is negative due to the lower intake and the increasing 
demand of nutrients for milk production. Plasma Phe and Tyr decreased at parturition and then 
recovered, as lactation advanced (Larsen et al., 2015; Larsen & Kristensen, 2009; Maeda et al., 
2012; Meijer et al., 1995). 
 Tryptophan is also glucogenic and ketogenic since it can be metabolized to pyruvate and 
acetyl-CoA (Gropper et al., 2009; Wu, 2013). The first enzyme that initiates Trp degradation 
(tryptophan dioxygenase) is activated by glucagon and cortisol (Gropper et al., 2009) and is 
down-regulated by insulin (Nakamura et al., 1980). Subsequent reactions through the kynurenine 
pathway, which accounts for 95% of Trp degradation (Wu, 2013), end up forming Ala and 
acetyl-CoA. In addition, Trp plays an important role as precursor for the neurotransmitter 
serotonin and the hormone melatonin (Bender, 2012c). Tryptophan catabolism also produces 
nicotinamide adenine dinucleotide (NAD+), which is a coenzyme form of the B-vitamin niacin 
(Bender, 2012c; Gropper et al., 2009) and is vital for the pathway of glycolysis due to its 
oxidative capacity (Gropper et al., 2009). Nevertheless, oxidation of Trp through the kynurenine 
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pathway is regulated by its own concentration, since the presence of Trp in liver activates 
tryptophan dioxygenase (Bender, 2012c). Therefore, lower Trp concentration will decrease 
degradation to spare Trp for the serotonin pathway. Serotonin plays a crucial role in regulating 
mammary gland metabolism, milk synthesis, and calcium homeostasis during the transition 
period (Hernández-Castellano et al., 2017). This saving mechanism could be one of the reasons 
why in our study we did not find a significant difference in Trp concentration between RC and 
AL (P = 0.37). However, as observed for Phe and Tyr, plasma concentration of Trp decreased (-
18%; P < 0.0001) during RC until d 3 (Fig. 73), resulting in a quadratic trend; whereas Trp 
concentration was stable across days in AL (P = 0.53). Nevertheless, is important to mention that 
the decrease was linear (P <.0001) for the RES group. Like the other aromatic AA, Trp 
concentration decreased after feed delivery and increased again later during night sampling 
(Table 6), with no difference between treatments (Fig. 74).  
  Laeger et al. (2012) reported a decrease (-33%) in plasma concentration of Trp after feed 
restriction. Increased catabolism during the transition period and the onset of lactation also has 
been reported, analogous to the effects on Phe and Tyr, decreasing during prepartum until the 
calving day and later recovering as lactation begins (Maeda et al., 2012; Zhou Z. et al., 2016). 
Even more, the liver increases its removal of Trp during early postpartum period (Doepel et al., 
2009; Larsen et al., 2015).  
Threonine, Glycine, and Serine 
 There are 3 different pathways for Threonine (Thr) metabolism. One is driven by 
threonine deaminase, which is the most important during fasting and ends up synthesizing 
succinyl-CoA that is a precursor in the TCA cycle (Bender, 2012a; Gropper et al., 2009; Wu, 
2013) or that can be used as precursor of Ile (Bender, 2012a). Also, Thr can be a precursor of 
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pyruvate when the concentrations of the AA are high (Gropper et al., 2009). Finally, Thr can be 
metabolized in the mitochondria to produce Gly and acetyl-CoA (Bender, 2012a; Gropper et al., 
2009). Therefore, Thr is a strictly glucogenic AA.  
 In our trial, average daily Thr concentration was lower (-11%) for RC but was not 
statistically different from AL (P = 0.28). However, during RC the plasma Thr concentration was 
affected by the effect of day during restriction (P < 0.0001), showing a quadratic (P < 0.0001) 
trend, with the biggest difference from AL treatment on d 2 and 3 (Fig. 77). In contrast, Thr 
concentration during AL treatment remained steady during the 5 d (P = 0.20). Laeger et al. 
(2012) also reported a similar decrease (-12%) in plasma and a larger decrease in the CSF (-
24%), which the authors suggested to mean that Thr acts as a potential signal for feed intake. 
Like the other indispensable AA discussed so far, Thr also decreases as calving is getting close 
and then increases as lactation advance (Larsen et al., 2015; Maeda et al., 2012; Zhou Z. et al., 
2016). According with the literature, addition of extra Thr does not seem to have a positive 
effect, but neither does its deletion cause a negative effect (Doepel et al., 2016). This latter result 
suggests that even on a low protein intake, the cow is able to meet its Thr requirements. 
Glycine (Gly) is a semi-indispensable AA, since even though it is possible to synthesize 
it from other metabolic components (such as the AA Thr and Ser, glyoxylate, and choline), under 
certain conditions Gly synthesis cannot meet the requirements (Bender, 2012e). The conversion 
between Gly and Ser is bi-directional, so Gly is considered a glucogenic AA since through Ser it 
can provide pyruvate as an intermediate in the TCA cycle (Bender, 2012e; Gropper et al., 2009). 
Moreover, Gly is a precursor of purines, porphyrins, glutathione, creatine, and the bile salt 
glycocholate (Bender, 2012e; Gropper et al., 2009). During our study, Gly concentrations had a 
strong tendency (P = 0.056) to be higher (+24%) during RC than in the AL treatment. Even 
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though Gly was higher since d 1 (Fig. 79), the difference with AL treatment was bigger on d 4 
and 5 because Gly concentration increased (P < 0.0001) across time for RC but remained steady 
for AL (AL by day, P = 0.33). This considerably higher concentration or even no variation in Gly 
concentration during NEB has been reported widely in the literature. During an induced NEB 
through feed restriction, Laeger et al. (2012) did not find any variation of Gly concentration, 
whereas Baird et al. (1972)  reported a non-significant decrease (-27%). It is important to remark 
that the latter authors applied a complete feed restriction (starvation) while Laeger et al. (2012)  
just used a 50% restriction compared with the measured ad libitum intake. Regarding the 
transition period, several authors reported an increase from prepartum to calving day and an 
onward decrease as lactation began (A. Pechova et al., 2000; Doepel et al., 2002; Larsen et al., 
2015; Maeda et al., 2012; Meijer et al., 1995; Zhou Z. et al., 2016) or no variation across the 
transition period (Larsen & Kristensen, 2009; Verbeke et al., 1972).  
At least in the current study, it seems that Gly was not importantly degraded for any 
purpose during feed restriction. Instead, it seems that it was synthetized from other components, 
probably from Thr during its pathway toward the synthesis of acetyl-CoA (Gropper et al., 2009) 
or also from choline (Wang et al., 2013). During the latter pathway, choline must be first be 
oxidized to betaine in the liver. Then, after donating its methyl group and reacting with folic 
acid, sarcosine  is generated, which is a direct precursor of Gly (Gropper et al., 2009; Wu, 2013). 
Even though total sarcosine concentration was not different between treatments (P = 0.96), there 
were an interaction with day only during RC (P = 0.002), resulting in an increasing linear trend 
during RC (Fig. 81). Therefore, it is probable that this pathway of Gly synthesis was activated 
during feed restriction (Soloway & Stetten, 1953). Higher plasma Gly concentrations also may 
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be due to the increase of tissue mobilization since, together with Gln, both are the AA with 
greatest content in connective tissue in muscle (Verbeke et al., 1972; Zhou Z. et al., 2016). 
Serine is a dispensable AA that is strictly glucogenic. Transamination of Ser can yield a 
precursor of Gly (glyoxylate) or a substrate for gluconeogenesis (3-phosphoglycerate) (Bender, 
2012e; Wu, 2013). Deamination of Ser by serine deaminase produces pyruvate, which is also a 
required precursor for the TCA cycle. This enzyme is activated by glucagon and other 
glucocorticoid hormones and deactivated by insulin (Bender, 2012e). Serine can also participate 
in Met metabolism by reacting with homocysteine to generate cystathionine (Wu, 2013), and 
also during the synthesis of phospholipids producing ethanolamine and choline (Gropper et al., 
2009). Even though there were no differences between treatments in our study (P = 0.73), the 
plasma concentration of Ser during RC treatment interacted with day (P < 0.0001), while during 
AL it remained constant (P = 0.07). The Ser concentration during RC manifested a clear 
quadratic trend (P = 0.001), decreasing sharply until d 3 (-22%), and then remaining practically 
constant until the end of the period (Fig. 83). Therefore, it seems that Ser could be also a 
precursor of Gly during this experiment. Even though Ser and Gly had different patterns across 
the period, Gly had the strongest correlation with Ser (r = 0.55, Table 10), suggesting a ready 
conversion between them regardless of time. 
Baird et al. (1972) also found a lower plasma Ser concentration after 6 d of starvation, 
and Laeger et al. (2012) reported a decrease of Ser concentration only in CSF, suggesting a 
potential central anorexic effect like Thr and Tyr (Laeger et al., 2012). However, in several 
transition studies, Ser concentration was found to remain constant (Doepel et al., 2002; Larsen & 
Kristensen, 2009; Verbeke et al., 1972; Zhou Z. et al., 2016) around calving, or showing the 
same pattern as Gly, increasing during prepartum until calving day and then decreasing during 
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the onset of lactation (Maeda et al., 2012; Meijer et al., 1995). Probably, the wide range in the 
concentrations of some of the Ser precursors such as choline, glucose, and Glu (Sun et al., 2016; 
Wang et al., 2013) due to dietary and other conditions in experiments with transition cows lead 
to this different behavior of Ser in comparison with studies like ours with feed restriction. Both 
AA (Ser and Gly) decreased (Table 6) within day after feed delivery (0900) and recovered by 
night 14 h later (2300 h) (Fig. 80 and 84) denoting the anabolic process promoted by insulin in 
both treatments (Lobley, 1992).  
Phosphoserine (P-Ser) is an intermediate in the phosphorylated pathway of Ser synthesis. 
In this pathway, Ser is synthesized from glucose and Glu (Bender, 2012e; Wu, 2013). However, 
P-Ser was not different between RC and AL (P = 0.78), and was not affected by day (P = 0.9). It 
is important to remark that P-Ser decreased to a bigger or smaller extent during all treatments 
(Table 7). Also, during AL P-Ser was strongly altered by the day effect (P = 0.004), decreasing 
in a linear trend (Fig. 85). This could be in relation to the slight decrease (AL by day, P = 0.07) 
of SER (-9%) concentration observed during AL treatment (Fig. 83). 
Ethanolamine (EA) is a component of phospholipid that results from decarboxylation of 
Ser followed by methylation becomes choline (Gropper et al., 2009). Phosphorylation of EA 
yields phosphoethanolamine (PEA), which is a derivative of ethanolamine used in phospholipid 
synthesis. While during AL treatment none of these compounds was altered, during RC, EA 
decreased (RC by day, P = 0.03, Fig. 87) across the experimental period and PEA tended to 
increase (RC by day, P = 0.06, Fig. 89). The PEA is a constituent part of sphingolipids, which 
also play a relevant role in signal transmission and cell recognition (Bartke & Hannun, 2009). 
However, the more likely scenario would be that, during feed restriction, Ser degradation 
contributed to form EA and PEA during synthesis and degradation of choline (Maldonado et al., 
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2014). Increasing concentrations of PEA can be due to decreased methylation since Met 
concentrations also decreased during restriction. This finding is in agreement with the increasing 
concentrations of sarcosine, which is an intermediate in the choline-to-glycine pathway (Cernei 
et al., 2013). 
α-Amino butyric acid (α-ABA) is a non-protein AA that is synthesized from the 
transamination of α-ketobutyrate; therefore, it can be derived from the metabolism of Thr, Ser, 
Gly, and also Met. Since α-ketobutyrate has another glucogenic pathway, the transamination 
toward α-ABA it is considered an indicator of liver malfunction connected with hyper-
catabolism of AA and hyper-aminoacidemia (Chiarla et al., 2011). In our study, α-ABA 
increased (P = 0.001) during the whole period in a linear (Fig. 91) trend during RC, similar to the 
response reported by Laeger et al. (2012). However, α-ABA also increased during AL treatment 
(AL by day, P = 0.021) in a quadratic (P = 0.007) manner, reaching the peak on d 4 and 
decreasing afterwards. The 3-MH concentration seems to be correlated with the concentrations 
of α-ABA during sepsis in humans (Chiarla et al., 2011). As observed in our study, both 
metabolites showed comparable linear increase during AL, matching the behavior during feed 
restriction. Therefore, probably the higher concentration of AA in the AL treatment promoted a 
higher protein synthesis and hence the higher AA catabolism of the excess.  
Sulfur (S)-Containing Amino Acids 
 Methionine (Met) and Cysteine (Cyst) are characterized by their side chain containing a 
Sulfur (S) atom (Wu, 2013). Catabolism of Met ends up producing succinyl-CoA, so therefore 
Met is a glucogenic AA; during that catabolic process Met also yields Cys (Gropper et al., 2009). 
However, its most important role is that Met is the major donor of methyl groups through S-
adenosyl methionine (SAM) for one carbon transfer reactions (Bender, 2012a; Zhou et al., 2016). 
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The methyl donor SAM is needed for synthesis of carnitine, creatine, epinephrine, melatonin, 
choline, anserine, 3-MH and polyamines (Bender, 2012a; Wu, 2013).  On top of that SAM also is 
required for methylation of DNA as an epigenetic reaction, therefore influencing gene expression 
(Gropper et al., 2009). Due to the relation of Met with choline and carnitine, this AA plays a 
relevant role in fatty acid metabolism during NEB. Recent studies have indicated the important 
effects of choline and carnitine in the transition period. Choline promotes the uptake of NEFA by 
hepatocytes and is a necessary component of VLDL synthesis (as phosphatidylcholine), and 
carnitine is a required component for fatty acid β-oxidation in mitochondria (Goselink et al., 
2013; Sun et al., 2016). These functions have been linked with a better performance in the 
postpartum transition during Met supplementation (Osorio et al., 2014; Zhou et al., 2016). 
Accordingly, during our study there seemed to be Met degradation during the RC treatment since 
Met plasma concentration decreased (-19%) along the 5 d (P = 0.001) in a linear trend (RC by 
day, P = 0.004, Fig. 93), with the biggest drop between d 1 and d 2 (-16%). In contrast, during 
AL concentrations of Met did not change (AL by day, P = 0.60) across the period. Nevertheless, 
probably due to the different initial values, there were no differences (P = 0.77) in Met 
concentrations between treatments. Laeger et al. (2012) reported also a non-significant change of 
Met concentration after feed restriction for 4 d. Regarding Met plasma concentration around 
calving, while some studies had reported a quick recovery from prepartum values after the nadir 
at calving day or no variation (Doepel et al., 2002; Larsen et al., 2015; Larsen & Kristensen, 
2009; Maeda et al., 2012; Verbeke et al., 1972), other studies found a lower value during early 
lactation than in prepartum (Meijer et al., 1995; Zhou Z. et al., 2016). The fact that Met is an 
indispensable AA and is considered one of the most potentially limiting AA in Western diets 
(NRC, 2001) could be one of the reasons why such a difference exists among studies. Moreover, 
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because the first product of Met catabolism is SAM, which stimulates Met degradation itself 
(Gropper et al., 2009) and is related with lipid metabolism as reviewed previously, the wide 
range of conditions affecting the transition period could have led to these diverse responses in 
peripartal Met concentrations. 
 Cysteine is a dispensable AA that is synthetized from Met (Wu, 2013). Cysteine 
can be used as precursor for synthesis of glutathione, taurine, and pyruvate, and therefore it is a 
glucogenic AA (Gropper et al., 2009). Since it is a required step for glutathione synthesis, Cys 
(and hence Met too) has an important role regulating the intracellular antioxidant status (Luo & 
Levine, 2009; J. S. Osorio et al., 2014; Sun et al., 2016). Nevertheless, during our study total 
plasma concentrations of Cys had a weak tendency to be higher during RC than during AL (P = 
0.15), especially on d 4 and 5 where Cys concentration was significantly higher (Fig. 95) for RC 
than for AL treatment. Laeger et al. (2012) also reported a numerical increase of Cys 
concentration after feed restriction. As observed for Met, there are different responses detected 
around calving. In general, it has been reported that Cys in most cases recovered to pre-calving 
concentrations quickly after calving, or even that Cys did not change significantly across the 
transition period (Larsen et al., 2015; Larsen & Kristensen, 2009; Meijer et al., 1995; Verbeke et 
al., 1972). However, Zhou Z. et al. (2016) detected that Cys did not recover the pre-calving 
values and remained low during the early post-partum. The role of Cys as precursor of 
glutathione could mark the difference between studies. The demand for glutathione as 
antioxidant around calving could be the major factor that determine the degradation of Cys and 
thus of Met. As in our case, it seems that 5 d of feed restriction did not require an excessive 
redox function so the demand for glutathione did not require catabolism of Cys. Moyes et al. 
(2009) also concluded that similar feed restriction conditions applied to mid lactation cows were 
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not sufficient to induce a significant oxidative stress. In fact, Cys concentration increased 
probably due to the higher metabolization of Met via glucogenic pathway to yield succinyl-CoA. 
The role that Cys plays as the only AA able to inhibit the activation of mTORC1, and 
therefore inhibiting protein synthesis and promoting tissue degradation, could be crucial during 
NEB periods and accordingly should be a good indicator of tissue mobilization (Dyachok et al., 
2016). Cystathionine (Cysta) is one of the intermediates within this pathway that is a result of the 
reaction of Ser with Homocysteine (Bender, 2012a; Wu, 2013). No differences were detected 
between AL and RC (P = 0.93). There was no significant interaction between RC and day (P = 
0.23), however when considering all treatments under restriction (RES), diet had a significant 
interaction with day (RES by day, P < 0.0001) and manifested a quadratic (P = 0.001) decreasing 
trend (Table 5) during feed restriction (Fig. 97). This interrelated decrease of Met, Ser, and Cysta 
indicates that they likely were utilized during the Cys synthesis pathway. Cysteine also is a 
precursor of Taurine (Tau), which  is mainly located in muscle and in the CNS (Gropper et al., 
2009). Taurine is not involved in protein synthesis, but has important roles as antioxidant, tissue 
osmolyte, bile salt component, and inhibitory neurotransmitter (Bender, 2012a; Gropper et al., 
2009; Kalhan & Marczewski, 2012). Concentration of Tau in plasma during RC treatment was 
not different (P = 0.97) than during AL, and no interaction with day was detected in either 
treatment (Table 7). Nevertheless, it is important to mention that Tau increased during the other 
treatments forming the RES group (Table 4 and 3), except in GLN. Even more, Tau only 
increased across the period in the treatment where Cys also increased and therefore showing a 
strong correlation in our experiment. 
Lysine  
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Lysine is an in-dispensable AA that allows for synthesis of only ketogenic precursors 
(acetyl-CoA and acetoacetate), and so it is considered a strictly ketogenic AA (Wu, 2013). The 
most common pathway for Lys catabolism is the saccharopine pathway, which uses α-amino 
adipic acid (α-AAA) as intermediate for synthesis of acetoacetate. This same intermediate also is 
involved in Lys synthesis from oxoadipic acid in bacteria, yeast, and some fungi (Bender, 
2012f). Once Lys is incorporated into muscle protein, it is a precursor for carnitine that is 
required for oxidation of fatty acids (Akbar et al., 2013; Gropper et al., 2009), and also is a 
precursor for de novo synthesis of Arg and Pro (Bequette, 2002). It seems that in our study, there 
was no excessive degradation of Lys since its daily concentration was higher during RC than AL 
(P = 0.05). Neither treatment had a significant interaction with day (Table 7), although the 
biggest differences were detected on d 4 and 5 (Fig. 101). Even though uptake of Lys by the liver 
does not change substantially in response to Lys supply (Lapierre et al., 2009), during calving 
increased hepatic uptake of Lys occurs (Larsen & Kristensen, 2009); uptake changes to a net 
release around 15 d after calving. 
Nevertheless, the organ where most Lys uptake occurs is the mammary gland and it is 
taken up beyond the requirements for milk protein synthesis (Bequette et al., 1998; Raggio et al., 
2006). Oxidation of the excess is supposed to provide the N-group for synthesis of other NEAA 
such as Arg and Pro (Bequette et al., 1998; Bequette et al., 2002; Lapierre et al., 2003; Roets et 
al., 1979). Lysine is considered in most Western diets as a limiting AA for milk protein synthesis 
(Clark, 1975; NRC, 2001; Schwab et al., 1976) and a positive performance response after Lys 
supplementation has been generally observed (Arriola Apelo et al., 2014; Robinson et al., 2010). 
Nevertheless, it seems that during the experimental period of this trial, there were an increased 
Lys concentration in circulation probably due to the higher tissue protein breakdown as observed 
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by Laeger et al. (2012) and Baird et al. (1972), who found an increases of Lys in plasma after 
feed restriction or starvation, respectively.  Furthermore, the decrease of milk protein production 
(Fig. 5) suggests that Lys was not limiting for this purpose. Similarly, Swanepoel et al. (2010) 
also reported a lack of effect on milk components during early lactation. Other studies assessing 
AA concentration around calving showed that Lys decreased from the prepartum period until 
calving and increased afterwards (Doepel et al., 2002; Larsen et al., 2015; Larsen & Kristensen, 
2009; Maeda et al., 2012; Verbeke et al., 1972). Mammary gland has the capacity to alter AA 
uptake to meet its requirements (Mackle et al., 2000). Specifically, Lys seems to have a regulated 
mechanism that allows the same mammary catabolism even when the mammary artery supply is 
diminished (Guo et al., 2017), probably by decreasing the uptake for milk protein synthesis since 
the Lys content in milk is rarely altered (Lapierre et al., 2009; Tucker et al., 2017), and driving it 
toward synthesis of other NEAA alike Arg, which was also higher during RC (P = 0.008). 
Those findings agree with our results because Lys concentration in plasma was higher 
during RC, despite a relevant catabolism of Lys indicated by the tendency (P = 0.12) for greater 
total concentration ofα-AAA than during AL, which suggests a regulatory role of the excess of 
Lys in circulation by hepatic and/or extrahepatic oxidation (Tucker et al., 2017). The plasma 
concentration of α-AAA had an interaction with day (P = 0.015), which resulted in the biggest 
differences on d 4 and 5 (Fig. 103) in, accordance with the days of higher Lys concentration (Fig. 
101). Therefore, it is probable that similar to what occurs when there is an excess of dietary 
protein (Broderick, 2003), the overload of Lys concentration in plasma would be degraded to 
produce energy through its carbon skeleton (ketone bodies and acetyl-CoA in this case) and then 
eliminating the 2 N via saccharopine (Wu, 2013), yielding 2 Glu for further metabolism. It is 
important to mention that, at least in vitro, the liver of ruminants (cattle and sheep) is able to 
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synthesize Lys from saccharopine (Fellows, 1973), and the activity of the enzyme required 
(saccharopine oxidoreductase) was higher than in non-ruminants (Fellows & Lewis, 1973). Even 
though concentrations of saccharopine are very low in circulation, its precursor α-AAA is 
available (Fellows & Lewis, 1973). Lysine concentration decreased after feeding (Fig. 102), with 
no differences between treatments (Table 6).   
Urea cycle 
The urea cycle takes place in the periportal hepatocytes and partially in the enterocytes 
and other extra-hepatic tissues (Bender, 2012c). Intermediates of the urea cycle are very tightly 
regulated (Morris, 2002). Some of them were measured in our study and will be discussed later 
in this section. The enzymes responsible for the urea cycle are regulated by glucagon, insulin, 
and glucocorticoids among other hormones (Morris, 2002). For instance, the uptake of the 
ammonium required for synthesis of carbamoyl phosphate is regulated by the mitochondrial 
carbamoyl phosphate synthetase (CPS-I), which is the main regulator of the urea cycle and is 
activated in response to glucagon and glucocorticoids (Bender, 2012c; Schoneveld et al., 2007). 
The urea cycle needs balanced entrance of carbamoyl-P and Asp (Lobley et al., 2000). To avoid 
the prejudicial consequences of an imbalance on any intermediate of the cycle, ruminant 
metabolism has its own mechanisms of compensation (Lobley et al., 2000). For example, 32% of 
the aspartate-N came from recycled ammonia in fasted sheep (Milano et al., 1996). It was also 
suggested that catabolism of AA can be down regulated in case of an excessive blood 
concentration of ammonia (Lobley et al., 2000).  
Enzymes involved in the urea cycle are not expressed in all cells (Morris, 2002); 
therefore, its completion requires an interorgan coordination (Reynolds, 1992) between liver and 
extrahepatic tissues. A big fraction of the dietary Arg is transformed to Orn in the small intestine, 
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which is later converted in the liver to citrulline (Cit). Thereafter, Cit is transported to the 
kidneys in order to synthetize Arg (Bender, 2012b; Reynolds, 1992). Without this interorgan 
cooperation, most of the dietary Arg would be degraded by the liver to produce urea and Orn due 
to the high activity of arginase in the liver, leaving very little Arg available for other organs 
(Bender, 2012b; Curis et al., 2005). Moreover, since Arg regulates positively ureagenesis (Meijer 
et al., 1990), this coordinated adaptation prevents an unnecessary production of urea (Bender, 
2012b; Curis et al., 2005).  
Urea cycle equilibrium during a short-term feed restriction also was reflected in our 
study. The daily concentration Arg during the RC treatment was higher (P = 0.008) than that 
during AL during the entire 5-d experimental period, but this increase did not fit in any 
recognized trend across time, similar to AL (Fig. 105). This suggests that an equilibrium in Arg 
concentration was achieved, even with increasing and variable amounts of urea synthesized (Fig. 
41, Table 3). According to our findings, higher (P = 0.07) and increasing (RC by day, P < 
0.0001) Cit concentrations (Fig. 107) during RC were derived from Orn, which decreased (RC 
by day, P = 0.007, Fig. 109) in an opposite trend (linear; P = 0.018), capturing ammonia through 
the merger with carbamoyl-P. Citrulline would later condense with Asp to form 
Argininosuccinate (not analyzed in this experiment), which is an immediate precursor of Arg 
(Husson et al., 2003). Therefore, it seems that during our short-term period of feed restriction, 
urea synthesis completed its cycle and achieved an equilibrium state of ammonia and Arg at the 
expense of Asp, which showed a decreasing (RC by day, P = 0.0001) linear trend (P < 0.0001, 
Fig. 111) during the entire period.    
As mentioned earlier, some of the enzymes catalyzing the urea cycle are regulated by 
insulin, glucagon, and glucocorticoids. For instance, glucagon and GH upregulate the production 
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of urea through the synthesis of argininosuccinate, which activates argininosuccinate synthetase 
(ASS) (Curis et al., 2005).  The uptake of ammonia into carbamoyl-P activates f N-
acetylglutamate (N-AG) synthetase, while insulin downregulates both enzymes. These known 
processes are in accordance with our results where the higher plasma concentration of urea 
coincided with the higher concentration of glucagon and the decreasing concentration of insulin 
during the first 3 d of feed restriction. The same mechanism seems to operate with the variations 
observed within day. Blood samples drawn after feeding showed lower concentrations of all 
metabolites implicated in the urea cycle than in pre-feeding samples (Table 6, Fig. 106 108, and 
109), except Asp and urea itself (Fig. 112 and 42). From these results, we can extrapolate that 
during the absorptive phase the higher urea concentrations were due to the production from 
rumen fermentation (Atasoglu & Wallace, 2003). 
The liver in mammals has a specific heterogeneity of morphology that ensures that little 
or no ammonia reaches circulation (Noro & Wittwer, 2012). The ammonia that escapes from 
GLDH located in the periportal cells is later metabolized in the perivenous cells where is 
incorporated to Glu and then converted to Gln by glutamine synthetase (Bender, 2012c; Noro & 
Wittwer, 2012). Glutamine has multiple metabolic functions in the body. It is the main energy 
substrate for dividing cells in the intestinal epithelium and in lymphocytes (Chwals, 2004), and 
also acts as neurotransmitter within the brain (Taylor & Curthoys, 2004). Muscle cells play a role 
as Gln reserves and are able to have up to 30 times higher Gln concentration than plasma (Meijer 
et al., 1993). During acute metabolic acidosis, muscle rapidly releases glutamine after the 
metabolic pH drops (Schröck et al., 1980) and uptake from the digestive tract decreases (Taylor 
& Curthoys, 2004). This interorgan coordination results in a significant increase of plasma Gln 
concentration (Bender, 2012b), which allows the kidneys to increase their uptake of Gln (Taylor 
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& Curthoys, 2004). The activity of glutaminase in the renal tubes responsible for the uptake of 
glutamine also is activated by metabolic acidosis (Curthoys & Gstraunthaler, 2001). The 
resulting Glu produced in the kidneys is catabolized by GLDH into ammonia to be expelled in 
the urine, and at the same time bicarbonate is formed to enter into circulation and compensate for 
the ionic imbalance (Bender, 2012b; Taylor & Curthoys, 2004).  
Cows during RC treatment in our study had a faster and compulsive ingestion of the 
limited amount of feed, which resulted in them ingesting all the feed offered (~12.4 kg DM) in a 
very short period of time (~2 to 3 hours). This probably led them to encounter an acute drop of 
the ruminal pH, developing a consequent temporary acidosis that would result in the above-
mentioned increase of Gln concentration in plasma. This seems to be the reason behind the 
different behavior of plasma Gln concentrations after feeding observed between AL and RC 
treatments in our study (Fig. 114). Even though no significant interaction of time with diet was 
established (P = 0.27), it is remarkable that in all restricted treatments (RES) Gln increased after 
feeding while it decreased during AL (Table 6). As a result, the biggest differences between diets 
occurred in the time points after feeding and especially at night (Fig. 114). Daily concentration 
of Gln was higher in RC (P = 0.03) and tended to be higher in RES (P = 0.089) than in AL, 
probably due to the higher requirements to detoxify ammonia concentration from AA catabolism 
(Meijer et al., 1990). Glutamine also is also tightly related with the urea cycle (Bender, 2012b).  
During fasting, intestinal cells take up plasma Gln to synthesize Cit besides Arg (Curthoys & 
Watford, 1995). The synchronized and opposite patterns of Cit (Fig. 107) and Gln (Fig. 113) 
across the period found in our trial seems to justify that urea formation was the preferred 
pathway at the beginning of the dietary restriction, probably due to the higher detoxification 
capacity of ammonia at lower energetic cost (Bender, 2012d; Noro & Wittwer, 2012; Reynolds, 
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2006), or just because of the higher ammonia resulting from AA oxidation (Haussinger, 1990). 
Urea synthesis might have been reduced later on in the period to save bicarbonate ions and 
maintain an adequate cation-anion balance (Meijer et al., 1993); however, since during fasting 
ruminal pH increases (Galyean et al., 1981), this option does not seem probable. During RC 
treatment, the peak Cit concentration and the nadir concentration of Gln coincide on d 2. This 
result suggests that there was an increased uptake of Gln to produce Cit, driving the expulsion of 
ammonia through urea. Around 75% of the ammonia is converted to urea while Gln accounts for 
the other 25% under normal physiological conditions (Haussinger, 1990). However, as days pass 
it seems that urea synthesis decreases and Gln increases, suggesting a switch in the preference 
for a low-capacity high-affinity method to detoxify ammonia as Gln (Lobley et al., 1995). 
Interestingly, the negative correlation between NH3 and Gln was greater than the correlation 
between NH3 and urea in our study (Table 10). This relationship likely reflects the tremendous 
importance of Gln in N metabolism. 
Accounting for the loss of amino-N due to the decrease of all the individual AA analyzed, 
and considering the increase of urea, Gln, and the other AA that increased during fasting (Lys, 
Cyst, Arg, Cit, Tau, α-ABA, sarcosine), there seems to be a large shortfall of amino-N sources to 
trigger the increase in urea observed during feed restriction. The increase from d 1 to d 5 of 
amino-N (~30 µg/dL) found in blood was very similar to the increase registered in milk (~37 
µg/dL). However, the assumed amount of amino-N provided by cleavage of the AA in 
circulation only represents around 15% of the urea increase. Therefore, since urea synthesis does 
not require extra uptake of AA (Reynolds, 2006) as was suggested in the past (Lobley et al., 
1995), tissue protein mobilization could be providing the AA required for energy generation and 
glucose synthesis, along with the subsequent excretion of the amino groups through urea 
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synthesis. According with the literature, this rapid reaction suggests that plasma proteins, liver, 
and gastrointestinal tract were the principal sources of AA at the beginning of the period, while 
skeletal muscle was increasing its contribution during the last days as indicated by the higher 
concentration of 3-MH (Swick & Benevenga, 1977). It must be realized that these estimates are 
not quantitative because fluxes of compounds and differential half-lives in circulation were not 
measured. 
CONCLUSIONS  
Feed restriction effectively caused lower BW and a greater degree of NEB. 
Consequently, milk yield decreased with higher milk fat percentage, lower milk protein 
percentage, and no difference in milk lactose content. Therefore, no differences were detected in 
ECM between AL and RC treatments. The lower concentration of insulin during RC quickly 
allowed lipid mobilization as reflected by higher NEFA and TG concentrations, and increased 
AA oxidation as reflected by the higher plasma urea N. The higher urea concentration was paired 
with lower concentrations of all essential AA except Lys, and nonessential AA except Cys, Gly, 
Arg, and Gln. Both Phe and Tyr deserve special mention because they were the only AA with 
significantly lower concentration, with Glu and Asp tending to be lower. These specific cases 
demonstrate their involvement as regulators and precursors in important mechanisms activated 
during homeostatic processes. However, in attempting to account for all the amino-N circulating 
in form of urea or eliminated in milk as MUN, the decrease in concentration of all the AA 
analyzed here was not sufficient for the amount of urea synthetized. Therefore, it seems probable 
that body tissue protein was rapidly mobilized at the beginning of the feed-restriction period, to 
produce the energy required to support the higher ECM especially through milk fat and lactose.  
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Despite the synchronized evolution of decreasing insulin, glucose, and AA concentrations 
paired with increasing NEFA and urea across the 5-d feed restriction period, the feeding effect 
within each day immediately provoked an analogous reactivity regardless of the diet. The spike 
of insulin after feeding caused a decrease of glucose and AA concentrations, which indicates an 
uptake for glycolysis or storage and protein synthesis, respectively, in insulin-sensitive tissues. 
Furthermore, NEFA concentration also dropped significantly to values close to those during AL 
after feeding. On the other hand, urea in circulation increased after feeding, which suggests 
higher urea cycle activity capturing ammonia absorption from rumen fermentation in accordance 
with the lower NH3 concentration after feeding. This series of reactions suggests that the feeding 
effect in RC rapidly restored metabolite concentrations to their regular behavior during normal 
fed conditions, possibly due to higher sensitivity to insulin during periods of negative energy and 
protein balance. 
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Figure 1 Schematic design of the experiment timeline and daily sampling and treatments application schedule. 
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Figure 2 Daily average of Dry Matter Intake (kg /day) in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 3 Daily average of Body weight (kg) in RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.001 
AL x d P = 0.67 
RC x d P < .0001 
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Figure 4 Daily average milk production (kg/day) of RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 5 Daily average milk protein percentage (%) of RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.002 
AL x d P = 0.39 
RC x d P = 0.008 
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Figure 6 Daily average of milk protein yield (kg /day) of RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
Figure 7 Daily average of milk fat percentage (%) of RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.034 
AL x d P = 0.16 
AL x RC P < .0001 
AL Quad. P = 0.015 
RC Linear P < .0001 
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Figure 8 Daily average of milk fat yield (kg/day) of RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
Figure 9 Daily average of milk lactose percentage (%) of RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.99 
Day P = 0.51 
Trt x d P = 0.34 
AL vs RC P = 0.2 
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Trt x d P = 0.31 
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Figure 10 Daily average of milk lactose yield (kg /day) of RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.001 
AL x d P = 0.44 
RC x d P < .0001 
AL Quad. P = 0.075 
RC Linear P < .0001 
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Figure 11 Daily average of Total Solids in milk (%) in RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 12 Daily average of milk Total Solids yield (kg /d)) in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 13 Daily average of Energy Corrected Milk (kg /d)) in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.078 
AL x d P = 0.83 
RC x d P = 0.069 
RC Linear P = 0.049 
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Figure 14 Daily Feed efficiency (ECM/DMI) of RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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AL vs RC P = 0.022 
Trt x d P = 0.1 
RC Linear P = 0.015 
 
AL vs RC P = 0.81 
AL x d P = 0.93 
RC x d P = 0.007 
RC Linear P = 0.001 
 
Figure 15 Daily Feed efficiency (Milk yield/DMI) of RC (Feed Restriction Control group) and AL (Ad libitum feeding 
group). Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL 
and RC) are marked with † (P < 0.10) and * (P < 0.05) 
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Figure 16 Daily Energy Balance (MJ/d) of RC (Feed Restriction Control group) and AL (Ad libitum feeding group). 
Values are given in Least Square Means (LSM) and ± standard error. Differences between treatments (AL and RC) 
are marked with † (P < 0.10) and * (P < 0.05) 
Figure 17 Daily average of milk urea nitrogen (mg/dL) in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.007 
Day < .0001 
Trt x d P = 0.79 
RC Quad. P = 0.004 
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Figure 18 Daily average plasma concentrations of Non Esterified Fatty Acids (NEFA) in RC (Feed Restriction Control 
group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05).  
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Figure 19 NEFA concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05).  
AL vs RC P = 0.001 
AL x d P = 0.14 
RC x d P < .0001 
RC Quad. P < .0001 
 
AL vs RC P = 0.0011 
AL x h P = 0.092 
RC x h P < .0001 
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Figure 20 Daily average plasma concentrations of Insulin in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P ≤ 0.10) and * (P ≤ 0.05). 
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Figure 21 Insulin concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P ≤ 0.10) and * (P ≤ 0.05). 
AL vs RC P = 0.013 
AL x d P = 0.38 
RC x d P < .0001 
AL Quad. P = 0.068 
RC Quad. P < .0001 
 
AL vs RC P = 0.013 
Hour P < .0001 
Trt x h P = 0.99 
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Figure 22 Daily plasma concentrations pre-feeding of Leptin in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.32 
AL x d P = 0.3 
RC x d P = 0.8778 
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Figure 23 Daily average plasma concentrations of Glucagon in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.67 
AL x d P = 0.016 
RC x d P = 0.13 
AL Quad. P = 0.013 
RC Linear P = 0.055 
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Figure 24 Glucagon concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05 
AL vs RC P = 0.67 
Hour P = 0.67 
Trt x h P = 0.99 
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Figure 25 Daily average plasma concentrations of Glucose in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 26 Glucose concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05 
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Figure 27 Daily plasma concentrations pre-feeding of Triglycerides in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 28 Daily plasma concentrations pre-feeding of Cholesterol in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 29 Daily average plasma concentrations of β-hydroxybutyrate (BHBA) in RC (Feed Restriction Control 
group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 30 BHBA concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 31 Daily plasma concentrations pre-feeding of Albumin in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
Figure 32 Daily plasma concentrations pre-feeding of Globulin in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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AL vs RC P = 0.053 
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Figure 33 Daily plasma concentrations pre-feeding of Total Protein in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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AL vs RC P = 0.2507
Day P = 0.53
AL x d P = 0.018
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AL Quad. P = 0.027
Figure 34 Daily plasma concentrations pre-feeding of Haptoglobin in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 36 Daily plasma concentrations pre-feeding of Total Bilirubin (TB) in RC (Feed Restriction Control group) 
and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 35 Daily plasma concentrations pre-feeding of Serum Amyloid A in RC (Feed Restriction Control group) and 
AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 37 Daily plasma concentrations pre-feeding of Alkaline Phosphatase Total (APT) in RC (Feed Restriction 
Control group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard 
error. Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 38 Daily plasma concentrations pre-feeding of Aspartate Aminotransferase (AST) in RC (Feed Restriction 
Control group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard 
error. Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 39 Daily plasma concentrations pre-feeding of γ-Glutamyl Transferase (GGT) in RC (Feed Restriction Control 
group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 40 Daily plasma concentrations pre-feeding of Glutamate Dehydrogenase (GLDH) in RC (Feed Restriction 
Control group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard 
error. Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 41 Daily average plasma concentration of Blood Urea Nitrogen (BUN) in RC (Feed Restriction Control 
group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 42 Blood Urea Nitrogen (BUN) concentration by hour relative to feeding in RC (Feed Restricted control) and 
AL (Ad Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) 
and ± standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same 
Upper case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked 
with † (P < 0.10) and * (P < 0.05). 
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Figure 43 Daily average plasma concentrations of Ammonia (NH3) in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 44 Ammonia (NH3) concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.35 
Day P = 0.046 
AL Linear P = 0.1 
 
AL vs RC P = 0.35 
Hour P < .0001 
Trt x h P = 0.82 
163 
 
   
Figure 45 Daily average plasma concentrations of Glutamate in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 46 Glutamate concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 47 Daily average plasma concentrations of Proline in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 48 Proline concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 49 Daily average plasma concentrations of Hydroxyproline in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 50 Hydroxyproline concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 51 Daily average plasma concentrations of Asparagine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 52 Asparagine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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AL Quad. P = 0.16 
RC Quad. P = 0.001 
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Figure 53 Daily average plasma concentrations of Histidine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 54 Histidine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 55 Daily average plasma concentrations of 3-Methylhistidine in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 56 3-Methylhistidine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 57 Daily average plasma concentrations of 1-Methylhistidine in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 58 1-Methylhistidine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 59 Daily average plasma concentrations of β-Alanine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 60 β-Alanine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 62 Carnosine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 61 Daily average plasma concentrations of Carnosine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 63 Daily average plasma concentrations of Alanine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 64 Alanine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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AL Linear P = 0.05 
RC Quad. P < .0001 
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Figure 65 Daily average plasma concentrations of Valine in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 66 Valine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.64 
AL x d P = 0.048 
RC x d P < .0001 
RC Quad. P = 0.001 
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Figure 67 Daily average plasma concentrations of Isoleucine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 68 Isoleucine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.80 
AL x d P = 0.14 
RC x d P = 0.038 
AL Linear P = 0.044 
RC Linear P = 0.027 
 
AL vs RC P = 0.8 
Hour P = 0.045 
Trt x h P = 0.99 
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Figure 69 Daily average plasma concentrations of Leucine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 70 Leucine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± standard 
error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper case letter are 
not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † (P < 0.10) and * 
(P < 0.05). 
AL vs RC P = 0.33 
AL x d P = 0.093 
RC x d P < .0001 
AL Quad. P = 0.09 
RC Quad. P = 0.001 
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AL vs RC P = 0.001
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Figure 71 Daily average plasma concentrations of Tyrosine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 72 Tyrosine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.001 
Hour P < .0001 
Trt x h P = 0.98 
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Figure 73 Daily average plasma concentrations of Tryptophan in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 74 Tryptophan concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.37 
AL x d P = 0.523 
RC x d P < .0001 
RC Quad. P = 0.012 
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Figure 75 Daily average plasma concentrations of Phenylalanine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 76 Phenylalanine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 77 Daily average plasma concentrations of Threonine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 78 Threonine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.28 
AL x d P = 0.2 
RC x d P < .0001 
RC Quad. P < .0001 
 
AL vs RC P = 0.28 
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Trt x h P = 0.96 
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Figure 79 Daily average plasma concentrations of Glycine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 80 Glycine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.056 
AL x d P = 0.33 
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AL vs RC P = 0.056 
Hour P < .0001 
Trt x h P = 0.98 
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Figure 81 Daily average plasma concentrations of Sarcosine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 82 Sarcosine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.96 
AL x d P = 0.53 
RC x d P = 0.002 
RC Linear P = 0.028 
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Hour P = 0.11 
Trt x h P = 0.99 
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Figure 83 Daily average plasma concentrations of Serine in RC (Feed Restriction Control group) and AL (Ad libitum 
feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 84 Serine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 85 Daily average plasma concentrations of Phosphoserine in RC (Feed Restriction Control group) and AL 
(Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 86 Phosphoserine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 87 Daily average plasma concentrations of Ethanolamine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 88 Ethanolamine (PEA) concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
185 
 
  
1.8
1.9
2
2.1
2.2
2.3
2.4
2.5
1 2 3 4 5
P
h
o
sp
h
o
et
h
an
o
la
m
in
e 
(µ
m
o
l/
d
l)
Day
RC
AL
AL vs RC P = 0.8
AL x d P = 0.89
RC x d P = 0.06
RC Linear P = 0.054
Figure 89 Daily average plasma concentrations of Phosphoethanolamine (PEA) in RC (Feed Restriction Control 
group) and AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. 
Differences between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
1.8
1.85
1.9
1.95
2
2.05
2.1
2.15
2.2
2.25
2.3
-1 0 3 4 5 9
P
h
o
sp
h
o
et
h
an
o
la
m
in
e 
(µ
m
o
l/
d
l)
Hour relative to feeding
RC
AL
AL vs RC P = 0.8
Hour P = 0.1
Trt x h P = 0.96
Figure 90 Phosphoethanolamine (PEA) concentration by hour relative to feeding in RC (Feed Restricted control) 
and AL (Ad Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means 
(LSM) and ± standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with 
same Upper case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are 
marked with † (P < 0.10) and * (P < 0.05). 
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Figure 91 Daily average plasma concentrations of α-Amino Butyric Acid in RC (Feed Restriction Control group) and 
AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 92 α-Amino Butyric Acid concentration by hour relative to feeding in RC (Feed Restricted control) and AL 
(Ad Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) 
and ± standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same 
Upper case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked 
with † (P < 0.10) and * (P < 0.05). 
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Figure 93 Daily average plasma concentrations of Methionine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
Figure 94 Methionine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
188 
 
 
0.02
0.04
0.06
0.08
0.1
0.12
0.14
1 2 3 4 5
C
ys
te
in
e 
(µ
m
o
l/
d
l)
Day
RC
AL
AL vs RC P = 0.15
AL x d P = 0.066
RC x d P = 0.011
RC Quad. P = 0.15
Figure 95 Daily average plasma concentrations of Cysteine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 96 Cysteine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 97 Daily average plasma concentrations of Cystathionine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 98 Cystathionine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad 
Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
190 
 
  
4.5
5
5.5
6
6.5
7
7.5
8
8.5
1 2 3 4 5
Ta
u
ri
n
e 
(µ
m
o
l/
d
l)
Day
RC
AL
AL vs RC P = 0.97
AL x d P = 0.79
RC x d P = 0.97
Figure 99 Daily average plasma concentrations of Taurine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 100 Taurine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05).   
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Figure 101 Daily average plasma concentrations of Lysine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 102 Lysine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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Figure 103 Daily average plasma concentrations of α-Amino Adipic Acid in RC (Feed Restriction Control group) and 
AL (Ad libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences 
between treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 104 α-Amino Adipic Acid concentration by hour relative to feeding in RC (Feed Restricted control) and AL 
(Ad Libitum control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) 
and ± standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same 
Upper case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked 
with † (P < 0.10) and * (P < 0.05). 
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Figure 105 Daily average plasma concentrations of Arginine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 106 Arginine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
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AL x d P = 0.69 
RC x d P = 0.62 
 
AL vs RC P = 0.008 
AL x h P < .0001 
RC x h P <.0001 
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Figure 107 Daily average plasma concentrations of Citrulline in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 108 Citrulline concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.074 
AL x d P = 0.37 
RC x d P < .0001 
RC Quad. P = 0.001 
 
AL vs RC P = 0.074 
Hour P < .0001 
Trt x h P = 0.99 
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Figure 109 Daily average plasma concentrations of Ornithine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 110 Ornithine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.66 
AL x d P = 0.16 
RC x d P = 0.007 
RC Quad. P = 0.048 
 
AL vs RC P = 0.66 
Hour P < .0001 
Trt x h P = 0.93 
196 
 
 
0.25
0.3
0.35
0.4
0.45
0.5
0.55
0.6
1 2 3 4 5
A
sp
ar
ta
te
 (
µ
m
o
l/
d
L)
Day
RC
AL
Figure 111 Daily average plasma concentrations of Aspartate in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
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Figure 112 Aspartate concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.13 
AL x d P = 0.59 
RC x d P = 0.0001 
RC Linear P < .0001 
 
AL vs RC P = 0.13 
Hour P = 0.004 
Trt x h P = 0.22 
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Figure 113 Daily average plasma concentrations of Glutamine in RC (Feed Restriction Control group) and AL (Ad 
libitum feeding group). Values are given in Least Square Means (LSM) and ± standard error. Differences between 
treatments (AL and RC) are marked with † (P < 0.10) and * (P < 0.05). 
a
a
a
a
a
a
A A A A A A
17
19
21
23
25
27
29
31
33
-1 0 3 4 5 9
G
lu
ta
m
in
e 
(µ
m
o
l/
d
L)
Hour relative to feeding
RC
AL
* *
*
*
Figure 114 Glutamine concentration by hour relative to feeding in RC (Feed Restricted control) and AL (Ad Libitum 
control). Average of the 5 days experimental period. Values are given in Least Square Means (LSM) and ± 
standard error. Bars with same lower case letter are not significant different at P<0.05. Bars with same Upper 
case letter are not significant different at P<0.05. Differences between treatments (AL and RC) are marked with † 
(P < 0.10) and * (P < 0.05). 
AL vs RC P = 0.03 
AL x d P = 0.95 
RC x d P = 0.07 
RC Linear P = 0.16 
AL vs RC P = 0.03 
Hour P < .0001 
AL x h P = 0.42 
RC x h P = 0.45 
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TABLES 
                            Table 1 Composition of diet fed as Total Mixed Ration 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     Table 2 EAA balance during feed restriction (RC) 
AA 
Absorbed 
(g/d) 
Required 
(g/d) 
Balance 
(g/d) 
% Req % MP 
MET 28 57.4 -29.4 48.70% 2.18% 
LYS 87.9 160.7 -72.7 54.70% 6.86% 
ARG 86.1 107.7 -21.6 79.90% 6.72% 
THR 61.8 85.9 -24.1 72.00% 4.82% 
LEU 100.3 214.6 -114.3 46.70% 7.83% 
ILE 65.4 116 -50.6 56.40% 5.10% 
VAL 72.5 126.6 -54.1 57.30% 5.66% 
HIS 34.7 53.5 -18.8 64.90% 2.71% 
PHE 64.7 119 -54.3 54.40% 5.04% 
TRP 18.1 33.4 -15.3 54.20% 1.41% 
TOTAL  619.5  AVG 58.92%  
  
Item 
 
     
Ingredient  % DM Chemical composition % DM 
 
Corn silage 34.12 
 
Dry matter 51.87 
 
Alfalfa silage 5.50 
 
Crude protein 16.47 
 
Wheat straw 1.00 
 
RUP 6.61 
 
Cottonseed fuzzy 5.00 
 
RDP 9.86 
 
Corn grain 17.00 
 
Soluble CP 5.17 
 
Soybean hulls pellet 7.26 
 
ADF 17.51 
 
Molasses beet 5.15 
 
NDF 28.90 
 
Soybean meal 47.5% 5.94 
 
peNDF 17.49 
 
Soyplus 4.90 
 
Lignin 2.89 
 
Corn gluten feed dry 4.81 
 
NFC 41.06 
 
Wheat midds 3.00 
 
Starch 28.59 
 
Energy Booster 100 1.64 
 
Sugar  6.534 
 
ProvAAl Advantage® 1.50 
 
Fat total 5.41 
 
Limestone ground 1.22 
 
NEl (Mcal/kg) 1.67 
 
Sodium bicarbonate 0.75 
   
 
Biotin 0.39 
   
 
Calcium phosphate 0.38 
   
 
Salt white 0.20 
   
 
Min/Vit premix 0.17 
   
 
Magnesium Oxide 0.05 
   
 
Vitamin A premix 0.02 
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Table 3 LS means per treatment 
Variable Treatments  P-value 
Production variables AL RC SE ALvsRC1 Day Trt*Day Hour Trt*Hour Diet2 Diet*Day Diet*Hour ALvsRES3 
Dry Matter Intake (kg) 27.5a 12.4b 1.91 <.0001 0.042 0.94 -- -- <.0001 0.003 -- <.0001 
Body Weight (kg) 671a 634b 8.84 0.001 <.0001 0.001 -- -- 0.001 0.001 -- 0.001 
Energy Balance (MJ/d) -11.3a -43.1ab 14.30 0.031 <.0001 0.47 -- -- 0.002 0.1 -- 0.005 
Feed Efficiency (kg milk/kg DM) 2.35 2.28 0.12 0.81 <.0001 0.056 -- -- 0.96 0.056 -- 0.86 
Feed Efficiency (kg ECM/kg DM) 1.93a 2.66b 0.14 0.022 <.0001 0.1 -- -- 0.011 0.49 -- 0.012 
Milk weight (kg) 37.7a 30.5b 2.00 0.002 <.0001 0.047 -- -- <.0001 0.001 -- 0.057 
Energy Corrected Milk (kg) 36.2 33.3 3.91 0.078 <.0001 0.14 -- -- 0.06 0.54 -- 0.065 
Milk protein             
 % 3.09a 2.95b 0.06 0.034 <.0001 0.12 -- -- 0.011 0.032 -- 0.003 
kg 1.15a 0.9b 0.07 <.0001 <.0001 <.0001 -- -- <.0001 0.001 -- <.0001 
Milk Fat             
 % 3.13b 4.30ab 0.37 0.005 0.003 0.34 -- -- 0.001 0.03 -- 0.001 
kg 1.15 1.30 0.21 0.99 0.51 0.28 -- -- 0.71 0.93 -- 0.75 
Lactose             
 % 4.66 4.56 0.10 0.2 <.0001 0.31 -- -- 0.39 0.64 -- 0.34 
kg. 1.75a 1.38b 0.07 <.0001 <.0001 0.015 -- -- 0.001 0.005 -- 0.001 
Total Solids             
% 16.71 16.86 0.35 0.67 0.19 0.052 -- -- 0.049 0.022 -- 0.049 
kg 6.1a 5.14ab 0.33 0.007 <.0001 0.097 -- -- 0.005 0.09 -- 0.005 
Milk Urea Nitrogen (mg/dL)  10.48a 15.27b 1.34 0.007 <.0001 0.79 -- -- 0.04 0.09 -- 0.013 
Energy-Related Metabolites and Hormones             
Non Esterified Fatty Acid (mEq/L) 0.062a 0.324b 0.09 0.001 <.0001 <.0001 <.0001 0.12 <.0001 <.0001 0.003 0.001 
Insulin (µg/L) 0.64a 0.44b 0.13 0.013 <.0001 <.0001 <.0001 0.97 0.015 <.0001 0.071 0.011 
Glucose (mg/dL) 64.4a 59.3b\ 2.47 0.041 <.0001 <.0001 <.0001 0.89 0.26 0.03 0.75 0.083 
Hydroxy-Butyrate (mmol/L) 0.62 0.59 0.15 0.46 <.0001 0.064 <.0001 0.99 0.99 0.025 0.14 0.56 
Glucagon (pg/ml) 48.5 51.4 11.45 0.67 0.002 0.005 0.67 0.99 0.98 0.001 0.86 0.87 
Leptin (ng/ml) 4.99 4.87 0.12 0.32 <.0001 0.01 -- -- 0.061 0.12 -- 0.06 
Acute-Phase Response             
Total Protein (g/dL) 7.76 7.746 0.13 0.92 <.0001 0.36 -- -- 0.52 0.71 -- 0.53 
Albumin (g/dL) 3.253a 3.108b 0.06 0.053 0.4 0.11 -- -- 0.83 0.96 -- 0.84 
Globulin (g/dL) 4.563 4.542 0.10 0.83 <.0001 0.45 -- -- 0.97 0.73 -- 0.73 
Haptoglobin (mg/ml) 0.92 0.82 0.21 0.25 0.53 0.14 -- -- 0.62 0.023 -- 0.5 
Serum Amyloid A (ng/ml) 109 83 58.09 0.44 0.47 0.79 -- -- 0.96 0.67 -- 0.9 
Liver Function variables             
Alkaline Phosphatase Total (U/L) 38.9 36.5 1.41 0.18 0.08 0.69 -- -- 0.042 0.028 -- 0.071 
Aspartate Aminotransferase (U/L) 73.3 74.9 4.61 0.73 <.0001 0.31 -- -- 0.72 0.69 -- 0.99 
Gamma-Glutamyl Transferase (U/L) 28.42 28.39 1.03 0.98 <.0001 0.05 -- -- 0.099 0.21 -- 0.15 
Total Bilirubin (mg/dL) 0.167b 0.265a 0.05 0.0123 <.0001 0.11 -- -- 0.001 0.001 -- 0.001 
Glutamate Dehydrogenase (U/L) 51 59 21.72 0.2 <.0001 0.94 -- -- 0.48 0.94 -- 0.5 
Cholesterol Total (mg/dL) 190.9 195.3 5.91 0.47 0.001 0.46 -- -- 0.11 0.53 -- 0.16 
Triglycerides (mg/dL) 8.04a 10.54b 1.04 0.015 <.0001 0.54 -- -- 0.02 0.37 -- 0.029 
Protein Metabolism variables             
Aspartate (μmol/dl) 0.480 0.401 0.05 0.13 <.0001 <.0001 0.004 0.22 0.25 0.002 0.1 0.41 
Alanine (μmol/dl) 19.7 18.5 1.70 0.23 <.0001 <.0001 <.0001 0.34 0.16 0.001 0.62 0.25 
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Table 3 (cont.) LS means per treatment 
Serine (μmol/dl) 8.20 8.03 0.85 0.73 <.0001 <.0001 <.0001 0.99 0.23 0.001 0.69 0.33 
Threonine (μmol/dl) 7.21 6.44 0.82 0.28 <.0001 <.0001 <.0001 0.96 0.4 0.001 0.49 0.34 
Cysteine (μmol/dl) 0.064 0.086 0.03 0.15 <.0001 <.0001 0.13 0.97 0.048 0.001 0.63 0.048 
Isoleucine (μmol/dl) 10.04 9.91 1.03 0.8 <.0001 0.023 0.045 0.99 0.85 0.11 0.39 0.8 
Leucine (μmol/dl) 21.2 19.0 1.90 0.63 <.0001 <.0001 <.0001 0.99 0.24 0.001 0.68 0.19 
Valine (μmol/dl) 26.4 24.4 4.02 0.64 <.0001 <.0001 0.28 <.0001 0.57 0.001 0.79 0.35 
Tyrosine (μmol/dl) 5.59a 4.04b 0.49 0.001 <.0001 <.0001 <.0001 0.98 0.001 <.0001 0.42 0.001 
Phenylalanine (μmol/dl) 5.47a 4.18b 0.56 0.032 <.0001 <.0001 <.0001 0.94 0.041 <.0001 0.75 0.1 
Tryptophan (μmol/dl) 3.02 2.81 0.23 0.37 <.0001 0.002 <.0001 0.91 0.72 0.2 0.62 0.63 
Histidine (μmol/dl) 4.94 4.85 0.33 0.17 <.0001 <.0001 0.042 0.99 0.17 <.0001 0.81 0.15 
Asparagine (μmol/dl) 4.07 3.75 0.48 0.47 <.0001 <.0001 <.0001 0.35 0.36 <.0001 0.39 0.42 
Proline (μmol/dl) 8.84 8.18 1.12 0.24 <.0001 <.0001 <.0001 0.91 0.082 <.0001 0.3 0.19 
 Ornithine (μmol/dl) 4.12 4.35 0.55 0.66 <.0001 0.015 <.0001 0.93 0.23 0.31 0.72 0.27 
Citrulline (μmol/dl) 8.98 10.89 0.95 0.074 <.0001 <.0001 <.0001 0.99 0.16 0.001 0.15 0.077 
Glycine (μmol/dl) 29.0a 36.1b 3.96 0.056 <.0001 <.0001 <.0001 0.98 0.21 0.57 0.14 0.1 
Methionine (μmol/dl) 1.92 1.95 0.21 0.77 <.0001 <.0001 <.0001 0.56 0.89 0.002 0.3 0.88 
Arginine (μmol/dl) 6.09a 7.73b 0.59 0.008 <.0001 <.0001 <.0001 <.0001 0.022 0.066 0.036 0.003 
Lysine (μmol/dl) 4.57b 6.20a 1.15 0.051 <.0001 0.038 <.0001 <.0001 0.043 0.25 0.38 0.001 
Glutamine (μmol/dL) 23.2a 28.0b 2.09 0.03 <.0001 <.0001 <.0001 0.097 0.089 0.3 0.27 0.022 
Glutamate (μmol/dl) 4.32 4.03 0.25 0.095 0.35 <.0001 <.0001 <.0001 0.25 0.004 0.003 0.25 
Urea (μmol/dl) 426 530 54.64 0.077 <.0001 <.0001 <.0001 0.99 0.3 <.0001 0.91 0.058 
NH3 (μmol/dl) 9.53 10.18 0.72 0.35 0.046 0.24 <.0001 0.32 0.86 0.97 0.5 0.83 
α- AAA (µmol/dl) 0.68b 0.848ab 0.10 0.12 <.0001 0.27 0.43 <.0001 0.87 0.12 0.91 0.4 
3-Methylhistidine (μmol/dl) 0.197b 0.244b 0.06 0.56 <.0001 <.0001 <.0001 0.99 0.027 <.0001 0.94 0.027 
1-Methylhistidine (μmol/dl) 0.963 0.935 0.07 0.57 <.0001 0.13 0.006 0.88 0.44 0.37 0.63 0.44 
Carnosine (µmol/dl) 1.13 0.12 0.20 0.99 <.0001 0.039 <.0001 0.99 0.94 0.2 0.72 0.94 
Sarcosine (µmol/dl) 0.64 0.48 0.17 0.96 <.0001 <.0001 0.11 0.83 0.29 0.003 0.75 0.44 
Hydroxyproline (µmol/dl) 1.03ab 1.13a 0.17 0.22 0.1 0.66 0.002 0.75 0.61 0.78 0.98 0.93 
Cystathionine (µmol/dl) 0.135 0.143 0.04 0.93 <.0001 <.0001 0.047 0.88 0.36 0.003 0.22 0.51 
β-Alanine (µmol/dl) 0.247 0.240 0.06 0.98 <.0001 <.0001 0.099 0.96 0.99 0.68 0.87 0.99 
Phosphoethanolamine (µmol/dl) 2.11 2.14 0.18 0.8 0.065 0.001 0.1 0.96 0.5 0.6 0.59 0.5 
Ethanolamine  (µmol/dl) 0.395 0.383 0.03 0.69 0.033 0.028 0.27 0.97 0.88 0.12 0.81 0.88 
α-Amino Butyric Acid  (µmol/dl) 1.77 1.89 0.22 0.5 <.0001 <.0001 0.02 0.99 0.64 0.036 0.97 0.64 
Taurine  (µmol/dl) 6.47 6.05 1.14 0.97 <.0001 0.002 <.0001 0.93 0.93 0.37 0.76 0.99 
P-Serine (μmol/dl) 1.371 1.322 0.10 0.78 <.0001 <.0001 0.13 0.99 0.59 0.59 0.41 0.44 
1 Contrast statement between ad libitum (AL) and restricted control (RC) treatments 
2 Effect of feed condition among all the treatments: fed (AL) or restricted (RC, LYS, MSG, GLN, VAL, GLC)  
3 Contrast statement between ad libitum (AL) and the group of restricted treatments (RES; RC, LYS, MSG, GLN, VAL, GLC) 
a,b LS means within a row with different superscripts differ (P < 0.05) 
 
 
Table 4 LS means per diet and day 
Variables  Days
1   
Production variables  1 2 3 4 5 SE 
Dry Matter Intake (kg) AL 26.4b 28.1ab 29.5a 27.9ab 25.5b 1.34 
 RES 12.9 13.0 12.9 12.9 12.6 0.95 
Energy Balance (MJ/d) AL -12.7 -2.1 -14.3 -4.1 -15.6 15.04 
 RES -63.0
b -49.7a -43.9a -40.8a -38.0a 3.69 
Feed Efficiency (milk yield/ DM) AL 2.24 2.35 2.28 2.32 2.40 0.25 
 RES 2.754
a 2.37b 2.185bc 2.116c 2.111c 0.07 
Feed Efficiency (ECM/DM) AL 2.05 1.83 1.83 1.81 1.92 0.29 
 RES 2.908 2.623 2.500 2.468 2.404 0.08 
Milk weight (lb.) AL 35.8 38.3 38.6 38.2 35.7 1.74 
 RES 35.8
a 31.6b 29.1c 28.3c 27.2c 0.91 
Energy Corrected Milk (lb.) AL 37.1 35.5 37.6 35.6 34.0 3.14 
 RES 37.9 34.6 32.8 32.6 30.5 1.77 
Milk protein        
 % AL 3.05 3.11 3.12 3.08 2.99 0.06 
 RES 3.05
a 3.03a 2.91b 2.85c 2.80c 0.02 
kg. AL 1.09 1.19 1.20 1.18 1.07 0.05 
 RES 1.08
a 0.95b 0.84c 0.80cd 0.76d 0.02 
Milk Fat        
 % AL 3.71 2.73 3.07 2.81 3.16 0.41 
 RES 3.76
b 4.17a 4.52a 4.52a 4.56a 0.14 
kg. AL 1.29 1.02 1.17 1.04 1.04 0.18 
 RES 1.38 1.32 1.30 1.33 1.23 0.09 
Lactose        
 % AL 4.653 4.679 4.645 4.623 4.655 0.06 
 RES 4.667 4.662 4.599 4.551 4.537 0.02 
kg. AL 1.677 1.801 1.800 1.771 1.668 0.09 
 RES 1.676
a 1.479b 1.341c 1.290c 1.246c 0.03 
Total Solids        
% AL 7.82 7.47 7.59 7.43 7.58 0.17 
 RES 7.726
b 7.887a 7.932a 7.890a 7.809ab 0.05 
kg. AL 6.13 6.25 6.42 6.19 5.86 0.38 
 RES 6.12
a 5.49b 5.06c 4.94c 4.71c 0.19 
Milk Urea Nitrogen (mg/dL)  AL 11.5 11.1 12.1 11.6 11.6 1.36 
 RES 12.12
c 15.36a 14.01b 13.49bc 13.66abc 0.58 
Energy Corrected Milk (kg) AL 37.1 35.5 37.6 35.6 34.0 3.14 
 RES 37.9 34.6 32.8 32.6 30.5 1.77 
Energy-Related Metabolites and Hormones        
Non Esterified Fatty Acid (mEq/L) AL 0.111 0.097 0.096 0.099 0.118 0.07 
 RES 0.119
a 0.311b 0.391c 0.371bc 0.358bc 0.03 
Insulin (µg/L) AL 0.55 0.69 0.66 0.53 0.46 0.13 
 RES 0.741
a 0.367b 0.273c 0.289bc 0.297c 0.03 
Glucose (mg/dL) AL 64.7 65.2 63.0 63.3 64.7 3.09 
 RES 65.36
a 60.64b 59.05c 59.01c 59.76bc 0.80 
Hydroxy-Butyrate (mmol/L) AL 0.56 0.60 0.58 0.57 0.56 0.10 
 RES 0.532
a 0.557a 0.639b 0.719c 0.735c 0.03 
Glucagon (pg/ml) AL 37.5c 45.3bc 53.6a 55.1ab 47.6abc 6.91 
 RES 51.6
a 50.3a 48.6a 41.9b 45.0ab 2.24 
Leptin (ng/ml) AL 4.86 5.03 5.01 5.11 4.94 0.15 
 RES 5.014 4.872 4.767 4.704 4.596 0.07 
Acute-Phase Response        
Total Protein (g/dL) AL 7.66 7.81 7.71 7.65 7.85 0.16 
 RES 7.673 7.853 7.961 7.786 7.878 0.05 
Albumin (g/dL) AL 3.226 3.270 3.235 3.237 3.270 0.05 
 RES 3.208 3.250 3.260 3.218 3.253 0.02 
Globulin (g/dL) AL 4.48 4.64 4.54 4.51 4.68 0.13 
 RES 4.460 4.613 4.688 4.555 4.638 0.04 
Haptoglobin (mg/mL) AL 0.80ab 0.79ab 0.74a 0.90ab 1.34b 0.25 
 RES 0.912 0.924 0.964 0.890 0.933 0.08 
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Table 4 (cont.) LS means per diet and day 
Serum Amyloid A (ng/mL) AL 86 68 100 140 166 56.87 
 RES 109 112 120 113 140 18.32 
Liver Function Variables        
Alkaline Phosphatase Total (U/L) AL 38.6 37.8 38.1 38.5 39.8 1.55 
 RES 37.12
bc 38.06c 36.80bc 35.55ab 34.77a 0.85 
Aspartate Aminotransferase (U/L) AL 79.0 77.1 73.1 70.4 69.1 5.01 
 RES 76.4 77.0 76.6 69.7 66.4 1.64 
Gamma-Glutamyl Transferase (U/L) AL 28.28 29.55 28.88 26.55 28.55 0.96 
 RES 28.47 29.93 30.39 29.36 29.42 0.31 
Total Bilirubin (mg/dL) AL 0.181 0.176 0.142 0.176 0.176 0.05 
 RES 0.169
c 0.286b 0.349a 0.311ab 0.286ab 0.02 
Glutamate Dehydrogenase (U/L) AL 56.9 52.9 50.3 50.1 47.3 17.79 
 RES 72.5 61.0 47.8 37.5 29.6 5.84 
Cholesterol Total (mg/dL) AL 189.4 192.8 190.5 189.2 188.8 6.24 
 RES 191.5 195.7 200.6 199.9 203.1 2.05 
Triglycerides (mg/dL) AL 7.6 7.0 7.4 7.4 8.0 1.27 
 RES 7.75 10.33 10.83 10.46 10.29 0.42 
Protein Metabolism Variables        
Aspartate (μmol/dl) AL 0.468 0.500 0.471 0.518 0.504 0.05 
 RES 0.535
a 0.479b 0.448c 0.412c 0.381d 0.02 
Alanine (μmol/dl) AL 21.3 20.3 20.2 18.9 18.2 1.31 
 RES 22.87
a 18.03b 17.51b 17.86b 17.42b 0.40 
Serine (μmol/dl) AL 8.19 8.22 8.36 8.16 7.17 0.60 
 RES 9.02
a 7.32b 6.88c 7.23bc 7.09bc 0.19 
Threonine (μmol/dl) AL 7.36 7.25 7.42 7.13 6.51 0.62 
 RES 8.27
a 6.35b 6.14b 6.52b 6.22b 0.19 
Cysteine (μmol/dl) AL 0.074 0.073 0.049 0.059 0.063 0.02 
 RES 0.0862
b 0.0959b 0.0870b 0.1106a 0.1199a 0.01 
Isoleucine (μmol/dl) AL 10.83 10.47 10.54 9.77 8.93 0.94 
 RES 11.25
a 10.16bc 10.26c 10.93ab 10.12c 0.49 
Leucine (μmol/dl) AL 21.6 21.2 22.1 20.9 18.6 1.83 
 RES 23.0
a 19.0bc 18.5c 19.7b 18.1c 1.14 
Valine(μmol/dl) AL 27.9ab 26.8ab 27.8a 26.2ab 23.4b 2.30 
 RES 29.8
a 25.00ab 24.5c 25.8b 24.1c 1.38 
Tyrosine (μmol/dl) AL 5.77 5.79 5.94 5.48 4.95 0.41 
 RES 6.66
a 4.52b 3.67cd 3.61c 3.35d 0.12 
Phenylalanine (μmol/dl) AL 5.37 5.60 5.89 5.53 5.34 0.40 
 RES 5.37
c 4.45ab 4.4263a 4.69b 4.60ab 0.12 
Tryptophan (μmol/dl) AL 3.18 2.99 3.02 2.99 2.93 0.20 
 RES 3.461 3.233 3.058 3.009 2.824 0.06 
Histidine (μmol/dl) AL 5.43a 5.48a 5.46a 5.26a 4.75b 0.32 
 RES 6.00
a 4.83b 4.38c 4.56bc 4.49c 0.10 
Asparagine (μmol/dl) AL 4.05 4.06 4.22 4.11 3.69 0.34 
 RES 5.04
a 3.73b 3.35c 3.62b 3.31c 0.10 
Proline (μmol/dl) AL 9.16 9.02 9.37 9.15 8.31 0.75 
 RES 9.99
a 7.61b 6.98c 7.47b 7.24bc 0.24 
Ornithine (μmol/dl) AL 4.43 4.11 4.28 4.15 3.78 0.41 
 RES 5.23 4.85 4.46 4.40 4.09 0.13 
Citrulline (μmol/dl) AL 9.39 9.12 9.46 9.69 9.56 0.74 
 RES 9.51
c 10.96ab 10.61ab 10.87a 10.30bc 0.24 
Glycine (μmol/dl) AL 31.2 30.1 29.8 30.9 29.3 2.99 
 RES 31.48 30.44 31.89 33.95 33.64 0.94 
Methionine (μmol/dl) AL 1.95 1.94 2.04 1.84 1.80 0.15 
 RES 2.3
a 1.9b 1.9b 1.9b 1.8b 1.96 
Arginine (μmol/dl) AL 6.63 6.20 6.38 6.25 6.28 0.50 
 RES 7.09
b 7.28b 7.56b 8.12a 7.39b 0.16 
Lysine (μmol/dl) AL 5.58 5.16 5.11 4.81 4.90 0.49 
 RES 6.17 6.04 6.27 6.65 6.02 0.18 
Glutamine (μmol/dl) AL 24.9 24.6 25.2 24.9 24.5 1.84 
 RES 28.88 26.53 26.43 27.37 26.71 0.77 
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Table 4 (cont.) LS means per diet and day 
Glutamic Acid (μmol/dl) AL 4.05 4.31 4.35 4.28 4.44 0.22 
 RES 4.27
a 4.15ab 4.03ab 4.01b 4.00b 0.14 
Urea (μmol/dl) AL 471 464 470 477 473 39.78 
 RES 472
c 600a 533b 493c 473c 13.10 
NH3 (μmol/dl) AL 9.73 9.67 9.59 9.35 9.38 0.59 
 RES 9.78 9.88 9.76 9.78 9.70 0.20 
α- AAA (µmol/dl) AL 0.694 0.703 0.682 0.699 0.680 0.07 
 RES 0.601
c 0.643c 0.709b 0.775a 0.758ab 0.03 
3-Methylhistidine (μmol/dl) AL 0.162b 0.192ab 0.189ab 0.198ab 0.243a 0.05 
 RES 0.198
d 0.258d 0.336b 0.3683a 0.371a 0.02 
1-Methylhistidine (μmol/dl) AL 0.893 0.938 0.978 0.978 1.005 0.06 
 RES 0.946 0.982 1.053 1.076 1.040 0.02 
Carnosine (µmol/dl) AL 1.13 1.13 1.12 1.15 1.13 0.16 
 RES 1.252 1.181 1.102 1.082 1.066 0.05 
Sarcosine (µmol/dl) AL 0.54 0.54 0.57 0.57 0.53 0.16 
 RES 0.490
c 0.589b 0.650a 0.697a 0.714a 0.06 
Hydroxyproline (µmol/dl) AL 0.97 0.87 0.92 0.90 0.87 0.20 
 RES 0.961 0.899 0.926 0.954 0.900 0.06 
Cystathionine (µmol/dl) AL 0.135ab 0.133b 0.144a 0.146a 0.129b 0.02 
 RES 0.1511
a 0.1319b 0.1296b 0.1399b 0.1325b 0.01 
β-Alanine (µmol/dl) AL 0.251 0.255 0.261 0.255 0.236 0.05 
 RES 0.262 0.259 0.240 0.247 0.222 0.02 
Phosphoethanolamine (µmol/dl) AL 2.17 2.15 2.16 2.09 2.08 0.15 
 RES 2.188 2.154 2.244 2.280 2.252 0.05 
Ethanolamine  (µmol/dl) AL 0.366 0.386 0.396 0.421 0.408 0.03 
 RES 0.4053
a 0.3947ab 0.4a 0.3867ab 0.3723b 0.01 
α-Amino Butyric Acid  (µmol/dl) AL 1.46c 1.62bc 1.89a 2.00ab 1.89abc 0.19 
 RES 1.559
d 1.734c 1.826b 2.078a 2.013a 0.06 
Taurine  (µmol/dl) AL 6.2 6.7 6.5 7.0 6.5 1.05 
 RES 5.61 6.15 6.50 7.11 6.85 0.43 
P-Serine (μmol/dl) AL 1.442 1.402 1.364 1.325 1.268 0.08 
  RES 1.368 1.322 1.294 1.285 1.264 0.03 
1 LS means per day and per feed condition (AL or RES). Data from treatments where values were significantly modified by 
the infusion, were removed from the calculations 
a,b,c,d LS means within a row with different superscripts differ (P < 0.05) 
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               Table 5 P-values from the contrast statements to test linear and quadratic trends of daily averages 
Variable Treatments 
 AL RC RES
1 
Production Variables Linear Quad Linear Quad Linear Quad 
Dry Matter Intake 0.34 <.0001 0.95 0.89 0.40 0.34 
Energy Balance (MJ/d) 0.78 0.19 0.053 0.94 0.001 0.077 
Feed Efficiency (kg milk/kg DM) 0.68 0.87 0.001 0.45 <0.0001 <0.0001 
Feed Efficiency (kg ECM/kg DM) 0.79 0.48 0.016 0.97 <.0001 0.043 
Milk weight (kg.) 0.91 0.063 0.001 0.91 <0.0001 <0.0001 
Energy Corrected Milk (lb.) 0.47 0.67 0.049 0.53 <0.0001 0.18 
Milk protein       
 % 0.60 0.015 <0.0001 0.47 <0.0001 0.82 
kg 0.71 0.002 <0.0001 0.59 <0.0001 <0.0001 
Milk Fat       
 % 0.42 0.16 0.098 0.21 0.000 0.026 
kg 0.42 0.60 0.78 0.43 0.55 0.71 
Lactose       
 % 0.57 0.60 <0.0001 0.74 <0.0001 0.79 
kg 0.82 0.076 <0.0001 0.91 <0.0001 <0.0001 
Total Solids       
% 0.28 0.16 0.11 0.10 0.30 0.001 
kg 0.60 0.23 0.001 0.65 <0.0001 0.003 
Milk Urea Nitrogen (mg/dL)  0.65 0.56 0.62 0.004 0.52 0.001 
Energy Corrected Milk (kg.) 0.47 0.67 0.049 0.53 <0.0001 0.18 
Energy-Related Metabolites and Hormones             
Non Esterified Fatty Acid (mEq/L) 0.97 0.53 0.002 <.0001 <.0001 <.0001 
Insulin (µg/L) 0.31 0.068 <.0001 <.0001 <.0001 <.0001 
Glucose (mg/dL) 0.89 0.55 0.001 0.001 0.083 0.041 
Hydroxy-Butyrate (mmol/L) 0.74 0.56 0.042 0.66 <.0001 0.77 
Glucagon (pg/ml) 0.074 0.011 0.055 0.86 0.001 0.45 
Leptin (ng/ml) 0.61 0.24 0.57 0.48 <.0001 0.54 
Acute-Phase Response       
Total Protein (g/dL) 0.82 0.68 0.71 0.33 0.035 0.008 
Albumin (g/dL) 0.88 0.90 0.28 0.032 0.37 0.36 
Globulin (g/dL) 0.6742 0.5657 0.6287 0.7812 0.009 0.0053 
Haptoglobin (mg/ml) 0.2106 0.0273 0.2107 0.9186 0.834 0.6488 
Serum Amyloid A (ng/ml) 0.3842 0.2898 0.8534 0.9883 0.23 0.7095 
Liver Function Variables       
Alkaline Phosphatase Total (U/L) 0.71 0.39 0.018 0.65 0.002 0.067 
Aspartate Aminotransferase (U/L) 0.16 0.93 0.25 0.28 <.0001 0.009 
Gamma-Glutamyl Transferase (U/L) 0.43 0.97 0.76 0.84 0.21 0.001 
Total Bilirubin (mg/dL) 0.81 0.50 0.15 0.12 <.0001 <.0001 
Glutamate Dehydrogenase (U/L) 0.79 0.98 0.042 0.41 <.0001 0.62 
Cholesterol Total (mg/dL) 0.64 0.91 0.21 0.19 <.0001 0.18 
Triglycerides (mg/dL) 0.68 0.74 0.17 0.001 0.001 0.001 
Protein Metabolism parameters       
Aspartate (μmol/dl) 0.62 0.85 <.0001 0.11 <.0001 0.31 
Alanine (μmol/dl) 0.051 0.77 0.015 <.0001 <.0001 <.0001 
Serine (μmol/dl) 0.41 0.056 0.055 0.001 <.0001 <.0001 
Threonine (μmol/dl) 0.25 0.27 0.015 <.0001 <.0001 <.0001 
Cysteine (μmol/dl) 0.43 0.22 0.40 0.15 <.0001 0.011 
Isoleucine (μmol/dl) 0.044 0.33 0.027 0.22 0.060 0.091 
Leucine (μmol/dl) 0.37 0.090 0.001 0.001 <.0001 <.0001 
Valine(μmol/dl) 0.27 0.20 0.037 0.001 0.03 <.0001 
Tyrosine (μmol/dl) 0.099 0.093 <.0001 <.0001 <.0001 <.0001 
Phenylalanine (μmol/dl) 0.74 0.045 0.001 <.0001 <.0001 <.0001 
Tryptophan (μmol/dl) 0.25 0.62 0.001 0.012 <.0001 0.13 
Histidine (μmol/dl) 0.06 0.043 0.001 <.0001 <.0001 <.0001 
Asparagine (μmol/dl) 0.67 0.16 <.0001 0.001 <.0001 <.0001 
Proline (μmol/dl) 0.62 0.20 0.001 0.001 <.0001 <.0001 
Ornithine (μmol/dl) 0.36 0.81 0.018 0.048 <.0001 0.053 
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Table 5 (cont.)  P-values from the contrast statements to test linear and quadratic trends of daily averages 
 
Citrulline (μmol/dl) 0.49 0.73 0.091 0.001 0.001 <.0001 
Glycine (μmol/dl) 0.91 0.99 0.27 0.90 0.040 0.022 
Methionine (μmol/dl) 0.32 0.36 0.004 0.097 <.0001 <.0001 
Arginine (μmol/dl) 0.40 0.49 0.42 0.62 0.001 <.0001 
Lysine (μmol/dl) 0.54 0.68 0.79 0.74 0.07 0.001 
Glutamine (μmol/dl) 0.49 0.83 0.16 0.33 0.55 <.0001 
Glutamate (μmol/dl) 0.06 0.52 0.059 0.015 0.10 0.062 
Urea (μmol/dl) 0.97 0.84 0.51 <.0001 0.12 <.0001 
NH3 (μmol/dl) 0.26 0.99 0.47 0.11 0.36 0.53 
α- AAA (µmol/dl) 0.92 0.88 0.002 0.070 <.0001 0.032 
3-Methylhistidine (μmol/dl) 0.003 0.46 <.0001 0.20 <.0001 <.0001 
1-Methylhistidine (μmol/dl) 0.033 0.42 0.49 0.019 <.0001 <.0001 
Carnosine (µmol/dl) 0.86 0.99 0.090 0.29 <.0001 0.006 
Sarcosine (µmol/dl) 0.94 0.53 0.028 0.97 <.0001 0.003 
Hydroxyproline (µmol/dl) 0.60 0.83 0.85 0.26 0.51 0.84 
Cystathionine (µmol/dl) 0.98 0.21 0.31 0.93 0.003 0.001 
β-Alanine (µmol/dl) 0.61 0.42 0.41 0.14 0.001 0.46 
Phosphoethanolamine (µmol/dl) 0.35 0.86 0.054 0.44 0.010 0.66 
Ethanolamine  (µmol/dl) 0.12 0.41 0.59 0.070 0.007 0.25 
α-Amino Butyric Acid  (µmol/dl) 0.011 0.007 <.0001 0.091 <.0001 0.005 
Taurine  (µmol/dl) 0.58 0.50 0.87 0.49 <.0001 0.030 
P-Serine (μmol/dl) 0.001 0.72 0.17 0.68 0.004 0.049 
1 RES: group of treatments under feed restriction (RC, MSG, GLN, VAL, LYS, GLC) 
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Table 6 LS means per diet and hour relative to feeding 
Variable Hours relative to feeding/infusion1   
Energy-Related Metabolism Variables -1 0 3 4 5 14 SE 
Non Esterified Fatty Acid (mEq/L) 0.479c 0.519c 0.121a 0.112a 0.123a 0.313b 0.022 
Insulin (µg/L) 0.309c 0.287c 0.490ab 0.524a 0.548a 0.384b 0.043 
Glucose (mg/dL) 61.3bc 62.0b 59.6bc 59.0c 61.0b 66.1a 1.308 
Hydroxy-Butyrate (mmol/L) 0.423a 0.419a 0.797c 0.818c 0.813c 0.517b 0.041 
Glucagon (pg/ml) 44.9 46.8 46.8 47.6 48.7 50.4 2.493 
Protein Metabolism Variables        
Aspartate (μmol/dl) 0.429a 0.470b 0.468ab 0.446ab 0.437ab 0.471ab 0.019 
Alanine (μmol/dl) 19.72ab 19.11b 17.77c 17.45c 17.45c 21.29a 0.448 
Serine (μmol/dl) 8.47a 8.18a 7.21b 6.98b 6.87b 8.45a 0.244 
Threonine (μmol/dl) 7.60a 7.44a 6.42b 6.03bc 5.84c 7.13a 0.205 
Cysteine (μmol/dl) 0.1008 0.0957 0.0898 0.0934 0.0997 0.0891 0.007 
Isoleucine (μmol/dl) 11.05a 10.90ab 10.18ab 9.99b 9.98b 10.77ab 0.545 
Leucine (μmol/dl) 20.9b 20.5b 18.3c 17.9c 18.1c 22.7a 1.269 
Valine(μmol/dl) 27.6 27.3 30.2 31.2 31.0 28.6 1.019 
Tyrosine (μmol/dl) 5.19a 4.86a 4.20b 4.03b 4.04b 5.05a 0.148 
Phenylalanine (μmol/dl) 5.10b 4.97b 4.44c 4.34c 4.45c 5.59a 0.128 
Tryptophan (μmol/dl) 3.320a 3.247a 2.888b 2.890b 2.965b 3.310a 0.064 
Histidine (μmol/dl) 5.15a 5.08ab 4.96ab 4.79ab 4.68b 4.93ab 0.123 
Asparagine (μmol/dl) 4.28a 4.06a 3.59b 3.45b 3.33b 4.27a 0.114 
Proline (μmol/dl) 8.67b 8.30bc 7.64cd 7.27d 7.15d 9.41a 0.263 
 Ornithine (μmol/dl) 5.02ab 5.03a 4.52bc 4.19d 4.06d 4.33cd 0.219 
Citrulline (μmol/dl) 11.57a 11.37a 10.37b 9.66c 9.04d 9.65bcd 0.253 
Glycine (μmol/dl) 36.3a 35.7a 29.3b 27.2c 26.9c 34.8a 1.065 
Methionine (μmol/dl) 2.214a 2.172a 1.913b 1.790c 1.715c 2.025b 0.048 
Arginine (μmol/dl) 8.04a 7.88ab 7.62b 7.16c 6.73d 7.16cd 0.136 
Lysine (μmol/dl) 7.39a 7.41a 8.80ab 8.47bc 7.80c 6.08c 0.331 
Glutamine (μmol/dl) 26.28ab 25.49b 28.20a 27.09ab 25.99b 26.65ab 0.790 
Glutamate (μmol/dl) 3.84c 3.68d 4.45a 4.45a 4.40a 4.12b 0.123 
Urea (μmol/dl) 513bc 529bc 576a 560ab 526c 373d 14.996 
NH3 (μmol/dl) 10.37c 9.98b 9.60ab 9.23ab 9.21a 9.98bc 0.200 
α- AAA (µmol/dl) 0.730 0.717 0.768 0.799 0.812 0.731 0.030 
3-Methylhistidine (μmol/dl) 0.298ab 0.292ab 0.288b 0.278b 0.275b 0.313a 0.015 
1-Methylhistidine (μmol/dl) 1.034a 1.024ab 1.006ab 0.990ab 0.969b 1.042a 0.020 
Carnosine (µmol/dl) 1.240a 1.198a 1.075b 1.060b 1.072b 1.170a 0.051 
Sarcosine (µmol/dl) 0.594 0.603 0.625 0.606 0.616 0.660 0.040 
Hydroxyproline (µmol/dl) 0.998a 1.002a 0.879ab 0.918ab 0.869b 0.927ab 0.050 
Cystathionine (µmol/dl) 0.140ab 0.145a 0.137ab 0.134ab 0.131b 0.140ab 0.010 
β-Alanine (µmol/dl) 0.259 0.252 0.254 0.238 0.237 0.241 0.022 
Phosphoethanolamine (µmol/dl) 2.195 2.153 2.254 2.256 2.256 2.143 0.047 
Ethanolamine  (µmol/dl) 0.4000 0.3980 0.3948 0.3829 0.3925 0.3856 0.010 
α-Amino Butyric Acid  (µmol/dl) 1.899a 1.926a 1.833a 1.788a 1.702b 1.843ab 0.074 
Taurine  (µmol/dl) 6.53ab 6.21a 6.58a 6.06a 6.04a 7.23b 0.378 
P-Serine (μmol/dl) 1.337 1.315 1.330 1.303 1.314 1.293 0.026 
1 LS means per hour relative to feeding/beginning of daily infusion and per feed condition (AL or RES). Data from treatments 
where values were significantly modified by the infusion, were removed from the calculations. Average of the 5 treatment 
days. 
a,b,c,d LS means within a row with different superscripts differ (P < 0.05) 
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Table 7 P-values of the slice statement from the significant interactions between Trt and Day effects 
Variables Treatments 
Production Variables RC AL 
Milk yield (kg) 0.008 0.39 
Feed Efficiency (milk yield/DM) 0.007 0.94 
Feed Efficiency (ECM/DM) 0.15 0.96 
Protein % <.0001 0.17 
Protein yield (kg) 0.001 0.43 
Lactose Yield (kg) <.0001 0.44 
Total Solids % 0.028 0.10 
Total Solids Yield (kg) 0.002 0.68 
Energy/Liver metabolism Variables   
NEFA <.0001 0.14 
BHBA 0.16 0.80 
Insulin <.0001 0.38 
Glucose <.0001 0.79 
Glucagon 0.128 0.02 
Leptin 0.88 0.30 
Albumin 0.16 0.97 
Haptoglobin 0.43 0.027 
Gamma-Glutamyl Transferase 0.39 0.061 
Total Bilirubin 0.040 0.46 
Protein Metabolism Variables   
Arginine 0.62 0.69 
Citrulline <.0001 0.38 
Ornithine 0.008 0.16 
Aspartate 0.001 0.59 
Glutamine 0.070 0.95 
Glutamate 0.005 0.21 
Valine <.0001 0.049 
Leucine <.0001 0.093 
Isoleucine 0.038 0.14 
Tyrosine <.0001 0.16 
Tryptophan <.0001 0.53 
Phenylalanine <.0001 0.25 
Glycine 0.005 0.33 
Serine <.0001 0.074 
Methionine 0.001 0.60 
Cysteine 0.011 0.066 
Histidine <.0001 0.035 
Lysine 0.48 0.57 
Threonine <.0001 0.20 
Asparagine <.0001 0.32 
Proline <.0001 0.13 
Alanine <.0001 0.34 
 Urea <.0001 0.88 
NH3 0.020 0.73 
Carnosine 0.27 0.92 
3-Methylhistidine  <.0001 <.0001 
1-Methylhistidine 0.23 0.088 
P-Serine 0.90 0.004 
Sarcosine 0.002 0.53 
Cystathionine 0.23 0.014 
β-Alanine 0.38 0.80 
Phosphoethanolamine 0.060 0.89 
Ethanolamine 0.030 0.47 
α-ABA 0.001 0.002 
Taurine 0.97 0.79 
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Table 8 P-values of the slice statement from the significant interactions between Trt and Hour effects 
    Treatment 
Variable Trt*Hour RC AL 
NEFA 0.124 <.0001 0.092 
Arginine <.0001 <.0001 <.0001 
Glutamine 0.097 0.45 0.43 
Glutamate <.0001 0.002 0.17 
Valine <.0001 0.75 0.67 
Lysine <.0001 <.0001 0.018 
α- AAA <.0001 0.73 0.97 
 
Table 9 Pearson correlation coefficients for milk yield (kg/d), milk components, DIM and BW 
Variables Milk 
Production 
Milk Fat 
% 
 Protein 
% 
 Lactose 
% 
Total 
Solids % 
Milk Urea 
Nitrogen 
Days in 
milk 
Body 
Weight 
Milk Production 1 -0.309 -0.351 0.271 -0.257 -- -0.465 0.253 
Milk Fat % -0.309 1 0.220 -0.327 0.882 0.445 0.339 -0.118 
 Protein % -0.351 0.220 1 -0.563 0.187 -- 0.214 0.141 
 Lactose % 0.271 -0.327 -0.563 1 -- -0.031 -- -0.363 
Total Solids % -0.257 0.882 0.187 -- 1 0.430 0.353 -0.291 
Milk Urea Nitrogen -- 0.445 -- -- 0.430 1 -- -0.209 
Days in milk -0.465 0.339 0.214 -- 0.353 -- 1 -- 
Body Weight 0.253 -0.118 0.141 -0.363 -0.291 -0.209 -- 1 
 
 
 
 
 
 
 
 
 
Table 10 Pearson correlation coefficients for plasma amino acids concentrations (µmol/dL) 
Variables Day Urea Asp Thr Ser Glu Gln Gly Ala Val Cys Met Ile Leu Tyr Phe Trp NH3 Lys His Arg Asn Pro Cit Orn 
Day 
1 -- -0.21 -0.24 -0.29 -- -- 0.08 -0.28 -- 0.10 -0.23 -0.07 -0.21 -0.55 -0.15 -0.27 -- -- -0.34 0.08 -0.36 -0.29 0.11 -0.26 
Urea 
-- 1 -0.27 0.13 -0.22 -0.15 0.23 -0.29 -- 0.09 0.18 0.10 0.29 0.11 -0.09 -0.50 0.18 -0.17 0.11 0.23 0.23 -- -- 0.59 0.21 
Aspartate 
-0.21 -0.27 1 -- 0.08 0.58 -0.13 0.16 0.08 -- -- 0.08 -- -- 0.22 0.34 -- 0.41 -0.16 -- -0.07 0.07 -- -0.27 -- 
Threonine 
-0.24 0.13 -- 1 0.67 -- 0.38 0.28 0.61 0.23 -- 0.82 0.64 0.69 0.73 0.40 0.71 -- 0.07 0.71 0.47 0.80 0.76 0.48 0.63 
Serine 
-0.29 -0.22 0.08 0.67 1 -0.10 0.32 0.55 0.57 -- -- 0.61 0.16 0.33 0.64 0.43 0.41 0.12 -- 0.60 0.34 0.79 0.71 0.17 0.46 
Glutamate 
-- -0.15 0.58 -- -0.10 1 0.16 -0.14 -0.08 0.12 -- -- -- -0.08 -- 0.21 -- -- -0.13 -- -- -0.08 -0.17 -0.31 -- 
Glutamine 
-- 0.23 -0.13 0.38 0.32 0.16 1 0.17 0.20 -- 0.08 0.37 0.25 0.15 0.22 -- 0.25 -0.32 0.09 0.56 0.48 0.44 0.37 0.26 0.50 
Glycine 
0.08 -0.29 0.16 0.28 0.55 -0.14 0.17 1 0.14 -0.07 0.13 0.23 -- 0.07 0.15 0.27 0.16 0.29 -- 0.32 0.26 0.41 0.31 0.15 0.29 
Alanine 
-0.28 -- 0.08 0.61 0.57 -0.08 0.20 0.14 1 -- -0.23 0.56 0.26 0.43 0.55 0.32 0.49 0.22 -- 0.67 0.25 0.61 0.79 0.20 0.40 
Valine 
-- 0.09 -- 0.23 -- 0.12 -- -0.07 -- 1 0.19 0.27 0.49 0.44 0.20 0.15 0.32 0.10 -0.08 0.12 0.09 0.15 0.08 0.17 0.17 
Cysteine 
0.10 0.18 -- -- -- -- 0.08 0.13 -0.23 0.19 1 -- 0.18 0.18 -- -- -- -- -- 0.09 0.12 -- -- 0.19 0.07 
Methionine 
-0.23 0.10 0.08 0.82 0.61 -- 0.37 0.23 0.56 0.27 -- 1 0.61 0.62 0.72 0.44 0.64 0.08 0.08 0.62 0.54 0.74 0.64 0.36 0.66 
Isoleucine 
-0.07 0.29 -- 0.64 0.16 -- 0.25 -- 0.26 0.49 0.18 0.61 1 0.88 0.48 0.27 0.57 -- 0.13 0.42 0.43 0.47 0.43 0.55 0.47 
Leucine 
-0.21 0.11 -- 0.69 0.33 -0.08 0.15 0.07 0.43 0.44 0.18 0.62 0.88 1 0.66 0.43 0.62 -- -- 0.53 0.25 0.60 0.63 0.45 0.44 
Tyrosine 
-0.55 -0.09 0.22 0.73 0.64 -- 0.22 0.15 0.55 0.20 -- 0.72 0.48 0.66 1 0.61 0.58 0.12 -- 0.64 0.24 0.81 0.69 0.15 0.52 
Phenylalanine 
-0.15 -0.50 0.34 0.40 0.43 0.21 -- 0.27 0.32 0.15 -- 0.44 0.27 0.43 0.61 1 0.43 0.22 -- 0.22 0.17 0.44 0.35 -0.22 0.23 
Tryptophan 
-0.27 0.18 -- 0.71 0.41 -- 0.25 0.16 0.49 0.32 -- 0.64 0.57 0.62 0.58 0.43 1 0.09 0.08 0.60 0.33 0.58 0.57 0.33 0.51 
NH3 
-- -0.17 0.41 0.03 0.12 -- -0.32 0.29 0.22 0.10 -- 0.08 -- -- 0.12 0.22 0.09 1 -- 0.10 -- 0.12 0.17 -- -- 
Lysine 
-- 0.11 -0.16 -- -- -0.13 0.09 -- -- -0.08 -- 0.08 0.13 -- -- -- 0.08 -- 1 -- 0.55 0.09 -- -- 0.36 
Histidine 
-0.34 0.23 -- 0.71 0.60 -- 0.56 0.32 0.67 0.12 0.09 0.62 0.42 0.53 0.64 0.22 0.60 0.10 -- 1 0.32 0.78 0.81 0.36 0.61 
Arginine 
0.08 0.23 -0.07 0.47 0.34 -- 0.48 0.26 0.25 0.09 0.12 0.54 0.43 0.25 0.24 0.17 0.33 -- 0.55 0.32 1 0.44 0.28 0.48 0.70 
Asparagine 
-0.36 -- 0.07 0.80 0.79 -0.08 0.44 0.41 0.61 0.15 -- 0.74 0.47 0.60 0.81 0.44 0.58 0.12 0.09 0.78 0.44 1 0.80 0.36 0.60 
Proline 
-0.29 -- -- 0.76 0.71 -0.17 0.37 0.31 0.79 0.08 -- 0.64 0.43 0.63 0.69 0.35 0.57 0.17 -- 0.81 0.28 0.80 1 0.36 0.50 
Citrulline 
0.11 0.59 -0.27 0.48 0.17 -0.31 0.26 0.15 0.20 0.17 0.19 0.36 0.55 0.45 0.15 -0.22 0.33 -- -- 0.36 0.48 0.36 0.36 1 0.37 
Ornithine 
-0.26 0.21 -- 0.63 0.46 -- 0.50 0.29 0.40 0.17 0.07 0.66 0.47 0.44 0.52 0.23 0.51 -- 0.36 0.61 0.70 0.60 0.50 0.37 1 
 
